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The foreign body response (FBR) comprises a general, ubiquitous host tissue-based 
reaction to implanted materials, often resulting in device failure due to an aggressive host attack 
by immune cells, degrading materials, providing a toxic environment to nearby cells and 
stimulating a fibroproliferative response often resulting in subsequent encapsulation. The 
increasing use of implantable materials and devices necessitates an increased understanding of 
the body’s response to implanted materials, and a better ability to screen the materials’ behavior 
in vitro for predicting in vivo performance and designing more compatible materials.  This work 
has focused on gaining a greater understanding of the in vitro behavior of both primary and 
secondary cells used to study the FBR and their respective ability to represent in vivo responses.  
We found that macrophages and fibroblasts in co-culture yielded more representative responses 
of in vivo signaling, than during mono-culture. We also identified fibroblasts that were capable of 
forming multinucleate giant cells in culture, and determined in vitro conditions in which 
macrophages senesce.  Throughout these studies, we identified variations between primary- and 
secondary-derived macrophages and fibroblasts, and conclude that secondary cells in culture 
often have unrepresentative behavior of in vivo responses, and their use should be substantiated 
by primary-sourced cells.  We further identified unique cell behavior in primary cultures that must 
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Impact of the foreign body response  
The use of biomedical implants, commonplace in current surgical practice to replace and 
repair tissue functions, is increasing with the aging population [1-3].  Though implants are 
successful in many cases and can improve the lives of those who receive them, they are 
notoriously plagued by insult from the host immune system and often fail. The failure rate of 
medical implants varies due to the type of implant, the material used, the age of the patient, as 
well as the genetics of the patient.  For example, some implants such as silicone breast implants 
are prone to capsule contracture in greater than 50% of cases, and complications requiring repeat 
surgeries due to pain, contracture, rupture, infection, and implant migration are also as high as 
50% after 10 years [4-6].  Hydrocephalus shunts have a failure rate of nearly 40% in pediatric 
patients within the first year [7-9].  Other implants such as total joint replacements have a far 
lower failure rate around 4% in total knee replacements (though that still accounts for over 22,000 
failures annually) [10] and 6% in total hip replacements [11, 12]. Host attack can greatly impede 
sensing implants such as neural recording electrodes which fail during chronic implantation [13] 
and glucose sensors that suffer from progressive loss of signal [14].  Though glucose sensors 
have made recent improvements (the Dexcom® SEVEN® system is now FDA approved for 7 
days compared to the previously approved 3 days for  the Medtronic MiniMed Paradigm System), 
longer term implantation is still a goal scientists are working towards.   
                                                 
1 This introduction has been adapted from the book chapter: Holt DJ, Grainger DW. Host 





Every material implanted in the body elicits some type of graded “foreign body response” 
(FBR), an abnormal, unresolved host healing response experienced over the life of the host, or a 
clinical nightmare if sufficiently adverse. Though improvements are continually being made and 
implants can succeed, the high failure rate of many implants requires increased focus. On-going 
efforts to improve biocompatible implant materials that reliably integrate with host tissue [15] 
without adverse events have not yet provided ideal materials performance, nor yielded design 
criteria for engineering this integration.  
“Host response” refers to the sum total of molecular, cellular, organ, tissue and systemic 
consequences on host physiology as a result of device implantation.  Though attempts have been 
made to fully characterize the FBR at the level of the complete human body, the organ, the 
specific tissue site, and the cell, it still remains an elusive phenomenon. The emerging picture is 
that the FBR is indeed a complex interaction of many cell types communicating back and forth 
with many different cell-cell and soluble protein-based signaling cues that elicit both normal and 
abnormal tissue-level responses.  These signals are all elicited and processed by cells at the 
implant site to produce their global FBR response.  This then compels further analysis at the 
cellular level to understand the basis for these processes and how they might relate to the 
concept of “implant biocompatibility”.  Discrimination of events from tolerated versus failed 
implants at the cellular level could enable changes to molecular aspects of both materials and 
drugs that could modulate cell interactions in the FBR, and thus improve implant compatibility.  
At the cellular level, the host macrophage cell is considered the primary modulator of the 
FBR, responding to early neutrophil activation from acute implantation trauma, invading and 
surveying the wound site and implant, and activating in situ by secreting cell signals (cytokines, 
enzymes and reactive oxygen species, ROS) attempting to orchestrate the resulting tissue 
response.  This response in the absence of a biomaterial, typically produces normal healing.  
However, in the presence of a biomaterial, the healing response goes awry, producing the FBR. 
 This chapter describes aspects of the foreign body response to implanted materials, the 
role of in vitro models in understanding this response, and details regarding the roles of 





The foreign body response  
All medical device implantations into human hosts, even a syringe needle insertion into skin, 
create wounds.  During normal wound repair, host tissue undergoes acute inflammation, scarring, 
tissue reconstruction, and remodeling [16]. Only in instances of unresolved infection in the wound 
will chronic inflammation recur. However, the presence of a foreign material interrupts the normal 
wound healing response, and the inflammatory phase persists in modified form, leading to a 
pathological condition at the implant site termed the “foreign body response” (FBR). The FBR is 
characterized by implant-associated cell activation, excessive fibrosis, inflammation, coagulation, 
possible infection and compromised healing.  This is coupled with distinct cellular, histological, 
and biochemical events localized at the implant site. Upon implantation, initial blood- or 
extravascular fluid-material interactions coat the implant with a surface-bound protein layer 
composed of many different soluble proteins. The adsorbed protein matrix primarily governs in 
vivo cellular interactions (cells rarely, if ever, see a bare implant surface) and thus can determine 
host integration or rejection of the introduced biomaterial.  The protein layer is a key event in the 
host response to implanted materials and how cells perceive this “invasion” but there are few 
methods known to actually control this layer adequately in vivo.  Cell responses to this layer 
generally cause release of cell signaling factors to recruit additional cells and induce wound 
healing.  Acute inflammatory responses produced early by infiltrating polymorphonuclear 
leukocytes (PMNs, including neutrophils) are generally resolved quickly (≤3 weeks [17]) and may 
appear normal.  However, subsequent chronic inflammatory events persist at the implant site [18, 
19] accompanying all implanted materials and eliciting an exaggerated and prolonged 
pathological response that counteracts normal healing processes.  These unresolved events 
result in numerous complications, including compromised healing, fibrotic reactions, pain, tissue 
resorption, and increased infection rates [20]. The FBR is ostensibly involved in various implant 
complications [16] including necrosis of nearby cells due to the abnormal inflammatory and toxic 
environment [21], osteolysis and sepsis in total joint replacements [22], fibrous encapsulation of 
prosthetics [23] and sensors [24], stress cracking in pacemaker wires [25] and general materials 
degradation [26] and failure [27, 28] in vivo. Hallmark implant-associated events include: 




• Cell interactions with adsorbed proteins on the implant surface 
• Production of and response to cell cytokines both at and adjacent to the implant site 
• Interaction with and activation of other cell types at the implant site 
• Cellular oxidative and respiratory burst activity involving enzymes and reactive 
oxygen species 
• Phagocyte differentiation to macrophage phenotype 
• Formation and persistence of foreign body giant cells near the implant interface 
• Fibrous encapsulation and excessive collagen production following fibroblast 
recruitment and proliferation 
• Granulation tissue formation 
• Chronic abnormalities eliciting unresolved wound healing 
These adverse implant-associated events, their time course, and intensity all vary with 
tissue, anatomical location, and bulk implant material properties, as well as device design. 
Nonetheless, it is now clinically recognized that certain generic aspects of the FBR are common 
to all implanted materials and often preclude effective and complete wound healing.  The concept 
of “biocompatibility” has therefore been modified from an absolute over-arching biomaterials 
criterion to an individualized relative performance-based criterion [29, 30]. Essentially, if the 
patient can live with it safely, it is “biocompatible”.  This result has few design specifications that 
inform the engineer or scientist about how to improve biomaterials.   
 
Macrophages 
The macrophage cell is a member of the mononuclear phagocyte family, a group of 
leukocytes, or white cells, originating in bone marrow as precursors and maturing in specific 
tissue sites to their terminal differentiated state [31]. Implant responses are thought to arise from 
both tissue-resident, mature macrophages, as well as blood-derived, recruited, newly 
differentiated macrophages.  Macrophages are characterized by a spherical concentric nucleus 
containing several nucleoli, typically exhibiting a ruffled margin and many fine cytoplasmic 




healing and healthy immune response, capable of removal or destruction of deleterious materials, 
pathogens, or cells from the body. Macrophages are considered primary modulators of the FBR 
by altering the local inflammatory and wound healing cytokine levels to recruit cells acutely, 
degrade implants, and potentially inducing fibrosis and unresolved inflammation [32]. The FBR 
proceeds through a series of cellular stages, with macrophages central to each phase, 
specifically: 1) blood-derived monocyte wound site infiltration into the wound site in response to 
an acute wounding chemotactic cytokine gradient, 2) differentiation into macrophage phenotypes 
in situ, 3) adhesion to and activation at the implant surface, 4) fusion with resident cells to yield 
FBGCs at the implant surface [18, 19] and 5) interaction with invading fibroblasts to stimulate 
excessive collagen and proteoglycans by the fibroblasts.  
Monocytes, as macrophage precursors, arise from bone marrow progenitor cells and are 
released regularly to travel the blood stream. Monocytes account for 1-6% of the circulating white 
blood cell population, remaining in circulation for 25 to 70 hours [33, 34]. Cues from the injured or 
traumatized tissue (i.e., surgical implantation) cause monocytes to extravasate from the blood 
and enter the tissue site. These monocytes then differentiate into tissue-resident macrophages, 
responding to both physical and chemical cues from tissue injury. Monocytes and macrophages 
have capabilities for excreting numerous pro- and anti-inflammatory cell signals.  Macrophages 
also have the ability to produce pro-angiogenic and pro-healing signals.  As phagocytes, both 
macrophages and neutrophils produce, excrete and use proteases, esterases, and highly 
oxidative chemicals to break down many types of foreign materials.  Once degraded to pieces 
smaller than 6 microns, phagocytes attempt to ingest these materials for further intracellular 
neutralization and digest these materials in phagosomes, lysosomes and endosomes. This is 
routine for macrophage-based clearance of debris, both foreign and natural.  However, 
biomaterials are often designed to be nondegradable and nonphagocytosable (e.g., as large 
ceramic, metal, and polymer devices).  Nevertheless, macrophages will attempt to degrade all 
materials, continuously excreting their arsenal of chemicals as they seek to engulf the material.  
This metabolically exhausting situation in local phagocyte populations, constitutes “frustrated 
phagocytosis” – a syndrome characteristic of cells encountering most nondegrading biomaterials 




cell size, macrophages can undergo fusion [39] to form foreign body giant cells (FBGCs), the 
histological hallmark of the FBR [18]. Macrophages undergoing frustrated phagocytosis often 
form a thin continuous cellular strata (up to two cell layers thick) directly adjacent to the material 
[35, 38]. The foreign body giant cell is generally considered a terminal stage for the phagocyte cell 
lineage in contact with macroscopic nondegrading materials [18, 27, 31], minimally containing 
three nuclei [40] though typically containing greater than twenty nuclei arranged in an irregular 
fashion [18]. FBGCs are not highly phagocytic, but they do exhibit increased lysosomal and 
respiratory enzyme activity [41], and are reported to exhibit fewer cell surface and complement 
receptors [42], suggesting a shift to a task-oriented phenotype directed to removing the insulting 
entity [18, 38]. 
As primary modulators of the FBR, macrophages are involved in many intercellular 
communication pathways between fibroblasts, lymphocytes, neutrophils and other macrophages 
[17, 38, 43] and are thought to stimulate angiogenesis (new vessel growth) at injury sites by 
secreting vascular endothelial growth factor (VEGF) [43].  During normal wound repair, the 
intensity of the signals secreted by macrophages typically allows for tissue repair, remodeling, 
and resolution. However in the presence of a foreign material, this signaling pathway diverges, 
often resulting in chronic inflammation, implant degradation, and fibrosis.  Previous evidence [18, 
19, 37, 44-52] suggests that localized, molecular events targeting macrophages from multiple 
implant site cues ultimately guide and promote abnormal host tissue response to implanted 
foreign bodies. Macrophages express surface receptors capable of sensing physical and 
chemical cues including mannose, deemed critical for FBGC fusion [18, 53, 54], and Fc [55], 
complement [56], lipoprotein, lectin-like, advanced glycosylation end-products (AGE), and 
adhesion and migration receptors. Additionally, macrophages respond to cues from the tissue 
milieu through molecular interactions with cytokine receptors including interleukin-4 (IL-4) [57], 
macrophage- and granulocyte macrophage-colony stimulating factor (M-CSF and GM-CSF) [58], 
and interferon-gamma (IFN-γ) [59] receptors among many others. Finally, macrophages 
coordinate the host tissue response to biomaterials by secreting a wide range (over 100) of 
substances varying in size (32-440,000 kD) and biological activity (from cell growth to cell death) 




well as enzyme inhibitors, complement components, reactive oxygen intermediates, and 
coagulation factors [31].  While many of the cellular and molecular players in the FBR have been 
identified, the precise mechanistic orchestration of these players in the host response to implants 
remains elusive.  As a work in progress, therefore, the ability of the biomedical engineer to alter 
the FBR remains limited until specific cause-effect hypotheses allow new rational design criteria 
to be proposed regarding actual determinants of implant biocompatibility.  
 
Macrophage senescence 
Materials and devices are at risk for infection after implantation, even decades later [20, 
22], despite high densities of macrophages localized to the surface throughout the duration of the 
implant [35, 38].  Over prolonged implant exposure, macrophages can become two-cell layers 
thick around monolithic implants [35, 38], completely infiltrate porous implants [61], and fuse to 
form FBGC at these surfaces [35-39].  That any of these commonly observed chronic responses 
result from macrophage in situ proliferation versus continual recruitment is not clear.  Importantly, 
changes in their resident phenotypes, functional competence and capabilities to address infection 
risk over this implant duration, prompted by or correlated with their prolonged exposure and 
reaction to a foreign body (e.g., implant), are largely unknown.   
This chronic infection risk may be due to the fact that unlike host tissue that is 
continuously renewed, limiting opportunities for bacterial colonization, tissue surrounding 
implanted materials remains relatively unchanged, encapsulated in fibrous scar tissue [17, 38, 62, 
63]. The isolation of the implant from the host as a function of the FBR has been previously 
implicated in the susceptibility of the implant to infection via pathogen colonization [64-68]. 
Furthermore, while abundant macrophages are present, they may be transformed by the isolated 
environment or by their reactions to implants into states of relative inactivity, incapable of 
addressing microbial presence as effectively as during initial implant site recruitment. This could 
thus explain the risk of infection near implants even years after surgical placement of the implant.   
Many cells in normal tissue are quiescent, a reversible nondividing state-of-rest.  
Importantly, quiescent cells can be stimulated to divide [69, 70].  Cells can also become 




mitogenic stimuli [71].  Senescent and quiescent cells are distinguished by altered patterns of 
gene expression [72, 73]. Senescent and quiescent transitions in macrophages at implant 
surfaces could explain their inability to adequately address bacterial infection in vivo in this 
context.    
Previous studies have demonstrated a decreased phagocytic ability in aged 
macrophages [74] and a susceptibility of cells under oxidative stress to senesce [74, 75]. That 
macrophages demonstrate increased intracellular reactive oxygen species with age [76] and 
reside in high oxidative stress environments surrounding foreign bodies [17] could indicate their 
propensity to senesce and their subsequent incompetence to phagocytose pathogens at implant 
surfaces over time. Interestingly, foreign body giant cells, the chronic multinucleated macrophage-
derived phenotypic hallmark surrounding implanted materials, also display decreased phagocytic 
ability [77], and increased lysosomal activity [41, 77], consistent with senescent cells [78] also 
known to multinucleate [79]. Macrophages have also been purported to undergo frustrated 
phagocytosis, an exhausting metabolic phenomenon that could compel macrophages to senesce 
around implants [35-38]. However, macrophage senescence around foreign bodies or in culture is 
not addressed in current literature. 
Macrophages are commonly employed in in vitro assays seeking information on aspects 
of their involvement in pathologies such as cancer, autoimmune diseases, and the foreign body 
response [80-85].  As an immunomodulatory cell, macrophages are highly susceptible to telomere 
attrition [76]. Therefore, macrophage cultures may exhibit increased potential to senesce.  
However, they are not commonly assayed for this senescent phenotype.  As both quiescence and 
senescence alter cell genetic profiles [72, 73], macrophage transitions to these states during in 
vitro culture likely influence assay outcomes. If the phenotypic state of the macrophage during 
culture is inconsistent with the in vivo phenotype it is intended to represent, it could lead to false 
conclusions, irreproducible results, and inconsistencies.  Thus, maintenance of consistent 
macrophage phenotypes and activation states between in vivo and in vitro conditions is likely 
critical to ensuring proper in vitro model fidelity.  Therefore understanding the possible 




both in vitro and in vivo.  Chapter 4 therefore describes macrophage quiescence and senescence 
in various culture conditions. 
 
Fibroblasts and the FBR 
Fibroblasts are the most common connective tissue cell type in the body [86, 87] and are 
effector cells of the FBR responding to cytokines, from surrounding macrophages [38] and 
fibroblasts, such as transforming growth factor (TGFβ) and IL-1β [88] (shown to increase 
fibroblastic collagen production [89-93]). Fibroblasts are nearly universally associated with the 
foreign body response [51] as part of the normal wound stabilization, scarring and remodeling 
process. Correlated with their presence, and normal woundsite production of collagen and 
proteoglycan matrices, is often the presence of an abnormal avascular fibrotic tissue sheath 
(fibrous collagenous capsule) around foreign bodies [17, 38, 62, 63, 94-101]. This often 
impenetrable capsule forms a membrane many microns thick that physically encloses and 
surrounds many types of implants, especially those in soft tissue, in diverse physiological 
placements [19].  The host isolation of the implant from surrounding tissue and associated tissue 
transport systems produces transport and healing problems near implants and is responsible for 
many device failures, such as glucose sensors [102].  
Fibroblasts can become altered in various pathologies such as fibrosis, cancer, aging, 
and the foreign body response (FBR) [38, 103-110].  One phenotypic alteration that is not widely 
acknowledged, but possible is fibroblast multinucleation [108-110].  Additionally, several other 
multinucleated cell types commonly derived from a macrophage cell origin are known including 
foreign body giant cells (FBGCs), Langhans’ cells, and osteoclasts [18]. Significantly, FBGCs can 
form from the fusion of multiple monocytes/macrophages [39] during the FBR mounted by the 
host against implanted biomedical materials [17]. The FBR can cause device failure due to 
degradation by enzymes secreted by macrophages and abnormal collagen production by 
fibroblasts, resulting in an impeding collagen capsule [17, 38, 102]. Though macrophages and 
fibroblasts are both primary FBR effector cells [17, 38], fibroblasts, unlike macrophages, are not 
commonly considered to form multinucleated giant cells. In the context of the FBR, the foreign 




at the surface of an implant [18].  However, the milieu surrounding implants is abnormal, can be 
toxic to cells [21], and has been speculated to stimulate tumorigenesis [111, 112]. This unusual 
environment elicits the formation of FBGCs [113] and may also prompt fibroblasts to alter their 
phenotype and form multinucleated giant cells.   
Previous studies have identified multinucleated cells in vivo ostensibly of fibroblast origin 
[108, 109], one describing cells appearing as “bizarre, atypical fibroblasts with hyperchromatic 
and large, pleomorphic nuclei and multinucleated floret-like giant cells”[110].  Several studies 
describe the presence of multinucleated fibroblasts in vitro [114-117] and in vivo in pathologies 
such as fibrosis and cancer and in aged tissue [103-110].  However, whether these cells 
multinucleate in vitro and in vivo via fusion similar to FBGCs [39] or through nuclear division 
without cytokinesis [114] is unclear. Chapter 3 of this work identifies multinucleate fibroblasts, 
both from primary and secondary cells and their mechanism for formation. 
 
 In vitro models of the FBR 
Though the FBR is a nearly universal response to implanted materials of widely varying 
properties and has been studied for decades, the precise mechanisms by which it is manifested 
are largely unknown. The consequence of not fully understanding this process impedes the 
development of more successful longterm indwelling devices such as glucose sensors, neural 
recorders, orthopedic implants and many other longterm devices [22-24, 27, 28]. A greater 
understanding of the FBR will enable better development of materials and therapies to combat its 
deleterious effects against implanted material.  In vitro models are commonly employed to study 
various mechanistic aspects of the FBR.  
In contrast to complex in vivo models, cell culture in various forms provides a simplified, 
more cost-effective and focused analysis, utilizing fewer animals and enabling higher throughput 
of biomaterials assays. However, as a reductionist approach, these cell culture systems are 
perhaps overly simplified and inaccurate, examining only limited numbers and/or types of cells 
and their responses, and missing much of the essential positive and negative feedback signals 
from key cells necessary to faithfully duplicate in vivo aspects of the FBR. Consequently, in vitro 




One important use of in vitro models is for regulatory approval of materials designed for in 
vivo use. The food and drug administration (FDA) requires ISO 10993 biocompatibility testing 
[118] that is often performed by the use of L-929 secondary mouse fibroblasts.  Common assays 
include direct contact, where the implant is placed directly on a confluent layer of cells, and the 
cells are subsequently tested for toxicity, changes in gene expression, changes in phenotype, 
upregulation of inflammatory markers, etc.  Agar diffusion is also used, where the media is 
removed from a confluent layer of cells and a culture medium containing 2% agar is added above 
the cells.  Material and device samples are then placed over the surface and incubated for 24 
hours.  After this time, the cells are analyzed for viability and other changes listed above.  Another 
common method is minimal essential medium (MEM) elution, where an extracted solution from 
the material is placed on cells to determine if any leachables are harmful to the cells [119-121]. 
These are standard practices for assessing the biocompatibility of a material or a device, but due 
to the simplicity of the in vitro model, these assays may be completely nonrepresentative of the 
response that would be elicited in vivo. 
Understanding the differences between in vivo and current in vitro models, and providing 
some basis for improvements is described in Chapter 2.  This study analyzed and compared 
extended duration in vitro co-cultures of primary and secondary macrophages and fibroblasts, two 
primary effector cells of the FBR [38, 93].  The premise of this study was to elucidate and 
distinguish signaling patterns between these cell types and determine relevant feedback systems 
that may enable more representative in vitro cellular responses to in vivo models, or provide 
evidence for confounding in vitro cell behavior.  
 
Primary versus secondary cells in culture 
Primary cells derived from living tissue can be close representations of in vivo cells, in 
respect to select responses, especially if used immediately postharvest [122].  However, after 
being removed from their extracellular niche and consequently missing integral adhesion proteins 
and dynamic signaling from their host, these cells may lose critical characteristics and behavior 
possessed by their in vivo counterparts. A prime example of this is decreased collagen production 




source, their isolation and purification can be expensive and time consuming.  Additionally, 
imperfect purification methods often result in unwanted contaminating cells in primary cell cultures 
[124]. Isolation and purification of primary cells often require steps including mechanical and 
enzymatic breakdown, centrifugation, labeling, and fluorescence activated cell sorting (FACS) 
that often result in low yields and decreased viability [125]. Primary cells also possess limited 
passaging capacity (i.e., Hayflick limit [126]), and therefore must be isolated frequently. 
Secondary cells or cell lines on the other hand are immortalized, do not undergo 
replicative senescence, and can be passaged and stored theoretically indefinitely. These cells are 
often highly proliferative and can be readily expanded, making their cost trivial in comparison to 
primary cells.  These cells are easily obtained from commercial and private sources and are 
presumed to be 100% pure.  Though not commonly known, secondary cells are frequently 
contaminated with other more aggressive but irrelevant cell types such as HeLa and K562, which 
can obscure assay results [127].   Additionally, their immortalization is often due to upregulation of 
oncogenes and through genetic transformation.  This inherently changes their phenotypes 
compared to the noncancerous in vivo cells they represent and can result in inaccurate models. 
For example, murine RAW 264.7 macrophages are immortalized, transformed 
monocyte/macrophage-like cells frequently utilized in inflammatory assays [128-130]. However, 
these secondary derived immortalized cells are poorly validated and display cellular responses 
distinct from primary cells, such as types and levels of external receptor upregulation, excessive 
internalization rates, rapid proliferation with lack of contact inhibition, and distinct cytokine 
production dynamics [84, 122].    
Though primary and secondary cells are frequently used in assays, they are not 
commonly substantiated for accuracy.  Therefore primary and secondary sourced cells have been 
implemented in each study presented in this body of work in order to further elucidate 








Introduction to this dissertation 
The foreign body response is a ubiquitous in vivo series of events that often results in 
implant failure. Due to their cost effectiveness and simplicity, in vitro models are commonly 
employed to study this phenomenon, but are often unable to recapitulate integral aspects of this 
reaction and may yield inaccurate cellular behaviors and phenotypic responses. This dissertation 
sought to address the hypothesis that cultured cell phenotypes are not representative of in vivo 
cell behavior around implants and these differences are exacerbated in immortalized cell lines 
compared to primary cells. The objective of this body of work was to understand the in vitro 
behavior of both primary and secondary derived cells used to study the foreign body response 
and their respective ability cultured together or alone to represent in vivo responses. This has 
been addressed in the form of several in vitro systems.  
Due to the inability of in vitro models to sufficiently recreate in vivo events, Chapter 2 
aimed to develop a more representative in vitro model and identify feedback mechanisms that 
may be necessary to recapitulate in vivo signaling. Data presented there demonstrated that: 
coculture of macrophages with fibroblasts is more representative of in vivo conditions than 
monocultures of either macrophages or fibroblasts based on cytokine signaling dynamics seen 
during coculture that are also seen in vivo but absent from monoculture; primary macrophages 
demonstrate endotoxin tolerance with repeated exposure to LPS in culture -- more representative 
of in vivo responses than secondary macrophages that did not exhibit this tolerance; and primary 
and secondary macrophages are not equivalent in in vitro culture as shown by disparate 
responses to LPS exposure, cultured morphology, and cytokine production. This work was 
published in Holt DJ, Chamberlain LM, Grainger DW. Cell-cell signaling in co-cultures of 
macrophages and fibroblasts. Biomaterials 2010;31:9382-94. Chapter 5 continues work from 
Chapter 2 in a new preliminary study aiming to develop a more representative in vitro model to 
address multiple aspects of the FBR, including fibrosis, cell migration, and cytokine gradients 
seen in response to an implant.  However because this work is incomplete, it has been placed 
into the future work section as a reasonable initiating project.  
Multinucleated giant cells are considered the hallmark of the foreign body response, but 




establish the existence and mechanism for formation of multinucleated fibroblasts in culture.  
Data presented there demonstrated that fibroblasts, like cultured macrophages, can form 
multinucleated cells in culture; secondary fibroblasts can form multinucleate via fusion with other 
fibroblasts in the presence of secondary macrophage cultures; primary fibroblasts can 
multinucleate in culture with or without the presence of primary or secondary macrophages, but 
not due to fusion, but rather senescence-associated nuclear division without cytokinesis; and 
primary multinucleated fibroblasts stain positive for replicative senescence. This work is published 
in Holt DJ, Grainger DW. Multinucleated giant cells from fibroblast cultures. Biomaterials 
2011;32:3977-87. 
Implants have a propensity for infection even years after implantation, despite being 
ostensibly covered in hundreds of macrophages, potentially due to a decreased state of action 
that macrophages may be in. The response of macrophages to bacterial challenge and stimuli 
may be affected by quiescence and senescence both in vivo and in vitro.  Therefore, Chapter 4 
aimed to determine the potential macrophages have to senesce in culture.  Data presented there 
demonstrated that: primary macrophages undergo quiescence during high confluence cultures 
and senesce during longterm culture; secondary macrophages undergo quiescence during high 
confluence cultures and longterm culture, but do not senesce; senescence is delayed in primary 
macrophages, and quiescence is ameliorated in secondary macrophages in the presence of 
lipopolysaccharide stimulation. This work has been submitted to Biomaterials (December 2011). 
Chapter 5 contains a summary of the accomplishments identified along each aim, plus a 
set of future experiments that I have proposed based on my analysis of strengths and 
weaknesses in my dissertation effort. This future work is focused on substantiating the in vitro 
findings presented here with in vivo models and developing more representative in vitro models of 
the FBR. 
Throughout this work I have attempted to establish high fidelity in vitro models of the 
foreign body response and identify phenotypic behavior of macrophages and fibroblasts in culture 
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The foreign body response (FBR) comprises a general, ubiquitous host tissue-based reaction to implanted
materials. In vitro cell-based models are frequently employed to study FBR mechanisms involving cell
signaling responses to materials. However, these models often study only one cell type, identify only
limited signals, and cannot accurately represent the complexity of in vivo inﬂammatory signaling. To
address this issue, a cell co-culture system involving two primary effector cells of the FBR, macrophages
and ﬁbroblasts, was employed. Cellecell signaling systems were monitored between these cell types,
including long-term 1) culture of one cell type in conditioned media from the other cell type, 2) non-
contacting cell co-cultures (paracrine signaling), and 3) contact co-cultures (juxtacrine signaling) of
primary- and secondary-derived cells. Cell culture media and cell images were collected on Days 1, 2, 3, 7,
14, and 21 and changes in soluble protein secretion, cellular behavior, and morphology were assessed.
Primary- and secondary-derived cells responded uniquely during each signaling scenario and to one
another. In general higher in vitro ﬁdelity to FBR-like responses was found in primary cell co-cultures
compared to their mono-cultures and all secondary cell cultures.
 2010 Elsevier Ltd. All rights reserved.1. Introduction
Implantation of any foreign material into living tissue evokes
a host inﬂammatory response generally described as the foreign
body response (FBR). The FBR e a cascade of cell-based soluble
signaling events e reacts to and modulates the interface between
an implanted device and the host tissue. This host response is
associated with numerous complications including ﬁbrosis, bone
resorption, implant degradation, increased infection rates, delayed
healing, pain, and general device failure [1e3].
In vitro models are commonly employed to study various
mechanistic aspects of the FBR. In contrast to complex in vivo
models, cell culture in various forms provides a simpliﬁed, more
cost-effective and focused analysis, utilizing fewer animals and
enabling higher throughput of biomaterials assays. However, as
a reductionist approach, these cell culture systems are perhaps
overly simpliﬁed and inaccurate, examining only limited numbers
and/or types of cells and their responses, and missing much of the
essential positive and negative feedback signals from key cellsmaceutics and Pharmaceutical
112-5820, USA. Tel.: þ1 801 581
. Grainger).
ering, and Materials Science &
, La Jolla, CA 92093 USA.
td. All rights reserved.necessary to faithfully duplicate in vivo aspects of the FBR. Conse-
quently, in vitromodels may be largely incapable of predicting and
correlating in vivo phenotypes. For example, a signiﬁcant incon-
sistency between in vitro and in vivo models is the observed lack of
inﬂammatory cell (e.g., macrophage) activation in vitro [4e6]. This
has prompted the standard practice of adding lipopolysaccharide
(LPS) [7] or other exogenous activating agents such as IFN-g [8] or
phorbol esters [9] to replicate cell activation seen in vivo [10]
around implants. It has been suggested that the mere presence of
a material in vitro in cell culture may be insufﬁcient to mount
ameaningful cell inﬂammatory responsewithout the use of LPS [5].
However, even LPS stimulation in vitro produces an attenuated
response compared to in vivo LPS activation. Reichert and co-
workers showed that in vitro production of the inﬂammatory
cytokine, IL-6, by secondary macrophages after LPS stimulation
appeared to be non-responsive compared to untreated groups [6].
Their subsequent study showed that in vivo stimulation with LPS
produced a drastic increase in IL-6 production compared to the
non-stimulated group, supporting the contention that in vitro and
in vivo responses were inconsistent [11]. Similarly, Roumestan et. al.
showed that after LPS stimulation, in vivo production of inﬂam-
matory cytokine, TNFa, was nearly double that secreted by in vitro
primary monocytes, underscoring the inconsistency between in
vivo and in vitro models [12]. Understanding the differences
between in vivo and current in vitro models, and providing some








































25Further compounding translation between in vitro and in vivo
models are variations seen in vitro between primary- and
secondary-derived cells used almost interchangeably in literature
reports for decades. Primary cells are derived from living tissue
possess limited passaging capacity (i.e., Hayﬂick limit [13]), and are
therefore best used almost immediately and for limited prolifera-
tive cycles. Secondary cells (cell lines) on the other hand are
immortalized (often through genetic transformation), can be
passaged and stored theoretically indeﬁnitely, are frequently
contaminated with other more aggressive but irrelevant cell types
such as HeLa and K562 [14], and often lack much phenotypic
semblance to their primary-derived counterparts. For example,
murine RAW 264.7 macrophages are immortalized, transformed
monocyte/macrophage-like cells frequently utilized in inﬂamma-
tory assays [15e17]. However, these secondary-derived immortal-
ized cells are poorly validated and display cellular responses
distinct from primary cells, such as types and levels of external
receptor upregulation, excessive internalization rates, rapid
proliferation with lack of contact inhibition, and distinct cytokine
production dynamics [4].
Macrophages and ﬁbroblasts are primary FBR effector cells
acting in concert in local implant-associated inﬂammation, cell
recruitment, implant degradation, ﬁbrosis, and chronic unresolved
healing [1,18]. Pro-inﬂammatory cytokines secreted by both
macrophages and ﬁbroblasts are immediately upregulated post-
injury and remain upregulated in the presence of a foreign mate-
rial [5,11]. These soluble signals are recognized by the same cell in
autocrine, and neighboring cells in paracrine, responses [19].
Macrophages and ﬁbroblasts in the FBR communicate via soluble
autocrine and paracrine signals as well as juxtacrine signals
associated with direct cellecell contacts. Hence, both chemical and
physical cues exchanged between macrophages and ﬁbroblasts at
the implant site modulate cell migration, proliferation, protein
synthesis, and enzymatic function associated with the FBR
[1,5,18,20]. Fibroblasts, acting on cues from both recruited and
tissue-resident macrophages, are thought to synthesize extracel-
lular matrix, speciﬁcally collagens and keratins, resulting ulti-
mately in implant ﬁbrosis [1,18,20e22]. However, the precise
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Fig. 1. A) Depiction of the four cell signaling feedback culture scenarios utilized in this in vitro st
condition.utual inﬂuences of these two cell types in the FBR are currently
known.
This study analyzes and compares extended-duration in vitro
-cultures of primary and secondary macrophages and ﬁbroblasts
elucidate and distinguish signaling patterns between these cell
pes and determine relevant feedback systems that may enable
ore representative in vitro cellular responses to in vivomodels, or
ovide evidence for confounding in vitro cell behavior.
Methods and materials
. In vitro secondary cell culture
Transformed murine secondary monocyte/macrophage-like cell line RAW 264.7
d ﬁbroblast-like cell line NIH 3T3were purchased from the American Type Culture
llection (TIB-71 for RAW and CRL-1658 for 3T3 ATCC, Manassas, USA). Frozen
cks were suspended in 20 ml of pre-warmed secondary cell control media
ulbecco’s modiﬁed eagle medium (DMEM) with 10% fetal bovine serum (FBS), 1%
tibiotic/antimycotic, and 1% 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
EPES), all sourced from Invitrogen, Carlsbad, USA) and cultured in T75 ﬂasks (BD
lcon, San Jose, USA) at 37 C with 5% supplemental CO2 until 80% conﬂuency
fore passaging. RAW cells were passaged by scrapingwith a rubber policeman and
ed below passage 10. 3T3 ﬁbroblasts were passaged in control media using bovine
psin (Invitrogen) and used below passage 20. For all studies, cells were seeded
o 12-well tissue culture-treated polystyrene plates (BD Falcon, San Jose, USA) and
ltured for a period of 21 days in a serum-containing media as speciﬁed at 37 C
th 5% supplemental CO2. Mono-cultures in control media, mono-cultures treated
th pre-conditioned media (see below), mono-cultures stimulated with LPS (see
low), non-contact co-culture (paracrine), and contact-culture (juxtacrine)
nditions were designed for two-dimensional (2-D) adherent cell cultures on rigid
aterials, see Fig. 1A. Transwell Permeable Supports (3-mm porous plasma-treated
lycarbonate inserts) (Corning, Corning, USA) were utilized for paracrine non-
ntact cell co-cultures. Fibroblasts (1.2 105 per well) were added tomono-culture
lls, juxtacrine co-cultures, and in the Transwell inserts of paracrine co-cultures.
acrophage-like cells (3.1  105) were added to mono-culture wells, juxtacrine
lture wells, and paracrine co-culture wells beneath the Transwell inserts con-
ning ﬁbroblasts. Cell seeding concentrations were selected in order for wells to
ach conﬂuency by Day 1 of the experiment.
Mono-cultured cells (negative controls) and paracrine and juxtacrine co-
ltures were grown in control media (Fig. 1B). Conditioned FBS-supplemented
edia (20 ml) was harvested from RAW cell cultures 3 days past conﬂuency and
m 3T3 cell cultures 7 days past conﬂuency in T75 ﬂasks. These times were the
gest periods the cells could grow before requiring a media change and were thus
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26served to normalize cytokine production as RAW cells aremore highlymetabolically
active than 3T3 cells, as seen by their use of media (i.e., turning the phenol red
indicator in the media from red to yellowmore rapidly than 3T3s). Each conditioned
medium was sterile ﬁltered and 10% v/v was added to the control media for
subsequent cell treatment. For positive cell activation controls, 1 mg/ml LPS (endo-
toxin, List Biological Laboratories Inc., Campbell, USA) was added to control media.
Media (2 ml) in each well was changed daily, and analyzed on Days 1, 3, 7, 13 and/or
14, and 19 and/or 21, and stored at 70 C for subsequent analysis. Media was
analyzed on Days 13 and 19 due to ﬁbroblast delamination from surfaces observed
beyond those times.
2.2. Murine primary macrophage sourcing
Speciﬁc-pathogen-free female C57BL/6 mice, 6e8 weeks old, were purchased
from Jackson Laboratory (Bar Harbor, USA). Animals were kept in the University of
Utah ILAAC-approved animal facility and given water, mouse chow, bedding, and
modes of enrichment ad libitum throughout this study.
2.3. Primary cell cultures
Bone marrow cells (BMCs) were collected from femurs and tibias of male C57BL/
6 mice and differentiated into bone marrow macrophages (BMMVs) using a previ-
ously described method [23,24]. On Day 7, cells were removed from plastic culture
surfaces by incubation in Caþ2/Mgþ2-free PBS and scrapingwith a rubber policeman.
Cells were spun at 500 rcf for 5 min to form a pellet and then resuspended in BMMV
control media (DMEM with 10% heat inactivated FBS, 1% antibiotic/antimycotic, 1%
MEM non-essential amino acids, 1% HEPES, and 1% sodium pyruvate, Invitrogen,
Carlsbad, USA). Transwell inserts were utilized for non-contacting paracrine co-
culture. BMMV cells were plated into mono-culture control wells (1.5  105 per
well), conditioned media-treated mono-culture wells, wells beneath Transwell
inserts containing seeded ﬁbroblasts (paracrine co-culture), and into contact culture
wells (juxtacrine co-culture). NIH 3T3 cells (1.5  105 per well) were plated into
Transwell inserts, and in juxtacrine co-cultures. BMMVs treated with conditioned
media were grown in control BMMV media supplemented with 10% 3T3-condi-
tioned media. Positive control media for BMMVs was produced by adding 1 mg/ml
LPS to BMMV control media (see Fig. 1 for pictorial summary representation of
culture media and conditions).
2.4. Cytokine secretion assays
BD Cytometric Bead Array (CBA) assay was used to determine RANTES, TNF,
MCP-1, MIP1-b, MIP1-a, IL-6, IL-2, IL-4, IL-5, IL-9, IL-10, IL-12P70, IL-13, and IFN-g
cytokine expression proﬁles over time. Mediawas collected from cells on Days 1, 2, 3,
7, 13 and/or 14, and 19 and/or 21 to be analyzed. The CBA has been shown to detect
comparable levels of cytokines to an Enzyme Linked Immunosorbant Assay (ELISA)
[25], and was implemented for this study due to its low technical error (attained by
averaging the relative ﬂuorescence of at least 300 beads per analyte) and ability to
multiplex multiple cytokines simultaneously.
2.5. Flow cytometry analysis
Data acquisition for the CBA assay was performed using an upgraded 5-color
FACScan Analyzer (BD Biosciences, Mountain View, USA), employing a benchtop
analyzer with two lasers for ﬂuorochrome excitation. The primary laser is a 15 mW
argon (488 nm) laser and the secondary laser is a 25 mW red diode (637 nm) laser.
The instrument uses seven detectors, two for light scattering (forward and 90) and
ﬁve for ﬂuorescence. CellQuest 3.3 software (BD Biosciences, San Jose, USA) and
Rainbow software 1.1 (Cytek, Fremond, USA), was used for data collection. WinMDI
2.9 (J. Trotter, The Scripps Research Institute, La Jolla, CA), Weasel (Walter & Eliza
Hall Institute, Melbourne, Australia) and Summit software (Dako North America,
Inc., Carpenteria, USA) were used for data analysis.
2.6. Cell quantiﬁcation
Adherent cell counts in culture were taken from 40 objective phase contrast
microscope images. For secondary cells, at least 3 frames per replicate, per condition,
and per day were counted and the mean of the replicates was used for analysis. For
primary cells, 10 frames per replicate, per condition, and per day were counted and
the replicates averaged for analysis.
2.7. Imaging
Cells were imaged on Day 1, 3, 7, 13 and/or 14, and 19 and/or 21 using a Nikon
Eclipse TE2000-U microscope (Nikon Inc., Melville, USA) equipped with ﬂuorescent
optics, CCD camera, and Metamorph (Molecular Devices, Sunnyvale, USA) and Q
Capture Pro software (QImaging, Surrey, Canada). Each image presented was
selected as a representative image of at least 3 independent replicates.
D.J. Holt et al. / Biomat93842.8. Cell staining
A hematoxylin and eosin stain (Fisher Scientiﬁc, Kalamazoo, USA) was
employed according to manufacturer’s instructions to stain for nuclei and cyto-
plasm respectively. For ﬂuorescence staining, cells were ﬁxed in 4% para-
formaldehyde (SigmaeAldrich, St. Louis, USA) for 10 min at room temperature and
stained with rhodamine-phalloidin and counterstained with 4,6-diamidino-2-
phenylindole (DAPI) (Molecular Probes, Eugene, OR) according to standard proto-
cols. All wells were preserved with Fluoromount-G (Southern Biotech, Birmingham,
USA). For live green ﬂuorescent staining, ﬁbroblasts were stained with Vybrant
CFDA SE Cell Tracer Kit (Invitrogen) according to manufacturer’s instructions prior
to seeding with macrophages.
2.9. Multinucleated cell characterization
Primary and secondarymacrophageswere stained using a tartrate-resistant acid
phosphatase (TRAP) assay (SigmaeAldrich) according to manufacturer’s instruc-
tions after being cultured on tissue culture polystyrene (TCPS) for 21 days in each
culture condition.
2.10. Endotoxin (LPS) analysis
Levels of LPS contamination in cell culture materials, reagents, and laminar ﬂow
hood were tested using Limulus Amebocyte Lysate (LAL) Assay (Lonza, Basel,
Switzerland). All solid samples were soaked for three days in pyrogen-free water,
and the water was used in the LPS colorimetric assay.
2.11. Statistics
Endogenous levels of cytokines in conditioned media were subtracted from cell-
produced cytokine proﬁles. All experimental results are presented as the
mean  SEM. Technical replicates using the CBA were taken as the geometric mean
ﬂuorescence of at least 300 beads. Replicates for secondary macrophages and
ﬁbroblasts are represented as 3 separate wells carried in parallel through the entire
experimental protocol; this experiment was repeated on 3 independent occasions
and revealed similar results (data not shown). Replicates for primary macrophages
were harvested from 4 mice. A Single-Factor ANOVA was utilized to determine
signiﬁcance between groups of samples for the conditioned media and LPS test
groups. A Two-Factor ANOVA without replication was utilized to determine signif-
icant differences between the co-cultures (paracrine and juxtacrine) and either the
mono-cultured macrophages or ﬁbroblasts, or sum of both mono-cultured macro-
phages and ﬁbroblasts. A post-hoc student’s t-test was used to determine statisti-
cally signiﬁcant differences between samples (p < 0.05). Samples treated with
conditioned media or LPS were compared against control mono-cultured wells,
while paracrine and juxtacrine co-cultures were compared against the sum total of
both control mono-cultured macrophages and ﬁbroblasts at each discrete time
point. This accommodates the problem of cytokines produced from both macro-
phages and ﬁbroblasts in the co-cultures that should be considered. Particular
comparisons to be tested were selected in advance and were reported individually
rather than as a group and therefore were not appropriate for correction by
a multiple comparison procedure [26]. In graphical representations, values below
the assay detection limit were set to 0. The detectable limit was determined using
the assay signal value of the 0 cytokine standard plus 1.5 times the standard devi-
ation for that cytokine assay result.
3. Results
3.1. Cytokine production
From an initial screen of cytokines, IL-2, IL-3, IL-4, IL-5, IL-9,
IL-10, IL-12P70, IL-13, IFN-g, and GM-CSF were found to be below
40 pg/ml (with the exception of GM-CSF, which increased above
this value only in the presence of LPS) and were not included in this
study (data not shown). IL-6, TNF, MCP-1, RANTES, MIP-1a, and
MIP-1b were detected above this value and were considered the
most relevant to the foreign body response and were thus included
in this study.
3.1.1. Conditioned media treated sample
Secondary and primary macrophages primarily decreased their
production of inﬂammatory cytokines in the presence of ﬁbroblast-
conditioned media, compared to control macrophages, with the
exception that they both increased their production of MCP-1
within the ﬁrst 3 days (Figs. 2 and 3). In contrast, primary
s 31 (2010) 9382e9394












Fig. 2. Cytokine production proﬁles for secondary RAW macrophages and ﬁbroblasts. Proﬁles were normalized to the sum total of all cells in the well including macrophages and
ﬁbroblasts during co-cultures. Cytokine production represents the average from 3 separate wells; each experiment was repeated four times with similar results and trends (data not
shown). IL-6, TNF, MCP-1, RANTES, MIP-1b, and MIP-1a were detected using a BD Cytometric Bead Array. Signiﬁcant difference from each internal control condition (p < 0.05) is
indicated by an *. Controls are represented by solid bars, combined RAW & 3T3 control represents the mathematical sum of mono-cultured 3T3 and RAW control cells for
comparison with co-cultures. Values below the assay detection limit were set to zero. All cells grown in wells were cultured on tissue culture polystyrene. Fibroblasts delaminated
on Day 19. Background endogenous levels of cytokines in conditioned media were subtracted from each data set.
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27secondary macrophages did not. Interestingly, ﬁbroblasts increased
their production of all inﬂammatory cytokines tested in the pres-
ence of macrophage-conditioned media compared to control
ﬁbroblasts, even after subtracting the background values for cyto-
kines in the macrophage-conditioned media (Fig. 2).
3.1.2. Co-cultures
Macrophage responses (both primary and secondary) during
paracrine and juxtacrine co-culture were more similar to each other
than to their cultures in conditionedmedia (Figs. 2 and 3). In contrast
to cultures with conditioned media, secondary macrophages during
co-culturewithﬁbroblasts dramatically increased their production of
IL-6, MCP-1, and RANTES compared to controls (i.e., mono-cultures).imary macrophages during co-culture increased only their
oduction of MCP-1 signiﬁcantly compared to controls.
.3. LPS stimulation
LPS stimulation produced the greatest amount inﬂammatory
tokines in both primary and secondary macrophages compared
all other culture conditions. Primary macrophages produced
gher maximum concentrations of inﬂammatory cytokines than
condary cells upon LPS stimulation. Additionally, primary
acrophages decreased inﬂammatory cytokine production with
peated LPS treatments, while secondary macrophages primarily
creased cytokines in the presence of repeated LPS stimulation
ig. 4). Interestingly, 3T3 ﬁbroblasts also appeared highly
Fig. 3. Cytokine production proﬁles for cultures containing primary macrophages and secondary ﬁbroblasts. Proﬁles were normalized to the sum total of all cells in the well
including macrophages and ﬁbroblasts during co-cultures. Cytokine production represents the average from 4 mice. IL-6, TNF, MCP-1, RANTES, MIP-1b, and MIP-1a were detected
using a BD Cytometric Bead Array. Signiﬁcant difference from each internal control (represented by solid bars) (p < 0.05) is indicated by an *. Mono-cultured BMMVmacrophages
were used as the control for BMMVs in conditioned media. The mathematical sum of mono-cultured BMMV and 3T3s were used as the control for paracrine and juxtacrine co-
culture (3T3 mono-cultured cell control data were taken from Fig. 2). All cells grown in wells were cultured on tissue culture polystyrene. Values below the assay detection limit
were set to zero (see Methods and materials). Fibroblast delamination during juxtacrine co-culture occurred on Day 13. Background endogenous levels of cytokines in conditioned
media were subtracted from the above data.












29responsive to LPS addition, signiﬁcantly increasing nearly every
cytokine tested. A qualitative summary of these relative changes
compared to controls is shown in Table 1.
3.2. Adherent cell morphology
Secondary macrophages during paracrine and juxtacrine co-
culture and those stimulated with conditioned media all retained
similar morphologies to mono-cultured control cells, displaying
D.J. Holt et al. / Biomateriaa more-rounded phenotype and growing near, or on top of, neigh-
boring cells at both early (Supplementary Fig. 1) and late time points
la
pr
Fig. 4. Cytokine production normalized to cell number comparing mono-cultures both with an
BMMV macrophages were used as the control for their respective cell type repeatedly stimula
solid bars) (p < 0.05) is indicated by an *. All cells grown in wells were cultured on tissue culture
zero.ig. 5) (also previously observed [4,27,28]). Primary macrophages in
nditioned media and in paracrine and juxtacrine co-culture all
hibited similar morphologies at early (Supplementary Fig. 1) and
te culture timepoints (Fig. 5), exhibitingmore cell attachments than
condary macrophages and remaining relatively contact-inhibited.
wever, control BMMVs (mono-cultured in the absence of ﬁbro-
ast stimulation), by contrast, lost their contact inhibition over time,
rming large dense clusters of cells in multi-layers. Over time, both
imary and secondary macrophages developed a few scattered
(2010) 9382e9394 9387rger single-nucleated cells, with RAW macrophages occasionally
oducing multinucleate giant-like cells (Fig. 5). These
d without LPS stimulation. Mono-cultured 3T3 ﬁbroblasts, RAW macrophages, and
ted with LPS daily. Signiﬁcant difference from each internal control (represented by
polystyrene. Values below the assay limit of detection for each cytokine were set to
Table 1
A) Summary of relative changes in inﬂammatory cytokine production for secondary macrophages and ﬁbroblasts, and B) primary macrophages in the presence of conditioned
media, during co-culture, and after repeated stimulationwith LPS. Arrows represent relative trends over 21 days in culture, andmultiple arrows indicate changes in trends over
the time course of the experiment. Background endogenous levels of cytokines in conditioned media were subtracted from the data.
A B
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30multinucleated cells were far larger than co-existing mononuclear
cells, with centrally clustered nuclei, and consistently stained nega-
tive for TRAP (Supplementary Fig. 2). The frequency of multinucleate
cells in RAW cultures remained similar for every treatment condition
with the exception of LPS-stimulated cells that resulted in far more
fused cells. In the presence of LPS stimulation, both primary and
secondary macrophages developed highly activated morphologies
compared to controls, displaying ahigh frequencyof larger cell bodies
with cytoplasmic vesicles (e.g., foamy appearance) and occasionally
multiple nuclei. In all primary macrophage cultures, LPS-stimulation
was the only condition that produced multinucleate cells (Fig. 5).
Fibroblasts maintained similar adherent morphologies in every
condition tested. During secondary cell co-culture experiments, ﬁbro-
blasts cultured alone, in RAW-conditioned media, and LPS media all
began to delaminate from the culture surface on Day 19 (Figs. 2 and 4),
a phenomenon also observed in previous extended ﬁbroblast cultures
[27,29]. During primary juxtacrine co-culture experiments, ﬁbroblasts
delaminated on Day 13 (Fig. 3). Due to this delamination, few ﬁbro-
blasts remained, but began to repopulate past those time points.
3.3. Cell proliferation kinetics
Secondary RAW cells in 3T3-conditioned media and in paracrine
and juxtacrine co-cultures possessed similar proliferation proﬁles as
secondary RAW cells. Primary macrophages appeared to increase in
cell number slightly in the presence of 3T3-conditioned media and
during co-culture. Secondary and primary macrophages displayed
distinct proliferation kinetics in culture (Fig. 6). Secondary macro-
phages proliferated rapidly within the ﬁrst week, peaking at Day 3,
and then decreased until Day 21, while primary macrophages
proliferated at much slower rates during the ﬁrst week, peaking at
Day 7, and then decreased very slowly during the remaining time
periods. Primary and secondary cells showed no apparent correla-
tions between cell proliferation and cytokine production (Figs.
2e4,6). Juxtacrine co-culture cell density dropped on Day 13 due to
ﬁbroblast delamination. Macrophage cultures below the ﬁbroblast
Transwell inserts in paracrine co-culture wells often became
contaminated by rapidly growing ﬁbroblasts around Day 13, result-
ing in observed dramatic cell density increases to Day 21 (see Fig. 6).
3.4. LPS assay
An LAL assay, employed to detect endotoxin contamination,
showed that all samples and materials had LPS levels below theassay detection limit (0.06 EU/ml) with the exception of the LPS-
treated cultures (data not shown). This validates that differences




two primary effector cell types in the FBR, might better reﬂect actual
FBR inﬂammatory proﬁles than their respective mono-cultures.
Therefore, primary and secondary cells were both co-cultured in
several different communication conditions in this assessment.
Macrophages were treated with ﬁbroblast-conditioned media and
vice versa in order to determine if cytokine presence alone, without
direct feedback from the other cell type in real-time, produced
distinctly different responses from direct contact co-culture or mono-
cultures. Transwell inserts were used to physically separate the two
cell types in co-culture, allowingcytokine transport betweencell types
tomimicparacrinesignaling.Bothcell typeswereco-culturedtogether
in physical contact to mimic juxtacrine signaling. As a positive control
of cell activation, primary- and secondary-derived macrophages and
ﬁbroblasts were stimulated with LPS, shown to activate macrophages
[30,31]. Each cell mono-culture served as a negative control.
Cytokines TNF, IL-6, MIP-1a andMIP-1b, and chemokinesMCP-1
and RANTES are some of the most potent inﬂammatory signals
responsible for orchestrating the cellular responses to foreign
material, frequently up-regulated in the presence of a foreign
material in vivo [5,11,32,33]. They were monitored as a quantitative
metric for cell behavioral changes arising from culture conditions
and cell origin. Cell proliferation was assessed to normalize cyto-
kine production to cell number to account for cell density changes
in each condition. Cell morphology was used as a qualitative metric
of phenotype. Murine cells were chosen due to the cost-effective-
ness, abundant reagent base, and relevant comparisons to themany
implant reaction studies performed in mice.
4.1. Cytokine response
4.1.1. LPS-stimulated cell cultures
LPS dramatically affected 3T3 ﬁbroblasts, statistically increasing
production of all cytokineswith the exception ofMIP-1a. Fibroblasts
are not considered primary contributors of inﬂammatory cytokines
upon endotoxin exposure. However, others have also reported
increased IL-6 and other inﬂammatory cytokines by ﬁbroblasts in













Fig. 5. Fluorescence and phase contrast microscope images of A) secondary RAW macrophages, and B) primary BMMV macrophages, in various 3T3 ﬁbroblast signaling conditions
after 21 days of culture. For ﬂuorescence staining, phalloidin (red) was used to stain cytoskeleton and DAPI (blue) was used to stain cell nuclei.
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31that both primary and secondary macrophages and ﬁbroblasts are
not maximally activated simply by in vitro culture on a synthetic
surface, another contrast to cell activation by polystyrene and nearly
every other synthetic material in vivo [37,38]. This discrepancy is
most pronounced with IL-6, shown in this and other studies to be
secreted at low in vitro and very high in vivo concentrations even in
the absence of LPS stimulation [6,11]. Lack of cell activation against
biomaterials in vitro has been a common challenge to such bioma-
terials assays, requiring use of exogenous stimulants such as LPS and
phorbol esters to mimic in vivo activation (vide supra). This ﬁnding
suggests that even in co-culture, cells may not be capable of
biomaterials-based activation levels shown in vivo.tokine production from macrophages after repeated LPS dosing,
phenomenon known as LPS or endotoxin tolerance [39,40]. This
fect is considered a natural cellular response to prevent uncon-
lled inﬂammation [41e43], and is readily apparent in cultured
imary-derived macrophages in this and other studies [44].
wever, the opposite effect was observed in secondary-derived
W macrophages, where this and other studies show increasing
ﬂammatory cytokine production after repeated LPS stimulation
5]. Though RAW 264.7 macrophages have exhibited endotoxin
lerance [43,46], it has only been over the span of a few hours and
ith one repeated dose, compared to the continual LPS stimulation
en in this study over the course of 21 days. This general increasing
Fig. 5. (continued).
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32inﬂammatory cytokine production from secondary macrophages
over a three-week period may result from their transformed onco-
genic phenotype, impeding the normal down-regulation of inﬂam-
matory cytokines observed in vivo and in primary cultures.
Additionally, primary macrophages exposed to LPS in this study
produced comparable relative increases of inﬂammatory cytokines as
in vivo serum levels produced in response to LPS stimulation [11,47]
(compared to non-stimulated controls). In contrast, secondary
macrophages stimulated with LPS exhibited less dramatic increases
in cytokine production, most pronounced with IL-6 and MIP-1a
(Fig. 4). These data suggest that endotoxin sensitivity in primary cells
may better reﬂect in vivo LPS response that in than secondary cells.
4.1.2. Conditioned media-treated cell cultures
Primary macrophage mono-cultures showed more dramatic
decreases in IL-6, TNF, and RANTES in the presence of 3T3-condi-
tioned media compared to controls than their paracrine and
juxtacrine co-cultures (Table 1). Secondary macrophages in ﬁbro-
blast-conditioned media displayed less drastic changes in cytokine
production compared to primary macrophages, more similar tocontrol cells. As RAW cells are oncogenically transformed, passaged
many times, displaying a moremonocytic phenotype [4,14,15], they
may exhibit less sensitivity to cellular cues in ﬁbroblast-condi-
tioned media than primary cells. This decreased primary and
secondary cytokine production falls below that in their co-cultures
(Table 1). Distinct differences in primary and secondary cell
response to conditioned media versus co-culture could result from
lack of dynamic cell feedback and reaction: co-culture allows for
real-time cell processing and feedback between macrophages and
ﬁbroblasts, prompting unique signaling proﬁles.
Another contrast is that 3T3 ﬁbroblasts increased production of
pro-inﬂammatory cytokines in RAW-conditioned media, while
RAW and BMMV cells generally decreased their pro-inﬂammatory
cytokine production in the presence of 3T3-conditioned media.
Cytokines present in ﬁbroblast-conditioned media may inhibit
macrophage production of cytokines tested while macrophage-
conditioned media may induce cytokine production in ﬁbroblasts.
This complex balance of cellecell signaling determines the host’s
response to an implanted biomaterial, and importantly, that factor

















































































































Fig. 6. A) Proliferation proﬁles for secondary macrophage and ﬁbroblast mono-cultures. Proﬁles for 3T3s stimulated with LPS and treated with conditioned media were comparable
to mono-cultured 3T3s, and RAWs in conditioned media were comparable to mono-cultured RAWs (not shown). B) Proliferation proﬁles for primary BMMVs in various culture
conditions. Juxtacrine co-culture cell density dropped on Day 13 due to ﬁbroblast delamination. Macrophage cultures below the ﬁbroblast Transwell insert in the paracrine co-
culture wells became contaminated by rapidly growing ﬁbroblasts around Day 13, resulting in dramatic cell density increases until Day 21. Cells in all conditions reached conﬂuence
by Day 1. Error bars not seen are smaller than symbols.
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334.1.3. Contact and non-contact co-cultures
Co-cultured primary and secondarymacrophages both generally
decrease production of MIP-1b, MIP-1a, and TNF compared to
mono-cultured controls. Previous studies also document reductions
of these cytokines in the presence of ﬁbroblast-released cytokines
[48,49]. Primary macrophages in co-culture also generally
decreased RANTES and IL-6 production compared tomono-cultured
controls, related possibly to mutual cytokine down-regulation
(Table 1). RANTES and IL-6 down-regulation were not observed in
secondary cell cultures: by contrast, IL-6 and RANTES were highly
up-regulated in bothparacrine and juxtacrine co-cultures compared
tocontrols. This invitrodiscrepancybetweenprimaryand secondary
macrophages cytokine expression may again be due to intrinsic
differences in cell sensitivity and responses to cytokine signaling.
Notably, both primary and secondary paracrine and juxtacrine
macrophage-ﬁbroblast co-cultures displayed signiﬁcant increases
in MCP-1 at nearly all time points (Figs. 2 and 3). MCP-1 could
participate in a positive feedback loop between cultured macro-
phages and ﬁbroblasts (seen in a schematic of known cytokine
communication between macrophages and ﬁbroblasts, Fig. 7),
resulting in its increased production in the presence of the other
cell type (Table 1). Importantly, this dramatic increase in MCP-1
was not seen in primary or secondary macrophage mono-cultures
treated with ﬁbroblast-conditioned media e a system that inher-
ently lacks cellecell reciprocal feedback signals found in vivo. This
MCP-1 increase is consistent with a positive feedback mechanism
for MCP-1 previously proposed to perpetuate the FBR [50].
Increasing levels of TNF are shown to increase MCP-1 production
[51,52] and act as a mitogen for ﬁbroblasts [53] (Fig. 7) which may
also then contribute to high MCP-1 levels seen during co-culture
(Table 1). Increased MCP-1 production during 3T3 co-culture with
both primary and secondary macrophages relative to mono-
cultured macrophages could reﬂect an important ﬁbroblast tran-
sition to a ﬁbrotic phenotype, as ﬁbrotic ﬁbroblasts are known to
increase TNF-induced MCP-1 [54], proliferation [55], and protein
secretion [56]. Though co-cultures do not replicate all compre-
hensive aspects of in vivo reactions, they are capable of cell
signaling patterns more representative of the in vivo environment
than their mono-cultures with or without conditioned media.
Interestingly, all cytokines signiﬁcantly increased in co-
cultures (compared cytokines produced from the arithmetic sum
total from both mono-cultured macrophages and ﬁbroblasts)
were only those appearing to be produced in greater amounts by
ﬁbroblasts over macrophages during mono-culture. Mono-
cultured ﬁbroblasts exhibited greater IL-6, MCP-1, and RANTEStokines than mono-cultured secondary macrophages, and
oduced greater MCP-1 cytokine amounts than primary cells.
latively strong ﬁbroblast cytokine response compared to
acrophages may initiate positive feedback during co-culture. As
tokines are pleiotropic [57], their dynamic production kinetics
d ﬂuctuations are expected, prompting dynamic production
d ﬂuctuations of other cytokines.
2. Adherent cell morphology
At early time points, adherent secondary RAW 264.7 macro-
ages behaved very differently from primary-derived BMMVs,
owing no contact inhibition and readily growing in multi-layers.
MVs maintained larger cell bodies, more cell attachments,
quent lamellipodia, and elongated morphologies, while RAWs
d smaller cell bodies andmaintained amore-rounded phenotype
mpared to primary cells during mono-culture, a characteristic of
eir less differentiated and more monocytic phenotype (images of
l cells on Day 1 are found in Supplementary Fig. 1) [4]. However,
er time both cell populations transitioned to larger cell bodies,
owing differentiation over time (Fig. 5). RAW control cells in
quently developed into FBGCs with large cell bodies and cen-
ally clustered nuclei, while primary control macrophages did not.
ese cells consistently stained negative for TRAP (Supplementary
g. 2). This supports an FBGC-like phenotype [58,59] over an
ternative osteoclastic phenotype also known to be derived from
W 264.7 cells [60]. Osteoclasts tend to have multiple nuclei
ing the cell periphery as opposed to clustered centrally (arrows,
pplementary Fig. 2), have larger cell bodies than FBGCs, and stain
sitive for TRAP [61].
Both in the presence of conditioned media and co-culture, RAW
lls maintained a similar phenotype to control cells, unlike
MVs in these conditions that remained contact-inhibited in the
esence of ﬁbroblast signaling. Both primary and secondary
ntrol macrophage cultures, absent of ﬁbroblast signaling, lost
eir contact inhibition, began to growmuch larger cell bodies, and
rmed dense multilayered clusters (notably not multinucleated as
r LPS-stimulated cells). Perhaps without appropriate signals,
ese cells may not be able to retain their original macrophage
enotype in culture.
LPS activates all macrophage cultures, inﬂuencing morphology
both primary and secondary macrophages more than any other
ndition, leading to the production of intracellular vesicles,
larged cell bodies, and occasionally multiple nuclei, seen previ-












































Fig. 7. Overview of the select cytokine signaling pathways known between ﬁbroblasts
and macrophages [12,33,50e56,64e73].
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34and extended lamellipodia in cells destined to become FBGCs [62].
This is witnessed in LPS-stimulated BMMVs (see Fig. 5 e the only
treatment of BMMVs leading to FBG-like cells). Neither primary
nor secondary macrophages appeared activated by culture surfaces
compared to LPS-stimulated cells, consisting with cytokine data.
This absence of cell activation during in vitro co-culture of macro-
phages and ﬁbroblasts may be due to the absence of acute wound-
derived inﬂammatory cues always produced in vivo during device
implantation, or insufﬁcient cell types, numbers and signals
necessary to accurately recapitulate host inﬂammatory reactions or
produce a clear foreign body response.
During contact co-culture, one cell type grew more aggressively
than the other, eventually creating a layer over the other cell type.
RAW cells over-layered 3T3 ﬁbroblasts, while 3T3 ﬁbroblasts over-
layered BMMVs, both within the ﬁrst 3 days. However, even with
this covering layer, the cells underneath did not die, but also did not
appear to proliferate. Supplementary Fig. 3 shows viable ﬂuores-
cent 3T3s beneath unlabeled RAWs, still maintaining a normal
morphology. But these cells did not reach conﬂuence like mono-
cultured ﬁbroblasts. Similarly, in the primary contact co-culture on
Day 13, the 3T3s delaminated, revealing a layer of viable BMMVs
underneath, which appeared to have retained their original plating
density and phenotype (Supplementary Fig. 4). Cell culture condi-
tions that enabled ﬁbroblasts to grow to conﬂuence all resulted in
eventual longer-term cell-substrate delamination seen previously
[29,63].
4.3. Cell culture proliferation kineticsSecondary RAW macrophages proliferated rapidly in the ﬁrst
week of culture, and then decreased cell numbers at later timepoints (seen previously [28]). Primary macrophages grew at far
slower rates, maintaining a relatively constant cell density. These
primary macrophages did not reach conﬂuency until Day 7, after
which their density decreased very slowly. By Day 3, secondary
cells were at their highest proliferative rate (Fig. 6), however, they
exhibited low cytokine secretion proﬁles during that time. Prolif-
eration of primary cells peaked at Day 7, but their highest cytokine
secretion levels were during the ﬁrst 3 days. These results suggest
that cell inﬂammatory signaling activity is independent of prolif-
eration. Also supporting this idea, LPS-stimulated secondary and
primary cells secreted the largest amounts of inﬂammatory cyto-
kines, but while undergoing the least proliferation.
RAW cell treatment with ﬁbroblast-conditioned media or direct
co-culture did not appear to affect their proliferation. These
cultures maintained comparable proliferation rates to control RAW
cells (as RAWs proliferated at much higher rates than 3T3 ﬁbro-
blasts and therefore dominated co-culture kinetics). However,
primary BMMVs in conditioned media and their paracrine co-
culture with ﬁbroblasts show slightly increased proliferation rates
compared to control BMMVs. This increased cell number compared
tomono-cultured BMMV controls is due to cell size in each culture:
control BMMVs without ﬁbroblast stimulation grew very large cell
bodies, while those with ﬁbroblast signaling maintained much
smaller cell bodies (Fig. 5), altering the cell densities. LPS-stimu-
lated primary- and secondary-macrophage cultures displayed an
overall decreased cell number compared to controls. This reduced
cell density may be due to this same cell size transition to larger
cells, toxic effects of LPS, or a phenotypic shift to a less proliferative
cell during LPS stimulation. Cell proliferation kinetics in primary
juxtacrine co-culture were comparable to mono-cultured ﬁbro-
blasts, because secondary ﬁbroblasts proliferate faster than primary
macrophages. With both secondary and primary macrophage jux-
tacrine co-cultures, growth kinetics are determined by this more
highly proliferative cell type.
s 31 (2010) 9382e93945. Conclusions
Several differences in cell signaling, adherent cell morphology,
and proliferation between primary- and secondary-derived
macrophages are shown in cultures, with greater apparent ﬁdelity
in primary over secondary cells to in vivo responses. Primary and
secondary macrophage cell sources also exhibit unique responses
in culture that provide different cellecell feedback mechanisms,
with reciprocal feedback (i.e., in paracrine and juxtacrine co-
cultures) eliciting more representative characteristics found in vivo
than mono-cultured cells in conditioned media. In general, co-
culture feedback signaling in primary macrophage co-cultures with
ﬁbroblasts improves on in vitro models currently employing
secondary cell mono-cultures. Despite co-culture feedback,
without cell-derived wounding cues or implant-associated healing
cascades in cell culture, FBR in vitro assays may exclude other acute
cellular reactions associated with implant placement in vivo.
Additionally, 2-D monolayer cell culture on rigid substrates and
absence of other inﬂammatory cells such as T-cells may also limit in
vitro approaches to duplicate the cell signaling observed in vivo. In
vitro cell assays may only be adequate to represent speciﬁc cell
types, functions, and simple biomaterials-associated signaling, but
may be insufﬁcient to approach or accurately represent more
dynamic cell-interactive acute inﬂammatory or resulting FBR
mechanisms found in vivo. The many in vitro assays (especially
those using secondary-derived cell cultures and/or mono-cultured
cells) used for FBR models, cell toxicity screening, drug and mate-
rials testing, and basic cell signaling research should all be validated































35contexts in order to assert ﬁdelity and relevance to the speciﬁc in
vivo phenomena they claim to represent.
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Many multinucleated giant cells are well-known to form from macrophage origin. Those formed from
other cell types are less described, but may be as prevalent in pathological tissue. Giant multinucleated
cells derived from secondary and primary ﬁbroblast sources in various cultures with similar character-
istics to foreign body giant cells are reported. Secondary-transformed NIH 3T3 ﬁbroblasts rapidly fuse
within 24 h in contact co-cultures with RAW 264.7 immortalized macrophages, while 3T3 monocultures,
non-contact (transwell) co-cultures, and macrophage-conditioned media-treated 3T3 monocultures all
do not fuse. Primary-derived murine ﬁbroblasts also form multinucleated cells, both in the presence or
absence of co-cultured macrophages that increase during long-term culture (5e30 days). In contrast to
3T3 fusion, this primary cell phenomenon is not due to ﬁbroblast fusion, but rather to nuclear division
without cytokinesis. That these multinucleated ﬁbroblasts can originate via different mechanisms may
inﬂuence and distinguish their behaviors in conditions under which they may arise, including various in
vitro culture assays, and in certain ﬁbroblastic pathologies such as the foreign body response, ﬁbrosis,
cancer and aged tissue.


















2.Fibroblasts are the most common cell type in the body and can
become altered in various pathologies such as ﬁbrosis, cancer,
aging, and the foreign body response (FBR) [1e9]. One phenotypic
alteration that is not widely acknowledged, but possible is ﬁbro-
blast multinucleation [6e8]. Additionally, several other multinu-
cleated giant cells including foreign body giant cells (FBGCs),
Langhans’ cells, and osteoclasts, all commonly derived from
a macrophage cell origin are known [10].
Signiﬁcantly, FBGCs can form from the fusion of multiple
monocytes/macrophages [11] during the FBR, mounted by the host
against implanted biomedical materials [12]. The FBR can cause
device failure due to degradation by enzymes secreted by macro-
phages and abnormal collagen production by ﬁbroblasts, resulting
in an impeding collagen capsule [9,12,13]. Macrophages and ﬁbro-
blasts are both primary FBR effector cells [9,12], though unlike
macrophages, ﬁbroblasts are not commonly considered to form
multinucleated giant cells. However, the mileu surrounding
implants is abnormal, can be toxic to cells [14], has been speculated
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Ltd.ompt ﬁbroblasts to alter their phenotype and form multinucle-
ed giant cells.
Previous studies have identiﬁed multinucleated cells in vivo
tensibly of ﬁbroblast origin [6,7], one describing cells appearing
“bizarre, atypical ﬁbroblasts with hyperchromatic and large,
eomorphic nuclei and multinucleated ﬂoret-like giant cells” [8].
veral studies describe the presence of multinucleated ﬁbroblasts
vitro [18e21] and in vivo in pathologies such as ﬁbrosis and
ncer and in aged tissue [1e8]. However, whether these cells
ultinucleate in vitro and in vivo via fusion similar to FBGCs [11] or
rough nuclear division without cytokinesis [18] is unclear.
This study deﬁnitively identiﬁes ﬁbroblasts that become multi-
cleated through both mechanismsdfusion and mitosis without
tokinesisddepending on ﬁbroblast phenotype and culture
nditions. Immortalized secondary ﬁbroblasts formed multinu-
eate cells via fusionwithotherﬁbroblasts during contact co-culture
ith secondary-derivedmacrophages after 24 h. Primary ﬁbroblasts
rmed multinucleate cells in mono-culture after becoming sen-
cent and undergoing nuclear division without cytokinesis.
Methods and materials
. Cell culture
.1. Secondary cell culture
Macrophage-like cell line RAW 264.7 and ﬁbroblast-like cell line NIH 3T3 were



























Scheme 1. Multinucleate cell origin was followed by ﬂuorescent cell labeling. A) Macrophages were labeled green and ﬁbroblasts were labeled red prior to co-culture. B) Cell fusion
was visualized as a co-localization of two different labeled ﬁbroblast populations (red and green) with macrophages receiving no dye (grey). Cell co-localization of red and green
dyes appears yellow. C) After 24 h, macrophage and ﬁbroblast cultures were labeled with DAPI (blue) and macrophage-speciﬁc anti-CD14(red)to identify possible macrophage
contamination within the plated ﬁbroblast population. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article).
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391658 for 3T3 ATCC, Manassas, VA) and cultured in 96-well tissue culture treated
polystyrene plates (BD Falcon, San Jose, CA) unless otherwise speciﬁed, during
contact co-culture experiments at 37 C with 5% supplemental CO2 for 24e72 h.
Fibroblasts were used at passages 6e30 and macrophages were used below passage
10. RAW cells were passaged by scraping with a rubber policeman. 3T3 cells were
passaged using TripLE (Invitrogen, Carlsbad, CA). For optimal cell fusion, 2  104
ﬁbroblasts and 1  104 macrophages were plated into co-culture wells. This same
number of ﬁbroblasts and macrophages were also plated into control wells for
comparison. Cells were always cultured in complete media (Dulbecco’s modiﬁed
eagle medium (DMEM) with 10% fetal bovine serum, and 1% antibiotic/antimycotic
(Invitrogen, Carlsbad, CA). Secondary NIH 3T3 ﬁbroblasts were cultured for 24e72 h
under four different conditions: 1) in direct co-culture contact with secondary RAW
264.7 macrophages, 2) co-culture but separated from RAW cells by a Transwell
microporous insert (RAWs in insert and 3T3s in well beneath), 3) in RAW-condi-
tioned complete media, and 4) alone, devoid of macrophage signaling [22]. Mono-
cultured RAW cells in complete media served as a control. Non-contact co-cultures
utilized 3 mm porosity plasma-treated polycarbonate Transwell Permeable
Supports (Corning, Corning, NY) in 12-well tissue culture treated polystyrene plates
(BD Falcon, San Jose, CA). Cell numbers were scaled linearly with respect to surface
area from the 96-well culture dishes to accommodate larger sized wells. In the same
12-well plates all 4 culture conditions i.e., mono-culture, conditionedmedia, contact
co-culture, and Transwell co-culturedwere also employed. Macrophage-condi-
tioned media was collected after 24 h of exposure to RAW cells (density ¼ 1  105
cells/well) and placed over mono-cultured ﬁbroblasts in 12-well plates. New
conditioned media was collected from the original RAW culture well every day for 3
days to be placed over the conditioned media-treated ﬁbroblasts.
2.1.2. Murine primary cell sourcing
Speciﬁc-pathogen-free, 2e3 month-old male C57BL/6 mice were purchased
from Jackson Laboratory (Bar Harbor, ME). Animals were kept in the University of
Utah animal facility, and provided water, mouse chow, bedding, and modes of
enrichment ad libitum throughout this study. Animals were euthanized via CO2.
2.1.3. Primary macrophage cell culture
Bone marrow cells were collected from the femurs and tibias of 2e3 month-old
male C57BL/6 mice and differentiated into bone marrow macrophages (BMMVs)
using a previously described method [23,24]. On day 7, the cells were removed from
surfaces by incubation in Ca/Mg-free phosphate-buffered saline solution and
scraping with a rubber policeman. Harvested cells were spun at 500 rcf for 5 min to
form a pellet and then resuspended in DMEMwith 10% heat-inactivated fetal bovine
serum, 10% L929-conditioned media, 1% antibiotic/antimycotic, 1% MEM nonessen-
tial amino acids, 1% HEPES, and 1% sodium pyruvate. Also in 96-well plates, 1 104
primary macrophages per well were seeded alone or in contact co-culture with
primary ﬁbroblasts. Alternatively, primary monocyte-like cells were obtained by
using the bone marrow cells on day 1, 2, or 4, before complete macrophage differ-
entiationwas expected [25e27]. Pure monocytes were obtained using the EasySep
Magnetic Mouse Monocyte Enrichment Kit (Stemcell Technologies Inc., Vancouver,
BC) from bone marrow cells according to the manufacturer’s instructions, typically
producing monocyte purity of 80%e93%.
2.1.4. Primary ﬁbroblast cell culture
Primary ﬁbroblasts were obtained post-mortem from ear dermal tissue of 2e3
month-old freshly sacriﬁced male C57BL/6 mice. Ear tissue was clipped at the base
of the ear and soaked in 70% ethanol for 5 min and then rinsed in sterile phos-
phate-buffered saline (BD Falcon, San Jose, CA). Tissues were placed in a Petri dish
and diced using a sterile razor, placed into 2 ml of 5 mg/ml collagenase solution in
DMEM and incubated for 2 h in a 37 C water bath with agitation [25e27] then
ﬁltered though a 70 mm cell ﬁlter (BD, San Jose, CA). An equal portion of completemedia was added to the ﬁltrate and spun at 500 rcf for 5 min to create a cell pellet.
Supernatant was aspirated off and the cell pellet was resuspended in primary cell
media (DMEM with 10% fetal bovine serum, 1% antibiotic/antimycotic, and 1% MEM
nonessential amino acids (Invitrogen, Carlsbad, CA), placed in T75 cell culture ﬂasks
(BD Falcon, San Jose, CA), and incubated at 37 C with 5% supplemental CO2. Cells
required 3e7 days to become conﬂuent and were subsequently passaged and used
in further experiments. Cells were passaged by incubation with TripleE (Invitrogen,
Carlsbad, CA). Primary ﬁbroblasts (1  104 cells per well in 96-well plates, char-
acterized by anti-CD14 and anti-vimentin labeling, as well as Oil Red O post-
differentiation, vide infra) were cultured alone or in physical contact with primary
macrophages for up to 30 days. On different occasions, primary ear-derived
ﬁbroblasts were also co-cultured with either secondary RAW 264.7 cells, primary




A hematoxylin and eosin (H&E) stain (Fisher Scientiﬁc, Kalamazoo, MI) was
employed according tomanufacturer’s instructions to stain for nuclei and cytoplasm
respectively.
2.2.2. Fluorescent cell labeling
For ﬁxed ﬂuorescence labeling, cells were ﬁxed in 4% paraformaldehyde (Sig-
maeAldrich, St. Louis, MO) for 10 min at room temperature and labeled with
rhodamine-phalloidin and counterstained with 4,6-diamidino-2-phenylindole
(DAPI) (Molecular Probes, Eugene, OR) according to manufacturer’s instructions.
Live cell in situ ﬂuorescent detection used either a green Vybrant CFDA SE Cell
Tracer Kit or a red Cell Trace Far Red DDAO-SE long-lived intracellular dye (Invi-
trogen, Carlsbad, CA) according to manufacturer’s instructions. These dyes label
100% of cells (data not shown) and have been shown not to transfer to neighboring
cells [28]. Macrophages were labeled with the green live dye, while ﬁbroblasts were
labeled with the red live dye prior to seeding in bothmono- and co-cultures in order
to distinguish ﬁbroblast and macrophage populations during co-culture and deter-
mine cellular origin of the resulting multinucleated cells (Scheme 1A). These same
dyes and experimental procedure were used to determine FBGC fusion [11]. Anal-
ogously two ﬁbroblast populations were labeled with either red or green live cell
dye prior to seeding in mono- and co-cultures to determine ﬁbroblast fusion by dye
co-localization (Scheme 1B). These same procedures were employed for both
secondary- and primary-derived ﬁbroblast cultures.
2.2.3. Antibody labeling
A phycoerythrin-conjugated macrophage marker, anti-CD14 (clone Sa2-8,
IgG2a, diluted 1:100, eBioscience, San Diego, CA) [29] was added to control RAW
cells, 3T3 cells, and co-cultures of RAW and 3T3 cells to determine possible inad-
vertent macrophage contamination in ﬁbroblast cultures and to conﬁrm multinu-
cleate cell origins (Scheme 1C). This marker was also added to primary-derived
macrophages and ﬁbroblasts to determine multinucleate cell origin. Cyanine3-tag-
ged ﬁbroblast marker anti-vimentin [30] (clone V9, IgG1, diluted 1:100, Sigma, St.
Louis, MO) was added to primary ﬁbroblasts to assert phenotype and multinucleate
cell origin.
2.2.4. Senescence
Both primary and secondary macrophages and ﬁbroblasts and primary adipose-
derived stem cells (ASCs, isolation and characterization described in Supplementary
Information) were stained with a senescence-labeling kit staining for beta-galac-

























































Primary ﬁbroblasts were cultured for 3 days prior to apoptosis testing. Positive
control ﬁbroblasts were incubated with 1 mg/ml bupivicaine (Hospira, Lake Forest,
IL) for 2 h at 37 C. Primary ﬁbroblasts were labeled with Poly Caspases FLICA in
vitro Apoptosis Detection Kit (Immunochemistry Technologies, Bloomington, MN)
according to manufacturer’s instructions.
2.2.6. Mycoplasma assay
Mycoplasma testing was performed using DAPI labeling, according to standard
protocols [32e34].
2.2.7. TRAP assay
Secondary ﬁbroblast-derived multinucleated cells were stained using a tartrate
resistant acid phosphatase (TRAP) assay (SigmaeAldrich, St. Louis, MO), speciﬁc for
osteoclasts [35], according to manufacturer’s instructions.
2.3. Imaging
Fluorescent, brightﬁeld, and colored microscopy images of cells in culture were
acquired using a Nikon Eclipse TE2000-U microscope equipped with ﬂuorescent
optics, CCD camera, and Metamorph and Q Capture Pro software. Confocal images
were captured using an FV1000 IX81 Olympus confocal microscope. Fluorescence
and confocal images were used to identify dye co-localizationwithin cells. At least 9
replicates from 3 separate cell experiments were imaged to determine representa-
tive image samples of all experiments in this study. Experiments producing multi-
nucleated ﬁbroblasts were repeated at least 6 times.
2.4. Video
Confocal time-lapse video was acquired using a Nikon A1 Confocal microscope
over 24e48 h. In videos taken from 0 to 24 h, cultured cells did not readily adhere to
the surface of the plate, most likely due to microscope micromotion (results not
shown). Four 20 ﬁelds were digitally stitched together into a mosaic for the video
included in this study.
2.5. Statistics
Numbers of giant cells per frame, percent nuclei fused, and percent multinu-
cleated cells between short-term co-cultures and long-term monocultures
compared to short-termmono-cultured ﬁbroblasts were evaluated using a student’s
t-test with signiﬁcance deﬁned as p < 0.05. A Single-Factor ANOVA was utilized to
determine signiﬁcance between groups of samples. A post-hoc student’s t-test was
used to determine statistically signiﬁcant differences between samples (p < 0.05).
Cell counts were taken from 15 objective images. Three frames per replicate were
counted and the mean was used for analysis. At least 3 independent replicates were
counted with independent replicates deﬁned as different experiments using
different mice for primary cells, and different passage numbers for secondary cells.
3. Results
3.1. Mycoplasma detection
All cell cultures, both those derived from primary and secondary
sources, stained negative for mycoplasma contamination using
DAPI ﬂuorescence (data not shown).
3.2. Secondary-derived multinucleate cells
Fig. 1 shows multinucleated cells appearing during contact co-
culture with secondary RAW macrophages (Row 5). RAW and 3T3
cells cultured alone (Rows 1&2, respectively) and 3T3s in the
presence of RAW-conditioned media (Row 3) do not form multi-
nucleated cells. In order to test for signaling effects of short-lived
excreted cytokines, 3T3s were co-cultured with RAWs separated by
Transwell inserts (Row 4), where the permeable polyester
membrane prevents physical contact of each cell type, but permits
mass transport of soluble culture components. No formation of
multinucleated ﬁbroblasts occurred in this co-culture system.
Multinucleated cells have been reported in vivo to have
“increased nuclear-cytoplasmic ratio, pale pink scant cytoplasm,
and indistinct cell boundaries (with rosette arrangement of
hyperchromatic nuclei)” [8] similar to those seen in this study
(Fig.1, Row 5). This can be seen bothwith live cells (Fig.1, column 1)
D.J. Holt, D.W. Grainger / Biomad ﬁxed cells stained with H&E (Fig. 1, Columns 2&3). 3T3 cells
gin multinucleation immediately upon adherence to tissue
lture surfaces in the presence of RAWs (data not shown) and is
adily apparent at 24 h (Fig. 2).
3. Multinucleate cell origin
Fig. 3 shows RAW cells (Fig. 3A) labeled with a cytoplasmic
orescent green dye prior to co-culture with ﬁbroblasts, and 3T3s
ig. 3B) labeled with a cytoplasmic ﬂuorescent red dye prior to co-
lture with macrophages. Resulting multinucleated cells (Fig. 3C)
hibited red ﬂuorescence, with no detectable green ﬂuorescence.
ditionally, as proof of negligible macrophage contamination in
e ﬁbroblast population, anti-CD14 added to themixed population
adily bound all mono-cultured RAW cells (Fig. 3D) but not mono-
ltured ﬁbroblasts (Fig. 3E). In the co-culture system, no multi-
cleated cells were ﬂuorescently labeled by anti-CD14 (Fig. 3F).
her external macrophage markers analyzed, including MHC-II,
40, CD18, CD11b, and F4/80, were analyzed (data not shown).
owever, anti-CD14 provided the most reliable and prominent
beling and was thus presented in this study.
4. Secondary ﬁbroblast fusion
Separate 3T3 ﬁbroblasts cultures containing either green or red
toplasmic dyes were added simultaneously to non-labeled RAW
acrophage cultures (Fig. 3 GeL). Fig. 3 I&L shows that resulting
ultinucleated cells exhibit both red and green nuclei with yellow
e. both red and green co-localization) cell bodies. A video of these
lls fusing between 24 and 48 h in culture is available online in
pplementary Data. This video also shows these cells to be highly
otile, traveling hundreds of microns over the course of 24 h Fig. 4
ows still frames from that video and the corresponding approx-
ate cell trajectories of one tracked multinucleated cell.
Multinucleated cells derived from 3T3 ﬁbroblasts exhibit similar
alities to FBGCs, with enlarged cytoplasms, multiple cellular
hesions, and multiple centric nuclei [36]. However, they do not
ssess punctate podosomal actin [17,37] but do possess prominent
ress ﬁbers, features consistent with ﬁbroblasts [38] but contrary
FBGCs and osteoclasts (Fig. 5A). Furthermore, secondary-derived
ultinucleated cells in this study did not stain positive for
acrophage marker CD14 (Fig. 3 DeF) or osteoclast-marker TRAP
upplementary Fig. 1).
Interestingly after passages greater than 20, 3T3s cultured on
e same surface for extended periods of time (>5 days) began
rming multinucleated cells even in the absence of macrophages
ig. 5 CeD). The spontaneously formed multinucleated cells
equently had nuclei that appeared polymorphonuclear.
5. Primary-derived multinucleate cells
Primary murine ear dermal ﬁbroblast isolations were conﬁrmed
be dominantly ﬁbroblastic using several cell phenotype assays
ee Supplementary Information and Supplementary Fig. 4).
Fig. 6 shows that primary ﬁbroblasts cultured in the presence of
imary bone marrow-derived macrophages (Fig. 6 AeC) or
condary-derived RAW cells (Fig. 6 DeF) also become multinu-
eated, while the macrophages alone do not over the same culture
e period. No noticeable differences between ﬁbroblast fusion
tes in the presence of either primary macrophages or monocytes
ere seen (data not shown). Primary-derived multinucleated cells
e not macrophage-like. Primary macrophages containing cyto-
asmic green dye cultured with primary ﬁbroblasts containing
toplasmic red dye for 24 h yield multinucleated cells with only
d ﬂuorescence (Fig. 6 GeI). Additionally, while both primary
ls 32 (2011) 3977e3987 3979
macrophages and ﬁbroblasts stained positive for CD14, upregulated demonstrating that primary multinucleated cells do not appear to
Fig. 1. Phase contrast and hematoxilin and eosin (H&E)-stained cell images. Cultured 3T3 ﬁbroblasts form multinucleated cells in contact co-culture with RAW macrophages
(bottom row), but not during mono-culture (top 2 rows), treatment with conditioned media (3rd row) or non-contact co-culture (4th row). Images shown after 3 days of culture in
complete media.
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41in macrophages [29,39], primary BMMVs stained strongly positive
(Fig. 6J), while ﬁbroblasts exhibited only very dim ﬂuorescence
(Fig. 6K). Differentiation between the two cell types is clear. Addi-
tionally, ﬁbroblasts stained positive for the ﬁbroblast-speciﬁc
marker, vimentin, including cells with multiple nuclei (Fig. 6 L&O).
Fig. 6 also shows primary multinucleated cells in monocultures
of ﬁbroblasts containing no added macrophages. No signiﬁcant
differences are noted between ﬁbroblasts cultured alone or during
co-culture both at short time points (<3 days) (Fig. 2). Primary
multinucleated cells do not appear to form via cellecell fusion.
Fig. 6 M&N shows two populations of primary ﬁbroblasts labeled
green or red prior to co-culture together. Resulting multinucleated
cells were either green or red, but not both, i.e., yellow,form via cellecell fusion.
3.6. Primary multinucleate cell morphology
Multinucleated cells from ﬁbroblasts can be seen as early as 1
day post-culture, though the frequency of multinucleated cells and
number of nuclei per cells increases at days 5e30 as seen in Figs. 2
and 7. Nonetheless, even after extended culture periods (5e30
days), the frequency of multinucleated cells from primary ﬁbro-
blasts was far less than those from secondary-derived ﬁbroblasts
during co-culture at short time periods (24 h, Fig. 2).
Over time, multinucleated cells from primary-derived ﬁbro-
blasts change their morphology, developing larger, more-extended
Fig. 2. Multinucleate cell characterization. A) Percent nuclei found in multinucleate giant cells, B) percent multinucleate giant cells found in cell population, C) number of
multinucleate giant cells per frame, and D) average number of nuclei per giant cell for primary and secondary-derived ﬁbroblasts and macrophages alone (short-term, 1e3 days, and
long-term, 30 days) and in co-culture (short-term, 1e3 days) without the addition of exogenous cytokines. So few giant cells per frame in the long-term ﬁbroblast culture condition
is due to the increase in size of those ﬁbroblasts compared to those cultured for short-term, consequently decreasing the overall number of cells per frame (see Fig. 7). Data
represent the mean  SEM from 3 independent replicates. Signiﬁcance (p < 0.05) was analyzed between primary and secondary ﬁbroblast short-term monocultures and short-term
co-cultures and between primary and secondary ﬁbroblast short-term monocultures and long-term monocultures. Images were taken with a 15 objective and yielded a frame size
of 260, 891 mm2.
Fig. 3. Fluorescence images showing A) RAW macrophages labeled green, B) 3T3 ﬁbroblasts labeled red, and C) an overlay of brightﬁeld and red and green channels showing a red
(circled), and therefore ﬁbroblastic, multinucleated cell. Fluorescence images showing D) macrophages and E) ﬁbroblasts incubated with DAPI (blue) and also ﬂuorescently labeled
anti-CD14 (red), revealing F) ﬁbroblasts that stain negative for CD14, are multinucleated (circled), and are therefore not macrophages. Fluorescent GeI) and confocal J-K) images
revealing co-localization of a red-labeled population of ﬁbroblasts fused with a green-labeled population of ﬁbroblasts in the presence of non-labeled macrophages, where G and J
are the green channel, H and K are the red channel, and I and L are overlays of I) brightﬁeld and red and green ﬂuorescent channels and L) red and green channels (co-localization
experiments with 3 replicates each were repeated 3 times). Images shown after 24 h of culture. (For interpretation of the references to colour in this ﬁgure legend, the reader is
referred to the web version of this article).
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Fig. 4. Frames AeC show the approximate motility trajectory (black line) of a secondary-derived multinucleated ﬁbroblast (circled) traveling hundreds of microns over the course of
24 h (from 24 to 28 h). This time-lapse image series also appears to show the ﬁbroblast beginning as only a few red-labeled cells and ending with several more nuclei including
those from green-labeled ﬁbroblasts (full video available online in supplementary data).
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43cell bodies and even developing what appears to be poly-
morphonuclei (Fig. 5 E&F). Cultured adipose-derived stem cells
(ASCs) (Supplementary Fig. 2, description of ASC isolation and
identiﬁcation are found in Supplementary Information) and car-
diomyoblasts (data not shown) were also observed to form multi-
nucleate cells under identical culture conditions, occasionally
possessing polymorphonuclei as well. Interestingly, primary-
derived multinucleated cells possessed prominent stress ﬁbers but
lacked punctate podosomal actin (Fig. 5B), consistent with ﬁbro-
blasts [38], but not FBGCs or osteoclasts [17,37].Fig. 5. Actin (red) and nuclei (blue) labeling for A) secondary-derived multinucleate ﬁbrob
stress ﬁbers (more prevalent in primary versus secondary multinucleate cells) and the abse
seen in macrophage-derived FBGCs. Secondary multinucleate cells are shown after 1 day a
and D 40) of secondary ﬁbroblasts which spontaneously formed polymorphonuclear mu
contain several pleomorphic and budding nuclei seen in E) a confocal image of DAPI (blue
chromatin, circled in black),shown after 30 days in culture. (For interpretation of the refe
article).3.7. Primary multinucleate cell senescence
A senescence assay [31] was employed for primary ﬁbroblasts
on Days 1, 2, 3, 10, and 20. Fibroblasts stained positive for senes-
cence ﬁrst on Days 10 and 20 (Fig. 8, Panel A). ASCs, also seen to
create multinucleate cells, were also tested for senescence during
the same time frame and began staining positive for senescence as
early as Day 1, though not prevalently until Day 3 onward
(Supplementary Fig. 3). Secondary-derived multinucleate cells
were also tested with this assay and found to exhibit no detectablelasts and B) primary-derived multinucleate ﬁbroblasts. These images show prominent
nce of podosomes surrounding single and multinucleate cells, features contrary to those
nd primary cells are shown after 30 days of culture. C&D) Phase contrast images (C 10
ltinucleated cells after >20 passages and culture for >5 days. E&F) Primary ﬁbroblasts
) and phalloidin (red) labeled cells and F) an H&E-stained cell (purple line, potentially

























Fig. 6. Phase contrast images of A) primary-derived BMMVs alone, B) primary ﬁbroblasts alone and C) contact co-culture of BMMVs and ﬁbroblasts. Note multinucleate cells in
both the mono-culture ﬁbroblasts and contact co-cultures (arrows). H&E-stained images showing D) secondary-derived RAWs cultured alone, E) ear ﬁbroblast cultured alone and F)
contact co-culture of RAW cells and primary ﬁbroblasts. Multinucleate cells can be seen in ﬁbroblast mono-culture as well as contact co-culture with RAW cells (arrows). GeI)
Fluorescent images of contact co-cultured primary macrophages (green channel, G), ﬁbroblasts (Red channel, H) and an overlay of red, green and brightﬁeld channels (I). These
images show that the multinucleated cell is red and therefore of ﬁbroblastic origin (H and delineated by dotted lines in I). Confocal images of primary-derived J) BMMVs and K)
ﬁbroblasts labeled with DAPI (blue) and macrophage marker CD14 (red), revealing a strong CD14 stain in macrophages but not ﬁbroblasts. L and O) show 40 and 20 confocal
images, respectively, of primary-derived ﬁbroblasts labeled with ﬁbroblast marker vimentin (red), showing that the majority of cells in this culture stain positive for ﬁbroblasts,
including multinucleate cells. M and N) Confocal images of mono-cultured primary ﬁbroblasts pre-labeled with red or green long-lived intracellular ﬂuorescence prior to culture,
where the multinucleated cells (arrows) found were either green or red, but not both (representative images from 3 separate experiments and a total of 9 replicates). This lack of co-
localization indicates an absence of fusion to produce cell multinucleation. Images are shown after 3 days of culture. (For interpretation of the references to colour in this ﬁgure
legend, the reader is referred to the web version of this article).
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44positive senescence in either 3T3s or RAWs during either co-culture
or mono-culture (data not shown). Signiﬁcantly, all multinucleate
cells regardless of the culture time period stained positive for
senescence and negative for apoptosis (Fig. 8, Panel B).
4. Discussion
The majority of multinucleated cells are believed to originate
from macrophages [10]. However ﬁbroblasts, the most prevalent
cell type in the body, are also capable of formingmultinucleate cells
both in vitro [18] and in vivo [1e8]. Though some studies claim they
form via fusion [4,7] and others mitosis without cytokinesis [18],
this study found that both of these mechanisms can create multi-
nucleated ﬁbroblasts, depending on cell sourcing and culture
conditions.
Secondary ﬁbroblast-derived multinucleated cells formed when
3T3 ﬁbroblasts were in direct physical contact with secondary-
derived RAW macrophages after 24 h (Fig. 1, Row 5). This was not
only seen during co-culture between RAW macrophages and 3T3
ﬁbroblasts but also in identical co-cultures between RAW and L929
ﬁbroblast cells (data not shown). Importantly, cell multinucleation
in secondary cultures did not occur 1) during 3T3 ﬁbroblast mono-
culture in either complete or RAW macrophage-conditioned
complete media, or in non-contact Transwell macrophage co-ltures with soluble media-phase diffusive exchange between
acrophages and ﬁbroblasts. Consistent with a previous study,
ntact co-cultures of RAW 264.7 macrophages and NIH 3T3
roblasts formed multinucleate cells while those with 3T3 ﬁbro-
asts and primary bone-derived macrophages did not [22]. Addi-
nally, cell multinucleation in secondary cultures did not occur
hen either cell type was allowed to adhere prior to adding the
her cell type (data not shown). Lack of observed cell fusion in
condary cell cultures of bothmacrophage-conditionedmedia and
answell co-cultures indicates that cell fusion requires 3T3
roblasts in physical contact with RAW macrophages rather than
st soluble signal exchange [22]. Necessity for physical cellecell
ntact may suggest involvement of external cell membrane
ceptors such as inter-cellular adhesion molecule (ICAM) 1 on
served secondary cell multinucleation. ICAM is deemed
sponsible for many interactions between macrophages and
roblasts [40], and signiﬁcantly, fusion between macrophages to
rm FBGCs [41]. In this study, cultured RAW macrophages were
ry motile, making contact with many cells over a 24-h period.
rprisingly, multinucleated cells derived from 3T3 ﬁbroblasts
ere also found to be highly motile, traveling hundreds of microns
ring the same 24-h period (Fig. 4 and video in Supplementary
ta). Cell mobility in these secondary-derived cultures, enabling
cile macrophage-ﬁbroblast and ﬁbroblasteﬁbroblast interactions,
Fig. 7. Phase contrast (column 1) and H&E-stained (columns 2 &3) cell images show changes in primary ﬁbroblast morphology over time. Columns 1 and 2 are at a 40
magniﬁcation and column 3 is at a 10magniﬁcation. Day 1 cells possessed spindle and stellate morphologies. By Day 15, cells began to develop larger cell bodies and nuclei. By day
30, the cells possessed very large cell bodies, with some containing multiple and pleomorphic nuclei.
Fig. 8. Panel A) Senescence staining (blue) in primary ﬁbroblasts after 3, 10, and 20 days expressed qualitatively as representative images and quantitatively in graph below. These
data show that at longer time points near day 10, senescence becomes prevalent in primary ﬁbroblasts. Data are represented as the mean  SEM from 3 independent replicates.
Importantly, all multinucleated ﬁbroblasts regardless of time point, stained positive for senescence. Panel B) Confocal images showing DAPI (blue) and apoptosis staining (red) in
primary ﬁbroblasts (top image) left untreated and (bottom image) treated with bupivicaine as a positive control. Multinucleate ﬁbroblastic cells even with highly polymorphic
nuclei did not stain positive for apoptosis. Images shown after 3 days in culture. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web
version of this article).


































































46increases the likelihood of physical stimulation of 3T3 ﬁbroblasts by
RAW macrophages and subsequent fusion with other 3T3 ﬁbro-
blasts (Fig. 3 I&L).
Multinucleated cells from RAWmacrophage contact co-cultures
with 3T3 ﬁbroblasts arise from the ﬁbroblast, not macrophage,
population. 3T3 ﬁbroblast cultures do not contain contaminating
macrophages: CD14 antibodies speciﬁcally bound RAW macro-
phages but not 3T3 ﬁbroblasts and multinucleated cells. Assayed
for TRAP, a prominent marker for multinucleate osteoclasts [35],
cultured RAW macrophages, 3T3 ﬁbroblasts, and multinucleate
cells all stained negative (supplementary data), indicating that
these cells were not osteoclastic.
In secondary 3T3 cell contact co-cultures with RAW macro-
phages, multinucleation is shown to result from fusion of two or
more ﬁbroblasts. Two separate populations of secondary-derived
ﬁbroblasts labeled with either a red or green cytoplasmic dye prior
to plating with non-labeled secondary-derived macrophages, an
experiment analogous to that used to determine macrophage
fusion to FBGCs [11], produced multinucleated cells with both red
and green nuclei and yellow (red plus green) cell bodies. Co-
localization of both red and green dyes was seen with both ﬂuo-
rescent and laser scanning confocal microscopy (Fig. 3 I&L,
respectively). Red and green coloration occupied the same volume,
shape, and focal plane (optical cross-section was 0.45 mm, less than
a cell thickness), conﬁrming cytoplasm fusion (Fig. 3L). All
secondary multinucleated cells displayed this colour co-localiza-
tion, with multinucleate cell density being approximately 15 giant
cells per 15 frame (Fig. 2). A 24 h time-lapse video (supplemen-
tary data) shows a red 3T3 ﬁbroblast traveling approximately 1 mm
and apparently fusing with several green and red 3T3 ﬁbroblasts to
accumulate approximately 5 nuclei that, conjoined together, move
within the same membrane containing both red and green
ﬂuorescence.
Primary ear-derived dermal ﬁbroblasts formed multinucleated
cells in physical contact with primary bone marrow-derived
macrophages (Fig. 6 AeC), secondary RAW macrophages (Fig. 6
DeF) and primary bone marrow monocyte-like cells and mono-
cytes (data not shown) in 24e72 h. Primary and secondary
macrophages formed extremely rare or no multinucleated cells
during the same culture time under these conditions (Fig. 2).
Primary ﬁbroblasts loaded with a red cytoplasmic dye and primary
macrophages containing a green cytoplasmic dye produce red
multinucleated cells (Fig. 6 GeI) (i.e., from the ﬁbroblast pop-
ulation, not from macrophages). Interestingly, primary ﬁbroblasts
also form multinucleated cells in mono-culture (complete absence
of macrophages, shown by very dim CD14 labeling (Fig. 6K) over
the same time frame, increasing in their density over 30 culture
days (Fig. 2). Though primary ﬁbroblasts are commonly cultured,
multinucleated ﬁbroblasts are not commonly reported, likely due
to the fact that any rarely occurring multinucleated cells may be
dismissed as contaminating cells or phenotypic anomalies. Fig. 6
M&N shows mono-cultured primary ﬁbroblasts loaded with
either red or green cytoplasmic dye prior to seeding. In these
representative images, multinucleated cells display only one colour
(either red or green) supporting a non-fusion mechanism to create
multinucleated cells in primary ﬁbroblast cultures. Similar multi-
nucleated cells are also observed in primary ASCs (Supplementary
Fig. 2) and cardiomyoblasts (data not shown).
This observed multinucleation event that retains colour ﬁdelity
in primary ﬁbroblasts is consistent with nuclear division without
cytokinesis. This phenomenon has been described previously
[18e21], and the dye co-localization studies performed here further
substantiate this phenomenon. This asserted nuclear division in the
absence of cytokinesis is also supported by Supplementary Fig. 5
E&F, showing the presence of globular or pleomorphic nuclei
D.J. Holt, D.W. Grainger / Biomaaring a membrane with one or more nuclei. In vivo presence of
ultinucleated giant ﬁbroblasts with pleomorphic nuclei has also
en reported in a ﬁbroma [8]. Polymorphonuclei exhibiting only 1
cleus but with multiple lobes are also possible. Fig. 5F shows
thread-like feature (circled) that may represent a strand of
romatin often seen connecting lobes of a polymorphonucleus
2]. This has also been seen previously in ﬁbroblasts cultured in
tro, displaying tumor-like phenotypes [43]. After high passage
mbers (>20), and extended culture beyond 5 days, secondary
3 ﬁbroblasts in mono-culture also occasionally express multiple
clei and develop amorphic nuclei similar to those seen in the
ono-cultured primary cells (Fig. 5C&D). That this type of multi-
cleation is more apparent in primary ﬁbroblasts after 1 week in
ono-culture and in secondary ﬁbroblasts at high passage
mbers in mono-culture, both in cells that appear to be non-
viding, is likely due to aging. Previous work foundmultinucleated
roblasts with pleomorphic nuclei in 17% of ﬁbroblasts in peri-
ontal ligaments of aged mice (20 months), while no such cells
ere seen in young mice (5 weeks) [7].
Aging has been shown to manifest as replicative senescence
4], and is suggested to result from damage to the mitotic
achinery of dividing cells [45]. To prove if multinucleation events
primary ﬁbroblasts are correlated with cellular age, as seen
eviously in ﬁbroblasts [18], primary ﬁbroblasts were cultured for
days in complete media, and stained for b-galactosidase,
common marker for replicative senescence [31]. At Day 10, (i.e.,
proximate time when multinucleation in primary cells was
served to increase) senescent cells also became more frequent
d all multinucleated cells, regardless of the culture time point,
ained positive for senescence (Figs. 2 and 8). Bothmultinucleation
d polyploidy (nuclear replication without nuclear division) have
en seen in senescent ﬁbroblasts [18,19]. Multinucleation and
lyploidy are also well-known in trophoblasts [46,47] and
ncerous tissue [20,43]. Though senescence has been proposed as
mechanism to prevent cells from oncogenesis [48], the nuclear
aterial in senescent multinucleate ﬁbroblasts is considered highly
stable, and on occasion cells can escape senescence by a nuclear
dding process known as neosis [20,21,49]. During neosis multi-
cleate senescent cells can shed karyoplasts to become highly
itotically active and tumorigenic Raju cells [20,21,49]. Interest-
gly, this nuclear budding process has also been reported in
teoclasts in order to create mononuclear cells from a multinu-
ate osteoclast [50].
The two types of multinucleated ﬁbroblasts identiﬁed in this
udy in vitro in both secondary and primary ﬁbroblasts correlate
ith those proposed in vivo due to fusion [4,7] and nuclear division
ithout cellular ﬁssion [43,45]. Depending on conditions, some
ultinucleated ﬁbroblasts found in vivo seen in aged tissue,
rosis, and ﬁbromas [1e8] may be senescent cells either under-
ing nuclear division without cytokinesis or fusion-derived
roblasts, although direct evidence for either mechanism is scant.
clinical cancer study described multinucleated ﬁbroblast
stologywith large numbers of nuclei (7e20), less prominent actin
aining, and a prevalence of 10e30% multinucleated cells per
icroscopic ﬁeld [3], characteristics similar to fused secondary
roblasts in this study. Multinucleate ﬁbroblasts with poly-
orphic nuclei seen in vivo [7,8,43] are better compared to the
imary multinucleate ﬁbroblasts formed from nuclear division
ithout cytokinesis as reported in this study. Cells resulting from
ch mechanism are multinucleate, yet as they derive from
fferent pathways, theymay possess distinct traits characteristic of
e pathologies in which they arise. Understanding these distinc-
ns should provide better insight into the etiology of pathologies
ch as ﬁbrosis, cancer, aging, and the FBR, where multinucleate
roblasts may play a signiﬁcant role.
ls 32 (2011) 3977e3987 3985
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47Secondary ﬁbroblasts in macrophage co-culture did not form
the same type of multinucleated cells as primary cells in co- or
monocultures. Secondary cells formed multinucleated cells readily
after 1 day, while primary cell multinucleation required several
days and was never as frequent (Fig. 2). Additionally, far more
nuclei per cell were observed in multinucleate cells produced from
secondary cells than from primary cells (Fig. 2), but primary cells
possessed more prominent stress ﬁbers (Fig. 5). Most interestingly,
secondary cells fused to form multinucleated cells that stained
negative for senescence (data not shown), while primary cells did
not appear to fuse but became multinucleated instead by nuclear
division without cytokinesis, correlated with replicative senes-
cence. These differences most likely reside in secondary cells that
are transformed, passaged many times, and display oncogenic
phenotypes, such as rapid proliferation, lack of contact inhibition
and immortalization. Distinct behaviors between primary and
secondary ﬁbroblasts in such cellecell fusions should be considered
both in model culture studies employing or clinical histopatho-
logical observations invoking this cell type.
5. Conclusions
Multinucleated cells are shown to form in both secondary- and
primary-derived ﬁbroblasts cultures in vitro under distinct condi-
tions. Differences are noted in multinucleation mechanism
between cultured ﬁbroblasts from primary and secondary sources.
Secondary cells produce multinucleation by fusion of multiple
ﬁbroblasts only in direct contact culture with macrophages.
Primary cells do not multinucleate by fusion, but rather from sen-
escent cells no longer undergoing cytokinesis, and in the absence of
co-cultured macrophages. Clinical studies identify multinucleated
ﬁbroblasts with pleomorphic nuclei, similar to those derived from
primary cells here, as well as the frequent appearance of claimed-
fused ﬁbroblasts similar to those from immortalized ﬁbroblast
cultures in this study, suggesting that both types of ﬁbroblast-
dependent multinucleation may be present in vivo in different
pathologies. Understanding the impetus for the formation of each
atypical multinucleated ﬁbroblast type is essential in under-
standing multinucleate ﬁbroblast involvement in pathologies such
as the FBR, aging, and ﬁbrotic diseases.
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Implants are predisposed to infection even years after implantation, despite ostensibly 
being surrounded by innumerable macrophages as part of the host foreign body response. The 
local implant environment could adversely influence the implant-associated macrophage 
phenotype, proliferative capacity, activation states, and ability to neutralize pathogens. This study 
monitored cultured macrophage proliferative states and phagocytotic competence on tissue 
culture plastic to address the hypothesis that extended contact with foreign materials alters 
macrophage phenotype.  That such macrophage alterations might also occur around implants has 
significance to the foreign body response, infection, cancer, autoimmune and other diseases.  
Specifically, multiple indicators of macrophage proliferation in various culture conditions, including 
cell confluence, long-term culture (21 days), lipopolysaccharide (LPS) stimulation, passaging, and 
mitogenic stimulation are reported. Importantly, primary murine macrophages became quiescent 
at high confluence and senescent during long-term culture. Senescent macrophages significantly 
reduced their ability to phagocytose particles, while quiescent macrophages did not. Cell 
senescence and quiescence were not observed with repeated passaging.  Primary macrophage 
stimulation with LPS delayed senescence but did not eliminate it. These results prompt the 
conclusion that both cell quiescence and senescence are observed under common macrophage 
culture conditions and could alter macrophage behavior and phenotypes in extended in vitro 
culture, such as the ability to phagocytose. Such macrophage transitions around foreign bodies in 
vivo are not documented: quiescence and senescence reported here in macrophage culture could 
be relevant to macrophage behavior both in vitro in bioassays and in vivo in the foreign body 
response and implant-centered infection. 
 
Introduction 
Macrophages play a primary role in modulating the foreign body response, immediately 
localizing to surfaces of every implanted material [1].  At the implant site, they are responsible for 
removing cell debris, foreign bodies and pathogens. After acute phase inflammation subsides, 
macrophages may reside at implant surfaces throughout the duration of the implantation, possibly 
for decades [2, 3], in some case producing multi-cellular macrophage layers around monolithic 
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implants [1, 4], completely infiltrating porous implants [5], and fusing to form foreign body giant 
cells at these surfaces [1, 4, 6-8].  That any of these commonly observed chronic responses result 
from macrophage in situ proliferation versus continual new cell recruitment is not clear. However, 
a recent study found that during T helper 2 (Th2) inflammation, macrophages were capable of 
undergoing rapid proliferation in vivo [9].  Importantly, changes in their resident phenotypes, 
functional competence and capabilities to address infection risk over this implant duration, 
prompted by or correlated with their prolonged exposure and reaction to a foreign body (e.g., 
implant) are largely unknown.   
Despite macrophage persistence at surfaces of implanted materials, implants retain 
substantial infection risk even years after implantation [10, 11]. This may be due to the fact that 
unlike host tissue that is continuously renewed, thereby limiting opportunities for bacterial 
colonization, tissue surrounding implanted materials remains relatively unchanged, encapsulated 
in fibrous scar tissue [1, 12-14].  This suggests that while abundant macrophages are present, 
they may be transformed by their chronic reactions to implants into states of relative inactivity, 
incapable of addressing microbial presence as effectively as during initial implant site recruitment. 
Many cells in normal tissue are quiescent, a reversible, viable, nondividing state-of-rest.  
Importantly, quiescent cells can be stimulated to divide [15, 16].  Cells can also become 
senescent, a viable but irreversible nondividing state that cannot be overcome even with 
mitogenic stimuli [17].  Senescent and quiescent cells are distinguished by altered patterns of 
gene expression [18, 19]. Senescent and quiescent transitions in macrophages at implant 
surfaces could explain their inability to adequately address bacterial infection in vivo in this 
context.    
Previous studies have demonstrated a decreased phagocytic ability in aged 
macrophages [20] and a susceptibility of cells under oxidative stress to senesce [20, 21]. That 
macrophages demonstrate increased intracellular reactive oxygen species with age [22] and 
reside in high oxidative stress environments surrounding foreign bodies [13] could indicate their 
propensity to senesce and their subsequent incompetence to phagocytose pathogens at implant 
surfaces over time. Interestingly, foreign body giant cells, the chronic multinucleated macrophage-
derived phenotypic hallmark surrounding implanted materials, also display decreased phagocytic 
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ability [23], and increased lysosomal activity [23, 24], consistent with senescent cells [25] also 
known to multinucleate [26]. Macrophages have also been purported to undergo frustrated 
phagocytosis, an exhausting metabolic phenomenon that could compel macrophages to senesce 
around implants [1, 4, 7, 8]. However, macrophage senescence and phagocytosis around 
chronically implanted foreign bodies or in long-term cultures on materials remains unaddressed in 
current literature.  
Cultured macrophages are commonly employed in assays seeking information on 
aspects of their involvement in pathologies such as cancer, autoimmune diseases, and the 
foreign body response [27-32].  As an immunomodulatory cell, macrophages are highly 
susceptible to telomere attrition [22], increasing their potential to senesce.  However, they are not 
commonly assayed for this phenotype.  As both quiescence and senescence alter cell genetic 
profiles [18, 19], macrophage transitions to these states during in vitro culture likely influence 
assay outcomes, potentially leading to false conclusions, irreproducible results, and 
inconsistencies, especially when compared to in vivo phenotypes they intend to mimic.  
Maintenance of consistent macrophage phenotypes and activation states between in vivo and in 
vitro conditions is likely critical to ensuring proper in vitro model fidelity.  Therefore, understanding 
the possible consequences of macrophage senescent and quiescent transitions has important 
implications both in vitro and in vivo.   
This study identified proliferation states for both primary and secondary macrophages in 
several experimental culture conditions, including cell confluence, culture time, passage number, 
and biochemical stimulation. Cultured macrophage capacity to phagocytose in quiescent and 
senescent states raises important questions about macrophage phenotypic competence in 
extended contact with materials.  Should this behavior also be observed in vivo, it has important 




Methods and materials 
Cell culture 
Immortalized RAW cell culture  
Macrophage-like transformed murine cell line RAW 264.7 was purchased from the 
American Type Culture Collection (TIB-71, ATCC, Manassas, USA) and cultured in 96-well tissue 
culture-treated polystyrene plates (BD Falcon, San Jose, USA), unless otherwise specified, at 
37°C with 5% supplemental CO2 according to the experiments detailed below.  All RAW cells 
were used below passage 10 after purchase, unless passage number was explicitly specified.  
RAW cells were passaged by scraping with a rubber scraper (Starstedt, Newton, USA).  Cells 
were always cultured in complete media (Dulbecco’s modified eagle medium (DMEM) with 10% 
fetal bovine serum (FBS), and 1% antibiotic/antimycotic, Invitrogen, Carlsbad, USA). Full media 
exchanges were performed every other day. 
 
Murine primary cell sourcing 
Specific pathogen-free, 2-3 month-old male C57BL/6 mice were purchased from Jackson 
Laboratories (Bar Harbor, USA).  Animals were kept in the University of Utah animal facility, and 
provided water, mouse chow, bedding, and modes of enrichment ad libitum throughout this study. 
For primary macrophage harvests, animals were euthanized via CO2. 
 
Primary macrophage cell culture 
Bone marrow cells were collected from the femurs and tibias of 4-5 month-old euthanized 
male C57BL/6 mice and differentiated into bone marrow macrophages (BMMФs) using a 
previously described method [33, 34]. On day 7, cells were removed from surfaces by rinsing cells 
3X and incubating them in Ca+2/Mg+2-free phosphate buffered saline (PBS, Invitrogen) for 30 
minutes at 37°C, and then rinsed from the surface using a 1 ml pipette tip, and collected.  Cells 
were counted using a hemocytometer and cultured in 96-well tissue culture-treated polystyrene 
plates (BD Falcon, San Jose, USA), unless otherwise specified, at 37°C with 5% supplemental 
CO2 according to the experiments outlined below.  At least an equal volume of complete BMMФ 
media (DMEM with 10% heat-inactivated FBS, 10% L929-conditioned media, 1% 
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antibiotic/antimycotic, 1% MEM nonessential amino acids, 1% HEPES, and 1% sodium pyruvate, 
Invitrogen) was added to the suspended cells after plating, and fresh media was replaced every 
2-3 days.  Unless otherwise specified, all BMMФs were passaged once after their differentiation 
for experimental use. 
 
In vitro culture conditions for senescence examination 
Cell confluence 
Immortalized RAW macrophages were plated at densities of 5 x103, 1 x104, 2 x104, 4 
x104, and 8 x104 cells/well, and primary macrophages were plated at densities of 5 x103, 1 x104, 2 
x104, 4 x104, 8 x104, and 1.6 x105 cells/well and cultured for 24 hours prior to fixing. To determine 
cell senescence versus quiescence, an equivalent cell density of 1.60 x105 cells/well was cultured 
in a 30-mm Petri dish (BD Falcon) in parallel and passaged and plated at low confluence. These 
cells were then cultured for 7 days further (seen previously to be the time for maximum 
proliferation).  Both control media and media with 50% serum (to encourage growth) were utilized 
to confirm macrophage proliferative capacity. 
 
Comparisons of longterm macrophage cultures 
Primary and immortalized macrophages were plated at 5 x103 cells/well and cultured for 
1, 2, 3, 5 and 7 days for secondary RAW 264.7 macrophages and 1, 2, 3, 5, 7, 10, 12, 14, 17, 19, 
and 21 days for primary BMMΦs prior to fixing. To determine senescence or quiescence in 
primary macrophages, a 30mm Petri dish (BD Falcon) with the same cell seeding density as the 
longterm experiment was passaged on Day 21 and plated at 5 x103 cells/well and analyzed for 
proliferation 5, 7, and 10 days later (i.e., the time at which the greatest proliferation during the 
initial 21 days was seen). Both control media and media with 50% serum (to encourage 
proliferation) were utilized to confirm macrophage proliferative capacity. 
 
Lipopolysaccharide (LPS) treatment of cell cultures 
For LPS-treated conditions, primary and immortalized macrophage cultures were treated 
with their respective media supplemented with 1 µg/ml LPS replaced every 2-3 days until the end 
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of the experiment (i.e., 7 days for RAWs and 21 days for BMMΦs). This concentration was 
selected because it has been shown to effectively activate macrophages [35, 36]. RAW cells were 
also stimulated with LPS during studies of increasing confluence (details listed above). 
 
Cell passaging 
RAW 264.7 macrophages were cultured in 30-mm tissue culture-treated polystyrene Petri 
dishes (BD Falcon, San Jose, USA) and passaged 30 times and subsequently plated into 96-well 
plates and assayed for senescence and proliferation markers.  Primary BMMΦs were cultured in 
100-mm tissue culture-treated polystyrene Petri dishes (BD Falcon), passaged and plated into 96-
well plates for subsequent characterization.  This was repeated up to 10 passages, where 
passage 1 was the first passage after differentiation.  Passages were fixed after 24 hours of 
culture for characterization. Both primary and secondary macrophage culture passages were 
performed every other day, to allow stock cultures sufficient time to properly adhere before serial 
passaging. 
 
Cell culture biochemical stimulation 
Primary BMMΦs were plated at 5 x103 cells/well and cultured for 21 days and then 
treated for 48 hours with cytokines IFN-gamma, IL-6, MCP-1, TNF, GM-CSF, MIP-1β, MIP-1α, IL-
4, RANTES, and IL-10, and mitogens TGF-β, IL-1β, MCP-1, and also 50% and 100% serum prior 
to fixing. This 48-hour incubation period was selected as the time reported for quiescent cells to 
reactivate [37].  
 
Predifferentiated BMMΦ cultures 
Bone-marrow cells were plated into 96-well plates and characterized on Days 1, 3, 5, and 
7 post-harvest for proliferation markers prior to full differentiation into macrophages. 
 
Phagocytosis 
Phagocytosis was measured in both senescent and quiescent cells.  Blue-green 
fluorescent polystyrene beads (diameter 1 µm, Invitrogen) at a dilution of 0.5 µl stock to 100 µl 
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media were added to macrophage cultures and allowed to incubate at 37°C with 5% 
supplemental CO2 for 12 hours.  After this incubation time, cells were washed to remove any 
beads not internalized and fixed with 4% paraformaldehyde (PFA, Sigma-Aldrich, St. Louis, USA), 
diluted in Ca+2/Mg+2-free PBS (Invitrogen) for 20 min at room temperature for subsequent 
imaging.  Fixed cells were incubated with propidium iodide diluted 1:100 in PBS (Invitrogen) for 
20 minutes which successfully stained the entire cell body.  Using ImageJ (NIH freeware) the area 
of the cell occupied by beads was divided by the total cell area to determine the percentage of 
beads occupying the cells in each frame. 
 
Cell labeling 
Cell phenotypic makers 
Mature macrophage-specific marker anti-F4/80 [38, 39] (clone BM8, rat anti-mouse 
IgG2a, pre-conjugated to phycoerythrin (PE),  eBioscience ,San Diego, USA) and M2 
macrophage marker anti-CD206, macrophage mannose receptor [40] (clone MR5D3, rat anti-
mouse IgG2a, preconjugated to fluorescein isothiocyanate (FITC), AbD Serotec, Raleigh, USA) 
were used to label macrophages on Days 1,7, and 21. Representative images from Day 21 are 
shown in Supplementary 4.1.   
 
Cell proliferation markers 
Primary anti-mouse Ki-67 (IgG1, Novacastra, Buffalo Grove, USA) and phospho-histone 
H3 (Ser10) (Cell Signaling Technology, Danvers, USA) antibodies, both markers of actively 
proliferating cells [41, 42], were used at dilutions of 1:50 and 1:100, respectively.  Secondary IgG1 
goat-anti-mouse antibody conjugated to Alexa 488 (Invitrogen), used against both Ki-67 and 
phospho-histone H3, was diluted 1:500. Samples were rinsed 2X in PBS+Ca+2/Mg+2 (Invitrogen,) 
and fixed in 4% PFA (Sigma-Aldrich), diluted in Ca+2/Mg+2-free PBS for 20 min at room 
temperature.  They were rinsed 2X in Ca+2/Mg+2-free PBS and then incubated in block solution 
(4% goat serum plus 0.1% triton-X 100, Invitrogen) for 1 hour at room temperature on a shaker 
plate.  Each primary antibody, diluted in block solution, was added to the samples and the plate 
was sealed and placed at 4°C overnight.  The primary antibody media was removed and the 
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samples were washed 3X in Ca+2/Mg+2-free PBS.  The secondary antibody, diluted in block 
solution, was added to the samples and incubated at room temperature for 1 hour on a shaker 
plate.  The samples were washed 3X in Ca+2/Mg+2-free PBS and counterstained with 4',6-
diamidino-2-phenylindole (DAPI, Invitrogen) according to manufacturer’s instructions prior to 
imaging. 
 
Cell senescence assay 
A colorimetric assay for senescence-associated beta-galactosidase (SA beta-gal) used 
as a labeling kit (Cell Signaling Technology, Danvers, USA) was used according to 
manufacturer’s instructions [21]. This commonly employed assay [17] labels fixed cells positive 
for SA beta-gal with a blue precipitate and allows for subsequent visualization of percent positive 
cells (imaging described below).  A second quantitative fluorescence-based SA beta-gal assay, 
employed according to a previously established protocol [17] requires cell lysis and subsequently 
measures the relative fluorescence of total SA beta-gal in the culture well, rather than distinct SA-
positive cells. Relative SA beta-gal fluorescence yield was analyzed using a plate reader (BioTek 
Synergy 2, Winooski, USA). All conditions were analyzed on the same plate at the same time, 
making comparison of RFUs meaningful between conditions. The quantitative fluorescent SA 
beta-gal lysate assay was normalized to cell density by dividing the relative fluorescence of the 
SA beta-gal assay by the BCA protein content from each culture well (described below). Both 
colorimetric and fluorescent senescence assays were conducted at pH 6, which suppresses the 
activity of native lysosomal beta-galactosidase that is only active at pH 4 [17].  Therefore, only SA 
beta-gal active at pH 6 could cleave the chromogenic substrate 5-bromo-4-chloro-3-indolyl-beta-
D-galactopyranoside (X-gal), reducing non-senescent cell staining and increasing signal:noise 
ratios [17].   
 
BCA cell protein assay 
Cell density was approximated using cell-derived protein content from each culture well 
detected by the microBCA assay (Pierce Thermo Scientific, USA) used according to 
manufacturer’s instructions. Relative fluorescence from the assay was analyzed using a plate 
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reader (BioTek Synergy 2, Winooski, USA).  All conditions were analyzed on the same plate at 
the same time, making comparison of RFUs meaningful between conditions. 
 
Cell imaging 
Fluorescent false-color, brightfield, and true color microscopy images of cells in culture 
were acquired using a Nikon Eclipse TE2000-U microscope equipped with fluorescent optics, 
CCD camera, and Metamorph and Q Capture Pro software.  Confocal images were captured 
using a FV1000 IX81 Olympus confocal microscope.  Representative images were selected from 
3 independent replicates. 
 
Statistics 
Statistics were performed using a one-way ANOVA with post-hoc Dunnett Multiple 
Comparisons Test or Student’s t-test, where specified. Cell counts were taken from 15X objective 
images in low confluency cultures and 40X images in high confluency cultures so that ~50-100 
cells occupied each frame. For the colorimetric SA beta-gal assay, Three frames per replicate 
were counted from three replicates from three mice per condition.  For the Ki-67 assay, two 
frames from two replicates were counted from three mice per condition. For the fluorescent SA 
beta-gal assay, lysates from three replicates were combined from each of three mice.  For RAW 
cells, six wells were counted in each condition for the colorimetric SA beta-gal and Ki-67 assays, 
and lysates from three wells were combined for each condition for the fluorescent SA beta-gal 
assay. For the colorimetric senescent assay, only dark blue cells were counted as they (and not 
any lighter blue cells) corresponded to cells that did not label for Ki-67.  Ki-67-positive cells with a 
definite labeled nucleus were counted as positive. No values for primary cells were below the limit 
of detection for any of the assays. For bead quantification in phagocytosis assays, two frames 






Macrophages maintained strong F4/80 staining throughout 21 days of culture, supporting 
their mature macrophage phenotype [38, 39] (Supplementary Figure 4.1).  Macrophages also 
maintained the strong M2 phenotypic marker, CD206 [40] (macrophage-mannose receptor), 
labeling to 21 days (Supplementary Figure 4.1), a macrophage polarization state shown capable 
of proliferation in vivo during inflammation [9].  Macrophage proliferation, peaked in culture near 
day 7 (Figure 4.1). Isotype controls for F4/80 and CD206 revealed some background staining; 
however, previous work also reported strong staining for these two markers after 21-day cultures 
(unpublished data, submitted 2012).  
 
Culture confluence 
Increasing adherent macrophage confluence increased expression of senescence 
marker, SA beta-gal, and decreased expression of proliferation marker, Ki-67, in primary BMMΦ 
cells (Figure 4.2). Both the colorimetric qualitative and fluorescent quantitative senescence 
assays yielded the same trends. After confluence was reached, cells were passaged and re-
plated at a low density and found capable of being restimulated to divide (Figure 4.3). 
 
BMMΦ proliferation over 21 days 
Primary BMMΦs initially increased and then later decreased their percent proliferation 
over the course of 21 days, peaking at day 7 and 10 (Figure 4.1).  This same trend in proliferation 
was seen previously by our lab [36]. The colorimetric senescence assay inversely correlated with 
the Ki-67 assay, while the fluorescent quantitative senescent assay diverged, showing a general 
increasing trend over 21 days.  Cells passaged and re-plated after 21 days were not capable of 
being restimulated to divide, even with mitogenic stimulation (Figure 4.3). 
 
Phagocytosis 
Primary BMMΦs showed reduced ability to phagocytose subsequent to passaging after 
21 days (Figure 4.4), under the same conditions by which the majority of cells within the culture 
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were shown to be senescent (Figure 4.3). Cells at high confluence (i.e., those deemed quiescent) 




LPS stimulation in primary BMMΦs delayed SA beta-gal staining over the course of 21 
days, but did not eliminate it.  The colorimetric senescence assay showed least amounts of 
staining for SA beta-gal from day 5 to day 10, with proliferation rates decreasing after day 14 
(Figure 4.5). Similar but delayed trends for both senescence assays were seen in the LPS-
stimulated condition compared to the non-LPS stimulated condition described above. 
 
Passaging 
Increasing passages of BMMΦs did not correlate to a definite increasing or decreasing 
trend of SA beta-gal or Ki-67 expression up to 10 passages. The qualitative colorimetric percent 
positive cell and quantitative cell lysate senescent assays followed relatively similar trends. The 
Ki-67 assay was inversely related at some passage numbers, but not all (Figure 4.6). 
 
Biochemical stimulation 
After 21 days of culture, BMMΦs positive for SA beta-gal and negative for Ki-67 could not 
be stimulated to proliferate using cytokines, mitogens, or passaging at a lower confluency as 
determined by an insignificant change in either SA beta-gal or Ki-67 expression after stimulation 
(Figure 4.3, Supplementary Figure 4.2).   
 
 
Figure 4.1. Proliferative capacity of primary BMMΦ cultures over 21 days. Fluorescence and color 
images of: A) DAPI and Ki-67, and B) SA beta-gal staining, respectively, in primary BMMΦs over 
21 days. Graphical representation of:  C) percent positive Ki-67 cells; D) percent positive SA beta-
gal cells (from fixed colorimetric beta-gal assay); E) relative fluorescence units (from lysed 
fluorescent SA beta-gal assay); and F) cells per frame, all over 21 days. These data show a 
decrease in Ki-67 staining and an increase in SA beta-gal staining after 21 days, suggesting an 
increase in macrophage senescence over 21 days. One-way ANOVA with post-hoc Dunnett 
Multiple Comparisons Test was applied, comparing all days to the day 1 time point. Significance 
is noted as p<.05 * and p<.001 **.  No significant increase in Ki-67 expression after passaging (C) 












Figure 4.2. Effect of increasing cell confluence on macrophage proliferation in culture. 
Fluorescence and color micrograph images of:  A) DAPI and Ki-67, and B) SA beta-gal staining, 
respectively, in primary BMMΦs with increasing confluence on tissue culture plastic.  Graphical 
representation of C) percent positive cells for Ki-67, and D) relative fluorescent signal, from lysed 
fluorescent SA beta-gal assay, showing increased SA beta-gal with increasing confluence in 
BMMΦ cultures. These data show decreased percent proliferative cells as seen by Ki-67 and an 
increase in SA beta-gal with increasing cell density.  These data also confirm the ability of SA 
beta-gal to represent non-proliferative cells and the decrease in proliferative capacity of 
macrophages with increasing concentration. One-way ANOVA with post-hoc Dunnett Multiple 
Comparisons Test was applied, comparing all concentrations the 5K condition.  Significance is 















Figure 4.3. Discrimination of senescent versus quiescent BMMΦs using Ki-67 staining of cultures. 
A) cells passaged after 21 days and allowed to grow for 5, 7, and 10 days.  Passaged cells with 
and without serum as a mitogenic stimulator were compared to their respective time point prior to 
day 21, indicating that after 21 days, cells decrease their ability to proliferate, reflecting 
senescence. B) proliferation of cells cultured for 1 day at high confluence and 7 days after those 
cells were passaged and plated at low confluence in the presence and absence of serum. These 
data indicate regained proliferative capacity of cells after being plated at sub-confluency, 
indicating confluent cells become quiescent and not senescent. One-way ANOVA with post-hoc 
Student’s t-test was applied, comparing post-passages to the pre-passaged condition (i.e. Day 5, 
















Figure 4.4. Macrophage phagocytosis in quiescent and senescent cells. A) Bead phagocytic 
uptake in macrophages passaged after 21 days (shown in Figure 4.3 to be senescent) and 
cultured for 10 days were compared with bead uptake of their corresponding time point prior to 21 
days.  Data show a reduction in phagocytosis in cells at time points past 21 days. B) Bead uptake 
in macrophages at low and high confluency, indicating no significant change in phagocytosis at 
high confluence (shown in Figure 4.3 to be quiescent). One-way ANOVA with posthoc Student’s t-
test was applied, comparing postpassages to the prepassaged condition (i.e. Day 1, 7, and 21). 
Significance is noted as p<.05 * and p<.001 **.  C) Representative confocal image of BMMΦs with 
internalized beads.  This image is an overlay of 10 z-sections through the cell, indicating beads 





Figure 4.5. Proliferative capacity of primary BMMΦs over 21 days in culture in the presence of 
continual LPS stimulation.  A)  Color images of SA beta-gal staining in primary BMMΦs over 21 
days in the presence of LPS. Graphical representation of: B) percent SA beta-gal positive cells 
from the colorimetric SA beta-gal assay, C) relative fluorescence from the fluorescent SA beta-gal 
assay, and D) cell density shown as relative absorbance from the microBCA assay. These data 
show a delay in the SA beta-gal response compared to non-LPS treated macrophages (Figure 
4.1). One-way ANOVA with post-hoc Dunnett Multiple Comparisons Test was applied, comparing 




Figure 4.6. Effect of serial passaging on BMMΦ proliferation.  Fluorescence and color images of: 
A) DAPI and Ki-67, and B) SA beta-gal staining, respectively, in primary BMMΦ cultures with 
increasing passage numbers.  Graphical representation of: C) percent positive cells for Ki-67 
markers, and D) SA beta-gal (from fluorescent senescence assay) with increasing passaging in 
BMMΦs. These data show no dramatic increasing or decreasing trends in senescence with 
increased passaging. One-way ANOVA with post-hoc Dunnett Multiple Comparisons Test was 
applied, comparing all passages to the passage 1 condition. Significance is noted as p<0.05 * and 
p<0.001 **.  
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Predifferentiated BMMΦs 
SA beta-gal increased while Ki-67 decreased during the first 7 days of macrophage 
differentiation from bone marrow hematopoietic cell precursors (Supplementary Figure 4.3).  
Though by day 7 many now-differentiated macrophages expressed SA beta-gal, they were still 
able to be restimulated to divide when passaged at lower confluency.  This is seen in Figure 4.1, 
representing recently differentiated macrophages after passage and plating at a lower confluency, 
exhibiting decreased SA beta-gal and increased Ki-67 expression after a couple days of culture. 
 
Transformed RAW cell cultures 
RAW 264.7 cells stained positive for SA beta-gal with increasing time and confluency.  
LPS exposure decreased SA beta-gal staining over long-term culture and with increasing 
confluency (Supplementary Figure 4.4).  RAWs always responded to restimulation to proliferate 
regardless of culture time (data not shown) and passage number (passaged up to 30 times, 
Supplementary Figure 4.5). 
 
Discussion 
Macrophage culture duration to 21 days was selected as a terminal time point as it is the 
approximate time required for the foreign body response (FBR) to mature in vivo [43]. After 21 
days in culture, macrophages were found to be senescent and decrease their ability to 
phagocytose (Figure 4.4). This is consistent with the observed propensity of implants to infect [10, 
11], and implies that macrophages could lose their ability to phagocytose bacteria after extended 
exposure to biomaterials. Importantly, Jenkins et al. recently discovered that macrophages 
proliferate in vivo during Th2 inflammation [9]; thus, their senescence shown in culture over time 
could suggest a decreased ability to properly proliferate at implant sites in the presence of 
infection. A previous study also found that macrophages decrease their production of 
inflammatory cytokines over 21 days [36].  All these findings support a phenotypic shift over time 
that decreases macrophage competence, contributing to their inability to respond to bacterial 
invasion at the surface of an implant over time.  Macrophages from aged animals have also 
shown a decreased ability to be stimulated to divide [22] and a decreased phagocytic capacity 
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[20].  Thus, the longer the implant resides in the body and the older the individual [44] may 
increase their susceptibility to implant-centered infection. 
Various culture conditions are known to affect cell senescence in other cultured cell types 
including confluency, culture time, and passage number [17, 21, 45].  Passaging macrophages up 
to 10 times did not appear to have observable effects on their proliferation (Figure 4.6).  Confluent 
culture disposes macrophages to quiescence but not senescence.  This was substantiated by the 
ability of macrophages to be restimulated to divide upon passaging and mitogenic stimulation 
post-confluence (Figure 4.3).  This result is consistent with contact inhibition-induced quiescence 
[21, 37] shown in other cell types to also stain positive for SA beta-gal. Decreasing SA beta-gal 
staining at early time points during the 21-culture is attributed to confluence-induced quiescence 
of predifferentiated BMMΦ-staged cells (which were passaged and plated at lower cell confluence 
for the 21-day experiment, Supplementary Figure 4.3).   Dimri et al. have also shown reduced SA 
beta-gal staining 2 days after highly confluent cultures of normal human fetal lung fibroblasts were 
passaged [37].  Confluent cultures stained positive for SA beta-gal, indicating that although this 
assay is specific for senescence in other cell lines [21, 37], it stains both quiescent and senescent 
macrophages. Interestingly, we found a slight decrease in phagocytosis in confluent versus 
nonconfluent cultures. This decrease was not significant and was not as dramatic as in senescent 
cultures (Figure 4.4). 
Two metrics were used to determine senescence: 1) senescence-associated beta-
galactosidase (SA beta-gal) activity at pH 6 [37, 46], and 2) active cell proliferation (i.e., absence 
from the cell cycle G0 phase).[41]  Many cells produce beta-galactosidase at pH 4-5 in lysosomes, 
but it is unique among senescent cells to exhibit beta-gal activity at pH 6 [37].  Senescent cells 
have been postulated to provide an environment wherein modified lysosomal beta-gal structure 
remains active at neutral or alkaline pH [21] and that its increased lysosomal content 
characteristic in senescent cells makes it detectable [25].  While macrophages frequently up-
regulate lysosomal activity [47], the SA beta-gal assay used here may not selectively reflect 
macrophage senescence.  Therefore, despite common cell culture use of the SA beta-gal assay, 
its validation for macrophage senescence -- to our knowledge not yet reported -- was required.  
Therefore, senescence used was anti-Ki-67 antibody labeling of cells to target a protein 
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expressed only during active cell proliferation [41] in parallel with SA beta-gal staining.  
Significantly, anti-Ki-67 labels all cells in all active cell cycle phases (i.e., interphase and mitosis).  
Therefore cells were also labeled with phospho-histone H3, which labels cells only during S-
phase of interphase [42].  Results showed similar trends between Ki-67 and phospho-histone H3 
labeling (data not shown), validating the proliferative activity of cultured macrophages using Ki-67. 
Inverse correlation between cell Ki-67 expression and SA beta-gal staining suggests that SA 
beta-gal labels macrophages with decreasing proliferation tendency and not nonspecifically as a 
general function of increased macrophage lysosomal activity. 
As senescent cells are incapable of being restimulated to divide [48], passaging, 
mitogens, and both passaging and subsequent mitogenic stimulation were all employed in culture 
to determine if macrophages could be restimulated to divide.  Macrophages were allowed to first 
grow for at least 7 days in the presence and absence of mitogenic stimulation after passaging to 
determine if cells were quiescent (capable of being restimulated to divide) or senescent 
(incapable of being restimulated to divide) at the time when greatest cell proliferation is seen 
(Figure 4.1). 
The cell lysate-based fluorescent SA beta-gal assay did not correlate with the fixed cell 
colorimetric assay during extended culture time, showing instead an increase in SA beta-gal over 
the 21 day time-course in both LPS-stimulated and non-LPS-stimulated BMMΦ culture conditions 
(Figures 4.1 and 4.5, respectively).  This discrepancy is attributed to the observation that over 21 
days of culture, cells becoming senescent produced increasing SA beta-gal amounts within 
positive cells (Figure 4.1) so that total SA beta-gal amounts in culture wells after cell lysis 
increased over 21 days. This explanation is also supported by observations from increased cell 
confluence-dependent culture experiments where initially different plated cell densities were 
cultured for identical times.  These results showed that both SA beta-gal senescence assays 
consistently correlated with each other and also inversely with Ki-67 expression.  Percent of cells 
positive for SA beta-gal detected in fixed cells using the colorimetric SA beta-gal assay correlated 
inversely with percent cells positive for Ki-67, suggesting that over increased culture time, 
determining senescence on a percent positive cell basis is more representative of changes in 
proliferation than cell lysis methods.   
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As a positive control for Ki-67 and a negative control for senescence, secondary RAW 
264.7 macrophages that also have intrinsically high lysosomal activity [49] were labeled with 
these markers.  These immortalized cells were always shown capable of being restimulated to 
divide and subsequently expressed high levels of Ki-67 regardless of culture time or passage 
number, displaying 100% Ki-67 staining even at passage 30 (Supplementary Figure 4.5).  
Interestingly, these cells began to express SA beta-gal and decrease Ki-67 with increasing 
confluence, seen previously in immortalized fibroblast cultures at high confluence [21, 50]. This is 
significant as the ability of immortalized and essentially transformed cancer-like cells to quiesce is 
not commonly known.  Primary bone-derived murine macrophage cultures on plastic have already 
been shown to exhibit several characteristic features distinct from the transformed macrophage-
like murine RAW 264.7 cell line commonly employed as a macrophage surrogate in cultures [51-
53].   These differences include variances in morphology, cytokine secretion, receptor expression, 
proliferation, response to LPS, and metabolic output [31, 36]. These studies now confirm integral 
changes in macrophage proliferative capacity. 
Endotoxin, a lipopolysaccharide (LPS) found on the membrane surface of gram negative 
bacteria [54], is commonly used to stimulate macrophages [36, 55].  To determine if macrophages 
might avoid senescence during perpetual stimulation that may occur at an infected implant site, 
both primary and immortalized transformed macrophages were treated with LPS in serum-based 
culture [31]. LPS delayed the onset of SA beta-gal expression in primary BMMΦs, but did not 
eliminate it (Figure 4.5), and also ameliorated SA beta-gal expression in RAW cells 
(Supplementary Figure 4.4). We previously reported reduced inflammatory cytokine secretion 
from primary macrophage cultures in continued presence of LPS in 21-day cultures [36].  We 
attributed this phenomenon to macrophage endotoxin tolerance.  However, increased cell 
senescence in primary macrophages over time may also contribute to their attenuated cytokine 
response.  This idea is supported by increased senescence seen in BMMΦs over 21-day cultures, 





This study identified important phenotypic changes that macrophages undergo in 
extended culture that decrease their competence over time, including a decreased ability to 
proliferate and phagocytose, both integral responses for proper implant surveillance and 
antimicrobial activity. This finding may explain macrophages’ reduced ability to combat infection 
around biomaterials.  Important future work should determine if macrophages become senescent 
and decrease their ability to phagocytose around implants in vivo. Understanding the 
mechanisms that predispose implant sites to infection years after device deployment will aid in 
better addressing this important clinical issue, perhaps also considering that senescent-state 
macrophages may increase throughout the duration of implantation. This study demonstrated that 
the commonly employed senescence-associated beta-galactosidase assay labels both 
quiescence and senescence cells in macrophage cultures, and revealed conditions inducing 
quiescence but not senescence in cultured immortalized macrophage cell lines.  This is yet 
another difference between primary and immortalized macrophage cultures that produces 
inequities in their direct comparisons and perhaps their fidelity to macrophage in vivo behavior 
around implants.  Future studies employing this SA beta-gal assay for macrophages should 
validate it against additional markers of senescence and proliferation.  This study also found that, 
unlike senescent cells that display significantly decreased phagocytosis, quiescent cells have 
only slightly reduced but insignificantly different ability to phagocytose particles. This important 
functional measure distinguishes macrophage competence between normal and quiescent and 
senescent cells in extended culture.  
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Supplementary Figure 4.1. Representative images of primary BMMΦs labeled with A) F4/80 
macrophage maturity marker and B) M2 macrophage marker, CD206 (macrophage mannose 




Supplementary Figure 4.2.  Effect of chemical stimulation on BMMΦs after 21 days of culture. 
A) Overlay of brightfield and fluorescence confocal images of Ki-67 staining in cells after 
mitogen stimulation; B) Percent positive cells for SA beta-gal after cytokine stimulation; C) Color 
images of SA-beta gal (blue) assays after cytokine stimulation. No significant increases in Ki-67 
expression or decreases in SA beta-gal were seen in response to stimulation, suggesting that 
these cells are senescent. One-way ANOVA with post-hoc Dunnett Multiple Comparisons Test 
was applied, comparing all conditions with the control. Significance is noted as p<0.05* and 









Supplementary Figure 4.3. Proliferative capacity of monocytes and bone marrow cells prior to full 
differentiation into bone-marrow macrophages during the first 7 days post-harvest. A) Fluorescent 
images of DAPI and Ki-67 labeling, and B) color images of SA beta-gal expression in 
predifferentiated BMMΦ cells. C) Percent positive cells for Ki-67. D) SA beta-gal expression using 
the fluorescent SA beta-gal assay. Decreasing Ki-67 labeling and increasing SA beta-gal staining 
indicate cellular quiescence. One-way ANOVA with post-hoc Dunnett Multiple Comparisons Test 
was applied, comparing all days to the day 1 condition. Significance is noted as p<0.05 * and 














Supplementary Figure 4.4.  Color images of SA beta-gal expression in murine RAW 264.7 cells 
during 7 days of culture: A) without, and B) with LPS stimulation.  Graphical representation of 
fluorescent SA beta-gal C) over 7 days of culture, and D) with increasing confluence in the 
presence and absence of LPS stimulation; E) color images of SA beta-gal expression in RAW 
cells with increasing confluence over 24 hours. Positive SA beta-gal staining indicates quiescence 
in immortalize RAW cells. These data also indicate an ameliorated expression of SA beta-gal in 
response to LPS stimulation, indicating a decreased quiescence response. Cell lysates from 3 
wells of RAW cells were physically combined for each condition prior to employing the fluorescent 


















Supplementary Figure 4.5. Fluorescent images of DAPI and Ki-67 labeling in murine RAW 264.7 
macrophage cells after 30 passages, signifying no decrease in RAW cell proliferative capacity 










 SUMMARY AND FUTURE DIRECTIONS  
 
Summary of results 
This dissertation sought to address the hypothesis that cultured cells are not 
representative of in vivo cell behavior and this difference is exacerbated in immortalized cell lines 
compared to primary cells. The specific impact of this work can be summarized as follows: 
Chapter 2 aimed to develop a more representative in vitro model and identify feedback 
mechanisms that may be necessary to recapitulate in vivo signaling. Data presented there 
demonstrated that: 
• Primary and secondary macrophages are not equivalent in culture as shown by disparate 
responses to LPS exposure, cultured morphology, and cytokine production. 
• Primary macrophages demonstrate endotoxin tolerance with repeated exposure to LPS in 
culture -- more representative of in vivo responses than secondary macrophages that did 
not exhibit this tolerance. 
• Coculture of macrophages with fibroblasts is more representative of in vivo conditions 
than monocultures of either macrophages or fibroblasts based on cytokine signaling 
dynamics seen during coculture that are also seen in vivo but absent from monocultures. 
These results were published in Biomaterials: Holt DJ, Chamberlain LM, Grainger DW. Cell-
cell signaling in co-cultures of macrophages and fibroblasts. Biomaterials 2010;31:9382-94  
Chapter 3 aimed to establish the existence and mechanism for formation of multinucleated 
fibroblasts in culture.  Data presented there demonstrated that: 
• Fibroblasts, like cultured macrophages, can form multinucleated cells in culture. 
 
 
• Secondary fibroblasts can form multinucleate cells via fusion with other fibroblasts in the 
presence of secondary macrophage cultures. 
• Primary fibroblasts can multinucleate in culture with or without the presence of primary or 
secondary macrophages, but not due to fusion, but rather senescence-associated nuclear 
division without cytokinesis. 
• Primary multinucleated fibroblasts stain positive for replicative senescence. 
 These results were published in Biomaterials. Holt DJ, Grainger DW. Multinucleated giant 
cells from fibroblast cultures. Biomaterials 2011;32:3977-87. 
Chapter 4 aimed to determine the potential macrophages have to senesce in culture.  Data 
presented there demonstrated that: 
• Primary macrophages undergo quiescence during high confluence cultures and senesce 
during longterm culture. 
• Secondary macrophages undergo quiescence during high confluence cultures and 
longterm culture, but do not senesce. 
• Senescence is delayed in primary macrophages, and quiescence is ameliorated in 
secondary macrophages in the presence of lipopolysaccharide stimulation. 
These results have been accepted for publication in Biomaterials (July 2012) 
 
Impact of this work 
The work from this dissertation has further elucidated the in vitro phenotypes of 
macrophages and fibroblasts, two primary effector cells of the foreign body response.  The first 
study analyzed intracellular signaling between macrophages and fibroblasts and identified what 
feedback systems resulted in the most relevant signaling patterns. We found that macrophages 
and fibroblasts in coculture had more representative cytokine secretion patterns of in vivo implant 
scenarios compared to monoculture. Where current models primarily involve only monoculture to 
assess biocompatibility of drugs and devices, this work may lead to the formation and adoption of 




 The second study identified the existence of multinucleate fibroblasts.  The foreign body 
response is often characterized by the amount of foreign body giant cells (FBGCs) present.  
FBGCs are often counted as any multinucleate cell found at the surface of an implant.  The 
presence of multinucleate fibroblasts may confound these results.  By identifying the existence of 
multinucleate fibroblasts, their potential presence can now be accounted for. Additionally, 
understanding the existence of multinucleate fibroblasts may aid in deciphering their role in 
various pathologies including, fibrosis, aging, and cancer, where their presence has been 
postulated. 
 The third study performed for this dissertation work identified the senescence of 
macrophages in culture.  This phenotypic shift by macrophages could greatly impact their 
responsiveness in culture.  Additionally, though the surfaces of implants are ostensibly coated in 
hundreds of macrophages indefinitely, if the macrophages are senescent and unable to respond 
to bacterial colonization, infection could proceed unchecked.  Understanding this potential change 
in macrophage behavior may also enable more appropriate prophylaxis and treatment of infected 
implants. 
 Each of these studies have compared the behavior of primary versus secondary derived 
cells and have identified large disparities between them, with primary cells representing in vivo 
behavior more accurately than secondary cells.  Though secondary cells are commonly employed 
in culture due to their ease of culture, cost effectiveness, and the lack of ethical concern 
associated with them, their use may yield misleading results.  This work substantiates their 
variability and suggests use of secondary cells be validated against primary cells and/or in vivo 
systems. 
 In general this work has identified unique behavior elicited by both macrophages and 
fibroblasts in culture.  This increased understanding of their behavior in various culture conditions 
will enable more accurate data interpretation and better experimental design in future studies. 
This dissertation work has also identified conditions where macrophages and fibroblasts better 
represent in vivo responses; however, further improvement can be made by adding increased 
sophistication to in vitro cultures including wounding and 3D growth .  A proposal for these in vitro 






Though the FBR is a ubiquitous phenomenon, there are ways to ameliorate its 
deleterious effects on implants; some of these methods are described below: 
  
Genetic targets to impact the FBR 
 Through the use of knockout (KO) models, potential gene targets that could one day be 
treated with pharmacological agents or genetic engineering approaches have been identified to 
ameliorate the FBR.   
 MCP-1 is an important chemoattractant for macrophages and has been hypothesized to play 
a role in FBGC formation and the FBR.  Kyriakides et al implanted cellulose ester filters and polyvinyl 
alcohol sponges in MCP-1 KO mice.  They found FBGC numbers surrounding the filters were 
reduced by 75% and the sponges were reduced by 90% within MCP-1-null mice.  They also found 
that the number of nuclei per cell was decreased in MCP-1-null mice.  They did however still find an 
abundance of macrophages even though there were fewer or no FBGCs. Importantly, despite a 
reduced formation of FBGCs in MCP-1-null mice, capsule formation proceeded normally around the 
implants [1].  The pleiotropic and redundant nature of the signaling pathways could account for the 
continued capsule formation, even with a KO of a significant signaling molecule and a subsequent 
reduction in FBGC formation. This study indicates that MCP-1 would not be a useful target against the 
FBR. 
 This same group also looked at the effect thrombospondin 2(TSP2) had upon the FBR.  They 
implanted polydimethylsiloxane (PDMS) into TSP2-null and control mice.  After 4 weeks, they found 
that fibroblasts aggregated on the surface of implants in the TSP2-null mice, rather than as a 
monolayer, as in the control mice.   Interestingly they found the collagenous capsule in the TSP2-null 
mice was highly vascularized and thicker than that formed in normal mice and consisted of 
abnormally shaped collagen fibers [2].   
                                                            
1 This section has been adapted in part from the book chapter: Holt DJ, Grainger DW. Host Response to 






 Another study added MMP-9 (a matrix metalloproteinase responsible for extracellular matrix 
remodeling) function-blocking antibodies to a macrophage culture and discovered a reduced ability of 
macrophages to fuse to form FBGC.  This discovery prompted the Kyriakides group to study the effect 
MMP-9 had upon the FBR.  They implanted cellulose ester disks and polyvinyl alcohol sponges into 
MMP-9 KO mice. After 4 weeks, they identified equal macrophage recruitment between wild-type and 
MMP-9 null mice. but found that null mice had decreased angiogenesis and increased capsule 
thickness compared to control animals [3], making MMP-9 a poor target against the FBR. 
 Plasma proteins such as fibronectin have been shown to modulate inflammatory cell 
recruitment and activation.  Because of this, the Garcia group selected plasma fibronectin as a target 
to ameliorate the FBR. They implanted fibronectin KO mice with polyethylene terephthalate disks and 
observed the fibronectin depleted mice had a twofold thicker fibrous collagen capsule compared to 
control wildtype animals.  Additionally, though acute leukocyte recruitment and macrophage numbers 
were unaltered in the KO mice, the formation of FBGCs was three times higher, indicating fibronectin 
as a poor FBR target.  It has been hypothesized that FBGCs form from frustrated macrophages, [4] 
and where the absence of fibronectin could perturb macrophage adherence, this KO could induce 
their fusion to form FBGCs.  
 SPARC (secreted protein, acidic and rich in cysteine) is a protein that modulates the 
interaction of cells with the ECM. After 4 weeks, SPARC-null mice implanted with 
polydimethylsiloxane (PDMS) and cellulose filters displayed significantly reduced vascular density 
and the associated collagen fibers were smaller, less mature and more uniform compared to wildtype 
animals.  Significantly the thickness of the capsule was decreased in SPARC-null mice compared to 
wildtype [5], indicating SPARC could be a viable FBR target. 
 Significantly, though many signals are prominently found in the context of the FBR, their 
absence has thus far not equated to the absence of the FBR.  As mentioned previously, this may be 
due to the redundancy of the signaling pathways within the body that enable other signaling 
mechanisms to proceed in the absence of others.  Interestingly, KOs of targets that are hypothesized 
to reduce capsule thickness due to an alteration in the effector cells of the FBR can actually result in 
thicker capsules.  However, the absence of some signals such as SPARC has been shown to reduce 




overlapping of signaling pathways, complete elimination of a fibrous capsule or localized inflammatory 
cells surrounding implants may not be achievable through eliminating pieces of signaling pathways.  
Eliminating entire signaling pathways or major players such as macrophages may provide more 
promise.  Clodronate for example can selectively deplete macrophages, and may be able to mitigate 
the FBR if applied locally [6]. However, the consequences of eliminating major players may yield more 
damaging consequences than the FBR. 
  
Increasing porosity to reduce the FBR 
 To increase implant-associated vascularity and associated transport and perfusion, 
tissue infiltration, and reduced overall FBR magnitude, biomaterials with controlled pore size and 
void fractions are often used. Interestingly, Rosognren et al. identified porous membranes or 
filters with pore sizes small enough to prevent macrophage infiltration that exhibited a more 
pronounced FBR when compared to membranes with pore sizes large enough to enable 
macrophage infiltration [7]. Additionally, they found that filter-associated capsule formation was 
correlated with macrophages found outside the filters as opposed to those infiltrating them. Filters 
with the largest pore sizes had the most macrophages residing in the internal porous structure, 
and the fewest found to the outside. They also found an increased vascularity within the filters in 
the larger pore sizes compared to smaller ones. Similar results showing a decreased FBR and 
increased implant site vascularity are described by Ward et al. [8] and Brauker et al. [9]. Others 
have also reported increased vascularity with increased porosity [10-12].  
Table 5.1 shows an increase in vascularity adjacent to implants with increased porosity. 
This trend was seen with various porous polymers including cellulose, PTFE, polyurethane, and 
acrylic polymers.  Macrophage penetration and colonization of the implant pores appears to 
promote angiogenesis over FBR fibrosis. However, though increased porosity of synthetic 
material decreases the FBR, macrophage insult and subsequent fibrous encapsulation still occur.  
 
Table 5.1. Comparison of implant pore size, cell penetration, vascularity, and relative FBR. 
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glucose sensors and pumps with a pseudo pancreas), but are infantile in their development and 
may still suffer from host attack. Thus, the solution to completely resolving the FBR, especially in 
the immediate future, will likely lie in the combination of multiple approaches elegantly executed. 
 
Next steps 
Though coculture of  macrophages and fibroblasts provided more representative 
signaling  behavior than monocultures as described in Chapter 2, this model could be improved 
by addressing missing key in vivo FBR events, including fibrosis, inflammatory cell migration, and 
cytokine signaling in response to an implant.  The incorporation of these events in an in vitro 
model may be able to provide a more representative in vitro model for studying the foreign body 
response as well as provide a more relevant platform for device screening compared to current in 
vitro models that do not address these events.  Specific experiments for this future work are 
proposed below in the preliminary study.   
Chapter 3 identified culture conditions and mechanisms by which primary and secondary 
fibroblasts multinucleate. However, further experiments identifying changes in phenotypic 
behavior of these cells such as metabolic rates and products, collagen secretion and ability to 
phagocytose etc. would be valuable as these behaviors may affect the host response to implants 
in vivo [2, 8, 9, 14-16, 34-40]. Important future work will be to identify if this phenotype exists at 
the surface of an implant in vivo.  Macrophage- and fibroblast-specific markers, (such as F4/80, 
CD14, CD40, macrophage mannose receptor (MMR), CD11b, and CD18 for macrophages [41, 
42] and FSP-1, FGF-1, and FGFR-1 for fibroblasts [43, 44]) could be stained around implants in 
vivo to determine the precise origin of the multinucleated cells. Macrophages and fibroblasts 
labeled with long lived intracellular red and green dyes, transfected or obtained from genetically 
engineered mice to express red and green fluorescent proteins can also be injected/implanted 
into animal models to determine 1) in vivo fusion or mitosis without cytokinesis and 2) confirm 
multinucleated cells of macrophage or fibroblastic origin as has been demonstrated previously for 
fusion experiments [42, 45]. 
Chapter 4 identified culture conditions by which primary macrophages senesce.  Future 




determine the Hayflick limit of this cell type.    Future work identifying changes in macrophage 
phenotypic responses due to quiescence and senescence including: phagocytosis, enzyme and 
cytokine secretion, and external receptor expression would be valuable as these behaviors 
determine the activity and consequently response of macrophages to both implants and invading 
pathogens in vivo [40, 46-48]. Macrophage quiescence and senescence in vivo could explain the 
decreased activity macrophages display over time and may address the risk implants have to 
become infected years after surgery even when ostensibly coated in hundreds of macrophages. 
Essential future work would be to identify if this phenotype exists in vivo at implant sites.  Tissue 
sections surrounding implants could be stained for senescence-associated betagalactosidase (SA 
betagal) expression in surrounding cells.  Colabeling experiments could identify colocalization of 
SA betagal specifically in macrophages, using macrophage-specific markers: F4/80, CD14, 
CD40, macrophage mannose receptor (MMR), CD11b, and CD18 [41, 42].  Animals could also be 
inoculated with bacteria such as Staphylococcus aureus (commonly employed for rodent infection 
models [49]) to 1) verify the propensity of the implant to become infected and 2) determine if SA 
betagal expression could decrease in macrophages over time (indicating senescence rather than 
quiescence as SA betagal has been shown to be expressed during both resting states in 
macrophages, detailed in Chapter 4).  The injection of fluorescently labeled macrophages using a 
long lived intracellular dye [42] into a rodent tail vein [50] after bacterial challenge could also 
determine the recruitment of new macrophages to the implant site in addition to resident 
macrophages that may be quiescent.  Determining the number of active macrophages after 
bacterial insult (those not expressing SA betagal), could shed light on the mechanism of infection 
of implants after long periods of times.  Multiple time points could be tested to analyze the 
threshold of time at which infection may become more prevalent, and potentially correlate this 
with SA betagal expression in implant-resident macrophages. 
 
Preliminary study: improved in vitro cell  
culture model of the FBR 
Though the FBR is a nearly universal response to implanted materials of widely varying 




are largely unknown. The consequence of not fully understanding this process impedes the 
development of more successful longterm indwelling devices such as glucose sensors, neural 
recorders, orthopedic implants and many other longterm devices [51-55]. A greater understanding 
of the FBR will enable better development of materials and therapies to combat its deleterious 
effects against implanted material. A highly controllable in vitro model will aid in deciphering this 
complex phenomenon. Additionally a more representative in vitro model of the FBR will enable: 1) 
increased fidelity of materials and device biocompatibility testing prior to in vivo implantation, 2) 
decreased screening costs compared to in vivo studies, 3) more accurate high throughput testing, 
and 4) increased identification of materials with a dampened FBR.  
Current in vitro models of the foreign body response involve culturing macrophages or 
fibroblasts to confluency on tissue culture polystyrene (TCPS) and then placing the material to be 
tested on top of the layer of cells [56, 57] or culturing cells on top of the material [58-60]. This 
rudimentary design is unable to properly recapitulate semblance of a fibrous sheath, cell 
migration, and changes in cellular phenotype with respect the implant interface as seen in vivo.  
 Cocultures employing both macrophages and fibroblasts, two primary effector cells of the 
FBR, yielded promising results, showing feedback mechanisms representative of in vivo 
conditions (Chapter 2) [61]. However, this model is inadequate to recapitulate fibrosis, ubiquitous 
to nearly all implanted materials, 
 A previous model aimed at addressing multiple aspects of the FBR yielded promising 
results. Reichert et al. cultured a mixed population of the neural cell types known to play a major 
role in the observed in vivo tissue reactions, such as neurons, astrocytes, and microglia, to 
confluency, and placed a stainless steel wire over the top of them [62]. In another culture dish, 
they also addressed tissue wounding occurring in vivo by culturing the cells to confluency and 
then scraping a portion of them away. They found a measure of gliosis, seen in vivo, was 
replicated in their system with infiltration of glial cells into the wound area and around the wire, 
surrounding hypertrophic astrocytes, and a reduced number of neurons. These results indicated 
that cells in vitro could respond to a device similar to in vivo cellular response. 
We established a comparable model to recapitulate integral aspects of the in vivo FBR, 




“implant” on the same size scale as cells.  The small scale of the wire readily enabled analysis of 
interfacial changes between the cells and biomaterial placed in culture. Cell localization, 
phenotypic alterations and collagen production with relation to the cell-implant interface were 
assessed. Events comparable to those that occur in vivo adjacent to implants, such as 
macrophage and fibroblast recruitment and organization [36, 63], altered cellular phenotype 
including upregulation of macrophage marker CD14, seen in activated macrophages [41, 42] and 
upregaulation of αSMA, seen in fibrotic fibroblasts [64-67] adjacent to implants were seen.  A 
measure of fibrous encapsulation, prominent surrounding implants in vivo [2, 8, 9, 14-16, 34-39] 
was noted as demonstrated by increased staining of Sirius Red, a collagen-specific dye.  This 
model may readily enable a better screening process for materials prior to in vivo implantation as 
well as provide a more accurate model to study the FBR in a controlled in vitro system. 
 
Methods and materials 
Primary fibroblasts were harvested from the ear dermal tissue of 3- to 4-month-old male 
C57BL/6 mice, while monocytes and hematopoietic cells precursor cells were harvested from the 
bone marrow and differentiated into macrophages using a previously established protocol7. 
Primary fibroblasts (5,000) and macrophages (20,000) were cultured in 96 well plates in physical 
contact with one another for 10 days. This ratio was selected to prevent the more highly 
proliferative fibroblasts from overtaking the surface of the well. 
 Implants were made of stainless steel flat wire (large: 76.2 µm high and 254 µm wide, 
medium: 25.4 µm high and 76.2 µm wide, and small: 12.7 µm high and 63.5 µm wide).  These 
dimensions were selected so that the implant would be on the same size scale and therefore 
plane as the cells, and readily enable imaging interfacial changes.  The size of these implants is 
also useful in representing electrodes, leads, and sutures, that are on the same size scale as the 
implants selected for this study, and commonly implanted in vivo [68, 69]. 
 Brightfield microscope images were taken of live cells. Cells were stained with a green 
Vybrant® CFDA SE or a red Cell Trace Far Red DDAO-SE long lived intracellular dye in order to 
distinguish between fibroblast and macrophage populations during coculture. A fluorescently 




activation near the implant interface.  Cell nuclei were stained with DAPI.  Sirius Red was used to 









Figure 5.1. Brightfield images of cocultured macrophages and fibroblasts over a period of 10 days 
(a time required for many aspects of the FBR to develop in vivo [71]).  This figure shows 
increased cell migration to the implant interface over time. Representative images were selected 
from three independent replicates.  
 
 
We were able to see migration, localization  and distribution of macrophages and 
fibroblasts adjacent to implant surfaces (Figure 5.1), regardless of implant size (Figure 5.2)  at 
short (Figure 5.6) and longterm (Figure 5.7) culture times, comparable to that seen in vivo [36, 
63]. Increased collagen, prevalent in vivo [2, 8, 9, 14-16, 34-39], was detected using the Sirius 
Red Assay at the interface of the implant in this culture system (Figure 5.3). Also, upregulation of 
macrophage and fibroblast activation markers, seen in vivo [41, 42, 64-67], were detected in this 








Figure 5.2. Brightfield images of large (top row) and small (bottom row) flat wires in cultures of 
macrophages only (column 1), fibroblasts only (column 2), and macrophages and fibroblasts in 
direct contact (column 3) after 10 days of culture. This figure shows increased cell localization 
near the implant interface regardless of cell type and implant size. Representative images were 








Figure 5.3. Brightfield images of Sirius Red stained (A and B small and (C large flat wires after 10 
days of fibroblast and macrophage coculture.  This figure shows increased red stain, and 
therefore collagen produced adjacent to the implant interface. Representative images were 











Figure 5.4. Confocal images of A) DAPI, B) macrophage marker—CD-14, and C) an overlay of the 
red and blue channels.  This figure shows increased CD-14 intensity adjacent to the implant 
compared to distal from the implant.  This is due to increased cell number at the implant interface 
and increased CD-14 expression per macrophage adjacent to the implant (as seen by dim CD-14 
staining per macrophage distal to the implant). Representative images were selected from three 










Figure 5.5. Confocal images of anti-CD14 labeling in BMMΦs cultured with a stainless steel wire 
(A and B).  These images show an increased intensity of CD-14 labeling in cells adjacent to an 
implanted wire.  C) α-smooth muscle actin (α-SMA) staining in a mixed population of primary 
BMMΦs and primary fibroblasts adjacent to an implanted stainless steel wire.  Upregulation of 
CD-14 and α-SMA are both seen in vivo at implant surfaces [41, 42, 64-67]. Representative 





Figure 5.6. Confocal images of a coculture of prelabeled fibroblasts (red, Column 1) and 
macrophages (green, Column 2) and an overlay (Column 3) of red and green channels 
surrounding large (Top Row) and medium (Bottom Row) flat wire after 3 days of culture.  This 
image shows a higher affinity for the implant surface in macrophages compared to fibroblasts.  
This phenomenon is consistent with implants in vivo where macrophages are found 1-2 cell layers 
thick directly adjacent to implants [36, 63]. Representative images were selected from three 




Figure 5.7. Confocal images of cocultured prelabeled fibroblasts and macrophages surrounding 
large flat stainless steel wire after 7 days of culture. A) Green fibroblast and B) blue macrophage 
channels are shown. C) Overlay of green and blue channels revealing labeled macrophages and 
fibroblasts.  This image shows macrophages directly adjacent to implants and fibroblasts more 
distal (both denoted by arrows).  This distribution is consistent with in vivo macrophage and 








Discussion and future work2 
 We were able to successfully develop and characterize an in vitro model that is able to 
recapitulate in vivo: migration of FBR-relevant cells (i.e. macrophages and fibroblasts), increased 
collagen (detected using the Sirius Red Assay at the interface of an implant), increased 
expression of macrophage and fibroblast activation markers, and distribution of macrophages and 
fibroblasts adjacent to an implant. 
It is difficult to elucidate if cell localization near the implant is due to an active foreign body 
response or if it is simply due to the presence of a material with increased surface area for cells to 
attach to. To address this issue, inflammatory cytokines should be stained in situ to determine if 
an active cytokine gradient is formed in response to the implant. 
The increased collagen staining seen in Figure 5.3 may due to increased collagen or 
simply increased cell density which may be nonspecifically stained with Sirius Red. A collagen 
specific antibody should be used in situ which will eliminate any misleading nonspecific binding.  
Confocal reflection microscopy can also be utilized to determine collagen alignment adjacent to 
the implant surface, as highly organized and dense collagen is seen in vivo adjacent to implant 
surfaces compared to distally found more disperse and randomly aligned fibrils [72-75]. 
Though this two-dimensional (2D) model has the potential to improve upon current 2D 
systems, it is inherently missing critical aspects of the in vivo FBR. 2D systems cultured on rigid 
TCPS plastic are inherently flawed for several reasons, including the fact that TCPS is a foreign 
material not found natively within the body and elicits a dramatic FBR when implanted [76, 77]. 
Furthermore, TCPS is a rigid surface to which cells are not accustomed, and they are never 
grown as a monolayer or sandwiched in between TCPS and a biomaterial in vivo as they are in 
current in vitro models. Thus any in vitro model of the FBR will be confounded by the presence of 
TCPS. Other studies have identified this problem and coat TCPS with collagen, laminin, 
fibronectin, or other naturally-derived materials in order to better represent the in vivo condition 
[78-81]. However, these studies 1) often only implement a single adhesion protein, 2) still possess 
a culture surface more rigid than any in vivo extracellular matrix (ECM) protein (not attached to 
                                                            




solid TCPS), and 3) do not address the intrinsic constraints of 2D cell culture. These constraints 
are not seen in vivo and may be just as foreign as TCPS, also producing confounding results.  
Every implant in the body will create a wound, yet this critical feature is inherently absent 
from 2D culture. In a 2D system, wounding and subsequent implantation cannot be duplicated, as 
wounding will merely remove the cells, preventing them from coming into contact with the device. 
In vivo, though a wound is created, cells remain on all sides of the implant, enabling their 
subsequent response to that implant. In contrast, a three-dimensional (3D) environment would 
allow for wounding and subsequent implantation in vitro while the cells are still able to be in 
contact with the foreign material, similar to the in vivo condition, where a confluent 3D construct 
can be sliced through (analogous to slicing in vivo) and allow an implant to be placed in the 
previously wounded area. 
Significantly, another missing aspect in 2D in vitro models is the ability to analyze 3D 
fibrosis, a ubiquitous in vivo phenomenon around most implants. Current models analyze 
production of TGF-β, procollagen in the media, or even collagen adhered to the plastic tissue 
culture surface dish, but are not able to recapitulate the 3D collagenous encapsulation that occurs 
in vivo. In vitro models are known to have incomplete procollagen processing and poor matrix 
formation compared to in vivo [82]. To combat this, efforts are made to artificially stimulate the 
environment to increase collagen production. One example of this is known as a “scar-in-a-jar” 
that adds exogenous dextran sulfate to increase the “molecular crowding” in the Petri dish, 
resulting in increased collagen production [82]. However, it has been shown that cells grown in 3D 
produce significantly more ECM than cells in 2D culture [83]. Perhaps this is due to cells being 
able to grow and behave in their native 3D confirmation. When cultured in a 3D scaffold, FBR-
relevant cells will likely be able to naturally produce increased collagen, eliminating the need to 
stimulate their production artificially.  
In vitro models constrained to 2D can only address certain aspects of cell inflammatory 
signaling and cannot adequately address more complex cellular dynamics such as fibrosis, 
implant-specific signaling, and 3D localization and phenotypic expression of macrophages and 
fibroblasts at the implant surface. In vivo, the FBR is marked by localization and phenotypic 




and increased concentrations and localization of inflammatory cytokines adjacent to implant 
surfaces. Future studies could address these issues by culturing a mixed population of 
macrophages and fibroblasts, both critical to the FBR, in 3D naturally-derived scaffolds made of 
multiple ECM proteins which will: 1) serve to stimulate 3D growth, 2) enable increased ECM 
production, 3) remove contact of the cells by any foreign material (other than that implanted), 
importantly 4) enable 3D encapsulation of an implant by cell-secreted ECM and 5) enable actual 
wounding and implantation more similar to that seen in vivo. 
The use of an in vitro model over an in vivo model will still enable highly controlled 
mechanistic studies that are capable of high throughput testing.  Human cells in lieu of animal 
cells can also be employed with this 3D in vitro model, compared to traditional animal models. 
Implementation of a more physiologically relevant in vitro model will facilitate more accurate 
material and device screening for highthroughput biomaterial response testing and provide a 
more representative yet simple tool to further investigate mechanisms of the foreign body 
response. 
3D cell culture has been proven to produce more accurate and relevant cell morphology 
and behavior and should allow for a more representative in vitro model of the FBR for 
fundamental mechanistic studies. Additionally, an improved ability to replicate in vivo cell-cell 
interactions and responses to a surgical wound and subsequent device implantation should 
provide a more realistic model for screening the FBR to new biomaterials and to study basic FBR 
mechanisms.  
Additionally, accurate models will need to incorporate proper serum and proper serum 
levels.  Many models continually expose cells to fetal serum.  This can produce misleading results 
due to the presence of perpetual fetal serum that is only seen during 1) fetal development and not 
adulthood (which most assays intend to model) and 2) acute phase healing that subsides after 
hemostasis in vivo.  A more representative model could be simulated with a low level of serum 
such as 2% adult serum for the first 24 hours (as has been used in other primary cell culture 
models [62]), levels found at the in vivo wound site, and would provide the necessary growth 




stimulation with serum, enriched serum-free media would be most representative of the chronic in 
vivo scenario. 
Due to the complexity of in vivo models and insufficiently representative in vitro models, 
the FBR remains a poorly understood phenomenon. The scientific community would greatly 
benefit from a properly designed 3D in vitro model capable of recapitulating in vivo FBR events, 
currently unattainable with existing 2D models and growth conditions.  
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Protocol:  3T3 cell culture     
Dolly Holt 
Date Entered:  03-7-2012 
  
• Complete Media 
o DMEM high glucose + L glutamine 
o + 10% FBS 
o + 1% antibiotic/antimycotic 
• Place 10 ml of complete media  in a T75 flask and place in incubator to prewarm for 10 
min 
o Spray with 70% ethanol and place in sterile hood 
• Thaw a cryovial of 3T3s in a 37 °C water bath (this will only take a couple of minutes) 
• When the vial is nearly thawed, remove from water bath, dry off, spray with 70% ethanol 
and place in hood. 
• Using a 5 ml pipette, transfer contents of vial into T75 
• Remove some of the media in the T75 and add it to the cryovial to remove any residual 
cells 
o Repeat this a couple of times until you feel you have removed all of the cells 
• Place T75 in incubator and allow cells to adhere.  This may take 2-5 hours. 
• After cells have adhered, prewarm complete media and replace media above cells 
o The purpose of this is to remove residual DMSO that was in the frozen cells 
• Replace T75 in incubator 
• Cells will take 3-4 days to reach confluency 
Passaging 
• When cells are 80% confluent they need to be passaged 
o This occurs when what appears to only be 20% of the area of the T75 is still 
available for cell growth 
• Fibroblasts are not contact inhibited, so they will begin to grow over the top of one 
another if they become more than 100% confluent. 
o Once they begin to grow on top of one another, they may change their 
phenotype, so it is important to keep a close watch on these cultures 
• To passage the cells, aspirate off the media, and add 3 ml of TryplE in a T75 flask, just 
enough to cover the cells 
• Watch the cells under the microscope, in about 5 minutes they will begin to ball up. 
• Before they have completely detached you can carefully return the T75 flask to the 
incubator (being careful not to hit it on anything as that will knock the cells off) and gently 
remove as much TryplE as possible.  Don’t tilt the flask, just remove the media from the 
top. 
• Add 5 ml complete media and using the pipette, gently wash the cells from the bottom of 
the flask. 
• Once they are all detached, transfer 10% of the volume (500 ul) into a new flask and add  
10 ml of complete media. 
o You may use the remaining cells for experimentation by using them directly or 
plating them into a 96-well plate for example. 
• Place T 75 in 37 °C incubator with 5% supplemental carbon dioxide 
o Cells will take 4 days to reach confluency.   
o You may always add more cells to reach confluency faster.  Be careful when 
adding fewer cells, if you add too few, the cells will never become confluent, but 
will grow in small clusters and become quiescent. If this happens, you may still 
passage them and plate them at a higher density to stimulate them to grow, but 
you have now affected their phenotype. 
• The passaging technique described can take some practice, so if you feel more 




the cells have become completely detached.  You can knock the flask on the counter to 
dislodge the cells 
• Add a greater amount of complete media than TryplE (eg 5 ml). Complete media has 
antitrypsin that will inhibit the function of the enzyme.   
• Use a pipette to gently rinse the remainder of the cells from the bottom of the flask. 
o Theoretically, your cells should be fine with residual triple, but if they are not 
behaving properly, you may want to remove any residual TryplE by adding the 
cells to a 15 ml conical tube and centrifuging them at 500 rcf for 5 min, aspirating 
the supernatant, and resuspending the pellet in complete media. 
? Centrifuging can be damaging to cells, so you can also plate them, and 
after they are adhered (a couple of hours), then you can replace the 
media with complete media (just as was done to remove the DMSO)  
• Transfer 10% of the volume to a new T75 flask and add 10 ml of complete media 
• Place T 75 in 37 °C incubator with 5% supplemental carbon dioxide 
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 Protocol: ASC Isolation 
Updated: 12.29.08 
Author: Dorthyann Isackson  
References: (Torres, Rodrigues et al. 2007), (Zuk, Zhu et al. 2001), (Prichard, Reichert et al. 





? Rabbit: dorsomedial behind cranium on shoulder region 
? Mouse: epididymal, inguinal (iliac region) and neck region 






? Sterile PBS 
? Sterile Falcon Tube or container for adipose 
 
Method: 
? Under sterile conditions, make small incision (~1 cm) over adipose compartment  
? Gently extract adipose tissue from epididymal fat pad 
? Place adipose in sterile PBS 
? Wash extensively in sterile PBS to remove residual blood 





? Collagenase, Type I (1 gram, Invitrogen, Cat No. 17100017) 
? Sterile PBS 
? DMEM w/10% FBS, 1% antibiotic/antimycotic 
? 160 mM NH4Cl 
? T-75 tissue culture flask 
 
Method: 
? Digest tissue ECM in is 0.2% Collagenase Type I (2 mg/ml) in PBS at 37°C for 45 
minutes in agitating water bath 
? Neutralize enzyme digest with equal volume of DMEM w/10% FBS and 1% anti/anti  
? Centrifuge at 1200g for 10 min at RT  
? Discard supernatant, resuspend pellet in 160 mM NH4Cl, incubate at RT for 10 min to 
lyse RBCs (optional) 
o 160 mM NH4Cl 
? .160 Mol/L x (0.5 L) = 0.08 mol x (53.45 g/mol NH4Cl) = 4.28 g NH4Cl + 
500 ml sterile PBS 
? Centrifuge at 1200g for 10 min at RT  
? Discard supernatant, resuspend in DMEM/F-12 (1:1) w/10% FBS and 1% 
antibiotic/antimycotic 




Plating and Cell Expansion: 
 
Materials: 
? DMEM/F-12 (1:1) w/10% FBS and 1% antibiotic/antimycotic 
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 ? T-75 tissue culture flask (or desired plating container) 




? Change media 24 hrs after plating, then change media every 2-3 days thereafter 
? Determine cellular viability and numbers at time of passage by trypan blue exclusion and 
hemacytometer cell counts 






* Alternative is 0.2% Collagenase (2 mg/ml) as last noted in lab book (Book 1, page 126-127) to 
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Protocol:  BMMΦ Media Details    
Dolly Holt 03-31-2011   
Reference(s):  Orme lab protocols 
 
Part I. L929 conditioned media 
 
Purpose: To define a procedure for L-929 Conditioned Media.  L-929 cells secrete growth factors needed 




? RPMI Medium 1640 (+ L-glutamine) with 10% heat inactivated  FBS and 1% antibiotic/antimycotic 
? Sterile T175 flask 
? Pipettes and pipettman 
? Micropipettes and micro-pipettor  
 
Procedure: 
? L-929 cells from ATCC are grown up at 4.7x105 cells total.  Cells are allowed to grow for 7 days or 
until confluent.  On day 7 collect the supernatant and filter through a 0.45 ųm Nalgene filter.  You 
can centrifuge the supernatant for 10 minutes, 1000 rpm, at 4oC prior to filtering to remove any 
large debris.  This will make the filtering go faster.  Then label and freeze at –20oC in 50 ml 
aliquots. 
 
Part II. BMMO Media 
 
BMMO Media (total 500 ml) 
• 10% (50 ml) Hi (heat inactivated) FBS 
• 10% (50 ml) L929 cond Media 
• 1% (5 ml) HEPES 
• 1% (5 ml) Antibiotic/antimycotic 
• 1% (5 ml)  MEMS non essential amino acids 
• 1% (5 ml) Na Pyruvate 
• In high glucose DMEM + L-Glutamine 
 
*Be sure to remove the same volume of liquid you are going to add back in so that your 





SOP for Flow Cytometry Portion of CBA Assay 
Prepared by Dolly Holt 
06/18/2008 
 
Prior to CBA 
• Collect media from cells and store at -80 deg C until all samples have been collected. 
• Once all samples are collected, thaw media aliquots and vortex to mix contents.  
• Spin at 500 rcf for 5 minutes 
• Remove 50 µl to be used in the CBA assay 
 
Before you go to the Cytometry lab: 
• Bring set up beads, P1000 and p10 pipette, tips for pipettes 
 
Once you get to the lab 
1. Log in at one of the FACSCANs 
2. Double-Click Rainbow 
a. FACSCAN 2:  File->import settings-> BD Applications->temp data-> Grainger-> 
CBA->CBA Settings 040407 
b. FACSCAN 1:  File->import settings->BD Applications->temp data-> Grainger-> 
CBA->CBA Settings Mac-> CBA Settings 040407 
3. Double-Click Cell Quest  
a. FACSCAN 2:  File->open-> BD Applications->temp data-> Grainger-> CBA-
>CBA Acquisition 061307 (or most recent data file) 
b. FACSCAN 1:  File->open-> BD Applications->temp data-> Grainger-> CBA-
>CBA Settings-> CBA Acquisition 061307 (or most recent data file) 
c. Acquire->Connect to Cytometer (If it will not connect it is because the computer 
needs to be turned on either before or after the flow cytometer) 
d. Cytometer->instrument settings->open-> BD Applications->temp data-> 
Grainger-> CBA->CBA Acquisition 061307 (I think it might be settings 040407) 
(or most recent data file)-CLICK SET!!->done 
e. Acquire->Acquisition and Storage-> 300 Xs # of Analytes = # of Events to collect 
of  gate G1=R1 
f. Acquire->Parameter Description->Folder->Select folder ex. 02052008->Select-
>File (rename the prefix and set the number to start counting at 1)->OK 
g. In Rainbow Preference Dialog Box->update 4/5 color settings->Choose Base 
Directory-> Select the folder that the files are being saved to ex. 02052008 in 
CBA in Grainger -> Choose->OK 
h. Acquire->Counters 
i. Must unclick the setup to save! (Now your 1st sample will show up in the 
directory heading). 
ii. If you have set your events properly it will stop once the # of events is 
collected, save, and automatically move to the next sample in the 
directory 
iii. If for whatever reason you need to stop earlier or manually->click pause 
and save. 
i. Turn the knob on the cytometer to run and high, make sure that the light that said 
“Standby” when the knob was at standby now says “Ready”. 
j. Run Test Beads to locate clusters.  Bead A9 should be in the upper right corner 
k. Run 0 standard and make sure you see all 6 clusters. The FL2 histogram should 
be around 0. 
l. In Rainbow Preference Dialog box->decrease or increase the FL4 or FL5 voltage 
settings to see all of the beads ex. 6 clusters 
m. In Rainbow Preference Dialog Box->Adjust compensation to resolve the bead 
clusters if they are too close together. 
4. Shutting Down  
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a. When you are finished, wash the cytometer with water, don’t need the Bleach 
Water 
i. Make sure the cytometer says “Run”. Fill water to top line and flush with 
the cytometer arm open until the line reaches the bottom line. 
ii. Let the cytometer run for 5 min with the arm closed. 
iii. Turn the cytometer to “standby” 
b. Shut down programs, Log off, if you are the last to use the cytometer turn it off 
 
Tips 
c. Press the apple key +1,2,3,4 to see all of the counters and parameters, etc. (also 
found under acquire) 
d. You can always open a previous acquisition file and that will give you the same 
settings in Cell Quest as was used before. Cytometer->instrument settings-
>open->select downstream data file ex. 5-> open->SET!->done 
i. Select a downstream data file because it usually takes the first couple to 
get totally set. 
e. If the cytometer  is “not ready” the buffer and waste containers may need to be 
emptied. 
i. Open the door at the front of the cytometer, click the switch to vent. 
ii. Pull out the waste container and dump down the sink, fill up with 200 ml 
of bleach (located below the sink) to make a 10% Bleach solution when it 
is full up to 2 Liters. 
iii. Unscrew the lid of the storage buffer and refill with buffer (distilled water) 




Cell culture notes  
• Always avoid making bubbles.  Bubbles have very high surface tension and if they come 
into contact with the cells will disrupt the membrane and kill them. 
• To avoid bubbles, always keep your tip submerged and never add all or remove all of the 
liquid when mixing, transferring etc. 
• When you add media to a flask, invert the flask so that you are adding the media to the 
roof.  This will ensure that you do not accidently rinse any of your cells off as well as 
ensure that any bubbles you produce will stick to the roof, rather than floating in the 
media when you turn the flask upright. 
• Centrifuging is very damaging to cells, spinning, the pellet, resuspending, it all causes a 
lot of cell death, so avoid it whenever possible. 
o Ways to avoid it are to let the cells adhere before rinsing them 
o Always use volulmes less than what you need so that media can be added rather 
than having to be removed 
? This is relevant when you are isolating BMMOs, use as little media as 
possible to rinse the bone marrow 
? When passaging, add less media than the amount you will ultimately 
need so that you can add media rather than having to spin. 
• Always be gentle when pipetting cells and use the largest bore hole possible.  This will 
reduce the sheer force applied to the cells that can lyse them. 
• Cells can be very stable even at room temperature, the key is to prevent stark changes in 
temperature.  For example, if your cells are at 37 deg c then you want to add 37 deg C 
media.  If your cells have been in the hood for a long time and are now at room 
temperature, then it is better to add room temperature media. 
• Cells will die in the absence of media almost instantly.  Make sure that you only remove 
the media from a small portion of wells, or even one at a time when you are first learning.  
The cells can take up to a day to die from drying out, so you may not know immediately if 
you let them dry out.  As you get faster, you can remove media from several wells at a 
time, but always be mindful of how quickly the liquid can evaporate. 
• Cells can tolerate, but do not do well in cold media, so avoid this. Though if you want to 
prevent receptor mediated endocytosis, then you can keep your cells at 4 deg C. 
• Cells can survive for at least 2 hours and up to 2 days, depending on the cell type, in PBS 
plus calcium/magnesium. 
• PBS without calcium/magnesium will prevent cells from using their integrins, that keep 
them stuck to the surface 
o This is beneficial if you want to gently remove them from a surface, but if you 
want them to stick, then you must ensure that you have PBS with 
calcium/magnesium. 
• To maintain proper aseptic technique, always make sure your tip never comes in contact 
with anything.  If in doubt get a new one. 
• Always replace lids immediately after adding or removing media.  This will increase your 
sterility as well as prevent you from accidentally adding waste for example into your fresh 
media bottle. 
• Media will lose its shelf life the more it is warmed. If your bottle has a lot of media in it, it 
may be beneficial for you to remove 50 ml and place it into a conical tube.  This way you 
can heat your media faster and can leave your stock at 4 deg C. 
o Another trick is to add cold media to your flask and place your flask in the 
incubator to warm, rather than warming your media and adding it to the flask (i.e. 
for passaging etc). 
• If you are using media out of a 500 ml bottle, you must make sure it is as sterile as 
possible.  If it gets contaminated, everyone’s experiments that use that media will get 
contaminated.  Because of this it should be the last lid removed and the first lid replaced. 
• Try to hold lids facing down when working if possible.  If you must set the lid down, make 
sure the open container and the lid are placed toward the back of the hood and away 
from your arms, as bacteria can fall from your arms as you pass over the top 
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• Also make sure your lids are placed facing upward, as it is the edge of the lid that can 
gather the most contamination. 
• When spraying vessels off with ethanol to place in the hood, make sure the lid gets the 
most attention as that is the area that is most likely to cause contamination. 
• With antibiotics/antimycotics you can get away with bad cell culture technique, but it is 
good to have good practices so that if you cannot use antibiotics that your cells will still 
remain sterile. 
• If something is contaminated, dispose of it immediately and use ethanol and/or bleach to 
wipe down any surface it has come in contact with. 
• Before you begin using cells, you can practice with empty containers and then secondary 
cells before primary cells to ensure you get down proper technique. 
• When you are beginning, you must train yourself to always be AWARE.  Be aware of 
where your tip is, be aware of your hands and arms moving over an open container.   
• Learn to be efficient.  Work smartly and quickly, this will increase the chances your cells 
have of remaining viable. 
• Never be rushed however, when you are rushed, you are more likely to make a mistake. 
• Mistakes can kill your cells and affect your results, and can take weeks and many 
experiments to decipher the problem. 
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Reference: Orme Laboratory Standard Operating Procedure 
Modified: Dolly Holt 03-12-2012 
 
Cell Counting/Viability Using a Hemacytometer 
 
 
Purpose: To define a procedure for proper use of a hemacytometer for obtaining an accurate 
count of cells in a suspension used in laboratory procedures.  A hemacytometer consists of a 
thickened glass slide into which a small chamber has been cut to allow for the introduction of cells 
to be counted.  The floor of the chamber is divided (etched) into nine sections; usually only the 
four corner sections are used in cell counting.  With a coverslip in place each square of the 
hemacytometer represents a total volume of 0.1 mm or 10-4 cm.  1 cm3 is approximately 
equivalent to 1 ml, the cell concentration per ml (and the total number of cells) can be determined. 
(Hemocytometers require special coverslip, it is not good to use “any” coverslip) 
 
Trypan Blue:  Trypan Blue is a dye that enables easy identification of dead cells. Dead cells take 
up the dye and appear blue with uneven cell membranes.  By contrast, living cells repel the dye 
and appear refractile and colorless. 
 
Materials: 
? Hemacytometer and coverslip for Hemacytometer 
? 70% ETOH 
? Kim-wipes 
? Micropipettors and tips 




1) Prepare a hemacytometer for use 
a. Carefully clean all surfaces of the hemacytometer and coverslip using 70% ETOH 
and a Kim-wipe. 
b. Dry with a kim-wipe 
c. Center coverslip on the hemacytometer. 
2) Prepare a cell suspension.   
a. Remove cells from surface of culture dish 
b. Gently mix to create a homogenius suspension 
c. Remove 10 µl of cells and place into a small microfuge tube 
d. Add 10 µl of Trypan blue and gently mix.  
i. This will give you a dilution factor of 2 (see formula below) 
e. Allow mixture to sit for 2-3 minutes to allow absorption of dye, however, cells 
must be observed within 5 minutes or living cells will also take up dye. 
f. If you choose to not use trypan blue, you do not need to account for a dilution 
factor 
3) Pipette 10 µl of the cell suspension (with or without Trypan blue) into one of the two 
counting chambers. 
a. Make sure suspension is well mixed. 
b. Place 10 µl pipette tip into notch at bottom of hemocytometer. 
c. Fill the chambers slowly and steadily, allow capillary action to spread the cell 
suspension over the surface of the hemocytometer. 
d. Avoid injecting bubbles into chambers. 
e. Do not overfill or underfill chambers. (overfilling will raise the coverslip and allow 
cells to migrate giving an inaccurate count). 
4) Count the cells. 
a. Allow cell suspension to settle for at least 10 seconds. 
b. Count the cells in each of the four 1 mm2 corner squares labeled A thru D in 
Figure 1. 
i. DO count the cells touching the top or left borders 
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ii. DO NOT count the cells touching the bottom or right borders. 
5) Determine the cell count. 
a. Calculate the total cells counted in the four corner squares. 
i. if more than 10% of the cells counted appear to be clustered, carefully 
remix the original cell suspension and repeat steps 2 through 4. 
ii. The most reliable concentration of cells to count is 50-100 per A-D 
square. You can dilute or concentrate the cells to get within this range. 
iii. If you are counting bacteria, hemopoeitic cells or other small cells, you 
may use the center square and count 5 of the little squares (down the 
diagonal), average them, multiply them by 25 and you will come up with 
the same area you would have if you averaged the cells in the four 
corners. 
b. Calculate the cell count using the equation: 
i. Cells/ml = (n) x 104 x dilution factor,  
where n = the average cell count per square of the four corner squares 
counted. 
ii. From this number, you can determine total cells in suspension by 
multiplying by the total volume of the suspension. 
6) Percent Viability 
a. Count all cells. (from same squares) 
b. Count unstained cells. (from same squares) 
c. Calculate viability using the equation: 
 
% Cell Viability = number of unstained (living) cells x 100% 























Protocol:  Heat Inactivation of FBS  Name:  Lisa Chamberlain   
Date Entered:  20080527   
Reference(s):  Orme lab protocols 
Modified: Dolly Holt 03-31-2011 
 




• Fetal Bovine Serum (aliquot or bottle) 




1. Thaw FBS (4°C over the weekend is best, but 37°C will work if you are in a hurry) 
2. Heat water bath to 56° C and start it shaking. 
3. Keep an eye on the water bath temperature.  Periodically check the temp (every 5-10 
minutes) with a thermometer.  Adjust temperature setting until it stabilizes at 56° C. 
4. Place FBS in water bath.  If using tubes, support them somehow so they’re not floating (in 
a beaker or a float) 
5. Feel the tubes and when they feel close to 56°C, then start the timer. 
6. Incubate FBS at 56° C for at least 30 minutes. FBS can incubate as long as an hour, but 
this is not necessary. 
7. Label and/or aliquot heat inactivated FBS as HI-FBS and store at -20° C 
 
 
Make sure the temperature is not above 56° C, and that the FBS doesn’t incubate for more than 
an hour.  If the FBS is at high temperature for too long, proteins will denature and fall out of 
solution making the FBS unusable.   
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Protocol:  Immunocytochemistry   
Name:  Dolly Holt   
Date Entered:  03-7-2012   












 (Invitrogen) Ph 7.4 
 Plate shaker 
 Antibodies 
 4% PFA (paraformaldehyde) 
 Goat block 
 
 
Immunocytochemistry staining:  staining for RAW and BMMOs with Ki-67 antibody 
 
 Remove media above cells 




 (Invitrogen) Ph 7.4 
 Add 4% PFA (paraformaldehyde) to cells 
 Incubate for 20 min at room temperature 




  Ph 7.4 
 Add block solution (4% goat serum plus 0.1% triton-X 100, Invitrogen) for 1 hour, RT 
(room temperature), on shaker plate  
 Add primary antibody (diluted in block) incubate for 1 hour, RT, on shaker plate or 4°C 
overnight 
o Overnight provides a slow and controlled binding that will decrease background, 
it is the better option if you have time. 
o Add just enough to cover the well (eg. 50 µl in a 96-well plate) 
 Wash 3X in PBS (15 min soaks if you need to reduce background) 
 Add secondary antibody (diluted in block) for 1 hour, RT, on rocker 
 Counterstain with DAPI (optional) 
 Wash 3X in PBS (15 min soaks if you need to reduce background) 
 Store in PBS at 4°C in dark and/or covered by tinfoil 
 
Primary Antibody 
 Ki-67 1:50 dillution for BMMO and RAWs 
 Primary anti-mouse Ki-67 (IgG1, Novacastra, Buffalo Grove, USA, product No. NCL-L-
Ki67-MM1) obtained from Tresco lab. 
 phospho-histone H3 1:100 for BMMO 
 phospho-histone H3 (Cell Signaling Technology, Danvers, USA) 
 
Secondary Antibody 
 IgG1 goat anti-mouse  1:500 for BMMOs; 1:2000 for RAWs 
 Secondary IgG1 goat-anti-mouse antibody conjugated to Alexa 488 (Invitrogen) 
 
Nuclei Counterstain 
 DAPI: 21,000 NM in PBS (from our stocks made in 2007, normally you use a much lower 
concentration, but I think our stocks were diluted improperly to begin with) 
 4',6-diamidino-2-phenylindole (DAPI, Invitrogen) according to manufacturer’s instructions 
prior to imaging. 
 
 Optimal antibody concentrations (if preconjugated to a fluoriphor is listed as the color) 
 Antibody, color, dilution 
 Primary Antibodies 
o vimentin red 1:50  
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o CD14 red 1:100 
o F4/80 red 1:100 
o CD40 green 1:50 
o CD11b green 1:75-1:100 
o MHC I green 1:100 
o MHC II green 1:100 
o MCP-1 red 1:50 
o MIP-1 alpha not dye conjugated 1:100 
o Col-1 (from HIro) no color 1:100-1:75 
o Alpha-SMA no color 1:1000-1:800 
 Secondary Antibodies 
o IgG (Rabbit) green 1:2000 
o IgG2a (Rabbit) green 1:2000 
 Notes 
o Use the lowest concentration of primary and secondary antibodies possible in 
order to reduce background 
o Obtain secondary antibody from the host species used to create the primary 
antibody 
o Use a serum block from the species from the host used to create the secondary 
antibody 
o Example  
 primary antibody = rabbit antimouse MIP-1alpha 
 secondary antibody = goat anti-rabbit IgG 
 Block serum = goat 
o Blocking in species (host) used to create the secondary antibody is beneficial 
because it will be more likely to not crossreact with its host proteins (because if it 
did, it would create an autoimmune disease) and thus it will reduce the 
nonspecific binding of the secondary antibody. 
o I have heard to use twice the concentration of secondary antibody as primary, 
because there are two binding sites.  However, from my own experience, I have 
needed almost 10X less secondary and primary because of too much 
background caused. 
o H & L means heavy and light chain.  Secondary antibodies will have this 
designation because they will bind all IgGs (IgG1, IgG2a, etc).  H & L is 
convenient because you can use 1 for many applications, however it will increase 
your backround as it is nonspecific.  A IgG1 will be more specific and will 
decrease your background.  However if you don’t have background problems, 
then H&L will be fine for your application. 
o Increasing rinse time will reduce background and nonspecific binding.  This is 
especially important when using H&L secondary antibodies. 
 Controls 
o Always do just a secondary antibody control.  This is to ensure that the signal you 
see is due to the specific primary antibody binding 
o In order to control for non-specific primary antibody binding, you must have an 
isotype control (i.e. an IgG antibody shape that doesn’t recognize anything).  You 
would need an isotype control for each isotype (eg. IgG1, IgG2a, IgG, etc).  You 
also need to make sure this isotype control is from the same host, but has no 
known reactivity.  
 Example: primary rabbit antimouse MIP-1a (IgG).  The isotype control 
would be rabbitt IgG. 
 Look to see if there is nonspecific binding of the rabbitt igG isotype 




Protocol:  L929 culture and conditioned media     
Dolly Holt 03-31-2011   
Reference(s):  Orme lab protocols 
Edited 4/01/03 JMH 
Modified by MGJ 03-18-04 
Modified by DJH 02-06-12 
 
 
L-929 (CCL-1) Fibroblast Support Protocol: 
Initiation of Cell Line 
 
Purpose: To define an SOP for preparation of L-929 cells.  L-929 cells secrete growth factors 
needed for macrophage growth (M-CSF/GM-CSF).  The supernatant of L-929 cells is used for L-
929 conditioned media.  
 




 Cryovial of ATCC L929 fibroblasts, or from our liquid nitrogen stocks 
o Make sure to cross off the vial of cells you remove from the stocks list 
o Also if there are less than 3 vials of cells, it is your responsibility to make 
more frozen stocks using the vial you remove. 
 Complete RPMI Media = RMPI Medium 1640 (+ L-glutamine) with 10% HI FBS and 
1% antibiotic/antimycotic 
 1 T75-cm2 tissue culture flask 
 Clean 37oC water bath 
 Pipettman and Pipettes 
 Pipette-box 




1) Add complete RPMI media T75 and place into incubator for 10 min to reach 37 deg C  
2) Thaw one cryovial of cells at a time by dipping bottom ¾ of cryovial in a 37
o
C water bath 
and swirl gently for 1-2 minutes until thawed (>3 minutes may damage cells). 
3) Wipe cryovial dry then and rinse with 70% Ethanol, note the color of the solution. (ideally, 
it should be pink) 
4) In a clean hood gently resuspend the cells in the cryovial before transfer. Add fresh media 
to the cryovial to rinse and remove any remaining cells 
5) In a clean hood, do one of the following: 
a. Transfer thawed cells into a T75-cm
2
 tissue culture flasks containing 10 ml of pre-
warmed RPMI medium (prepared in step 1).  Gently rock flask to disperse cells.   
i. Allow the cells to adhere for a couple of hours, then replace the media 
with fresh pre-warmed complete RPMI media to remove residual DMSO 
b. Transfer thawed cells to a conical tube filled with 10 ml of 37
o
C complete RPMI 
media. Gently resuspend.   
i. Centrifuge at 500 rcf for 5 min.   
ii. Remove supernatant, be careful not to disrupt the cell pellet.   
iii. Pull 5 ml of RPMI media from the T-75 flask (prepared in step 1) and add 
to the conical tube and resuspend the pellet.  Then transfer all of the 
contents of the conical tube into the T-75 flask.  
 
6) Place culture flask in 37
o
C incubator with 5% CO2, 90% Humidity 
 
7) Change the media every 2-3 days after that while examining them daily.  Continue 
feeding cells until 80% confluent. 
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*Removal/addition of media is done on the roof of the flask as opposed to directly on top 
of cells to avoid damage to cells.  This is done by turning the flask upside down and 
adding the media.  This will also serve to leave any bubbles on the roof, rather than in 
contact with the cells, as bubbles can disrupt cell membranes.    
 
8) Clean hood with 70% ETOH when finished. 
 
9) Replace media every 2-3 days until 90% 
confluent 
 
10) Cells need to be passaged after they are 90% confluent 
a. Remove media 
b. Rinse cells with calcium/magnesium-free PBS (optional, this will just speed up 
the process) 
c. Add just enough TryplE to cover the cells (3 ml for T-75) 
d. Place T-75 on scope and when cells begin to ball-up, remove 2 ml o f TrypleE 
(optional, you can leave all 3 mls, but it may be healthier for cells to remove any 
excess). 
i. You can also place flask in incubator for 3-5 min to speed the 
detachment process 
e. Once cells have detached, add an equal volume of complete media (media with 
FBS,  FBS has anti-trypsin which will stop the action of the trypsin enzyme) 
f. Using a 5 ml pipette, rinse the bottom of the flask with the media to remove cells 
(be careful to avoid creating bubbles). 
g. Place 10% of the volume of cells to a new flask and add sufficient complete RPMI 
media (eg. enough media to bring the volume to 10 ml in a T75 flask).  Cells will 
become confluent in 3-4 days. 
 
Conditioned media 
11) After the cells are 80% confluent, they can be passaged and expanded in several T-150 
flasks.  10 T-150s is a good number of conditioned media stocks. 
 
12) Add 49 ml of complete RPMI media to 10 T-150 and place in incubator to pre-warm. 
 
13) Add 1 ml of cell suspension (from passaging) to each of the 10 T-150 flasks. 
 
14) Allow cells to grow for 3 days after they become confluent.  Do not replace media. 
a. L-929 cells from ATCC are grown up at 4.7x10
5
 cells total.   
 
15)  After the time required for step 14, collect the supernatant, centrifuge supernatant for 10 
minutes, 1000 rpm, at 4
o
C or filter through a 0.45 ųm Nalgene filter (Filtering will take out 
any small celluar debris and is best, but if no filter is available, centrifuging will remove 
any contaminating viable cells) 
16) Freeze at –20
o
C in 50 ml aliquots. 
 
**Do not fill the TC flacks above neck line with media, can cause contamination issues.  
If cells are: Then feed them: 
< 25% confluence 1 ml per 5 cm
2 
25-45% confluence 1.5 ml per 5 cm
2 




Protocol:  Long-lived intracellular stains     
Dolly Holt 
Date Entered:  03-7-2012 
Cell Trace Far red taken from Invitrogen tech support   
 
green Vybrant® CFDA SE Cell Tracer Kit 
• Used according to manufacturer’s instructions 
Cell Trace Far Red 
• Prepare a stock solution (1-10 mM in DMSO) 
o Add 9.89 µl DMSO to 1 vial of Red cell tracer 
• Working concentration 
o Dilute stock solution in PBS (or media without phenol red) 
• Add working concentration to cells and incubate cells for 30 minutes at 37 °C 
• Wash 2X in PBS 
• Use no greater concentration than 1 million cells in 1 ml of working concentration of Red 
cell tracer) 
• Green dye gets into nucleus, red dye doesn’t 
• Both dyes in stock solution remain stable when frozen for several months without needing 
to create new stock solutions 
• Ideal dye concentrations 
o Secondary 3T3 fibroblasts 
? 10 µM Red 
? 10 µM Green 
o Secondary RAW 264.7 macrophages 
? 7 µM Red (though this is dim, it is cytotoxic to increase the concentration) 
? 5 µM Green 
o Ideal fusion conditions for secondary cells 
? 10,000 RAWs and 20,000 3T3s per well of 96-well plate 
o Primary Fibroblasts 
? 3 µM Red 
? 7 µM Green for co-culture 
? 10 µM Green when need it to last a long time in monoculture 
o Primary Macrophages 
? 3 µM Red 
? 5 µM Green for co-culture 
? 10 µM Green when need it to last a long time in monoculture 
o Get the greatest cell viability when cells are seeded in a small enough dish to 
stain while adherent and then passaged after staining, rather than in suspension.   
? Even 100 mm Petri dishes only require 3 ml of dye solution 
o 10 µM = 1 µl of dye stock in 1000 µl 
o 7 µM =0 .7 µl of dye stock in 1000 µl 
o 5 µM = 0.5 µl of dye stock in 1000 µl 
o 3 µM = 0.3 µl of dye stock in 1000 µl 
• At the end of the experiments cells were fixed in 4% paraformaldehyde for 20 minutes at 
room temperature 




Protocol:  Mouse Sacrifice    
Dolly Holt 
Date Entered:  June 2, 2008   





To use this protocol you must: 
• Be listed on an IACUC protocol for mouse sacrifice (or be supervised by someone who is) 
• Have access to animal facility of BPRB with fingerprint and authorized University Card (or 
be supervised by someone who is) 
• Be wearing long pants and closed-toed shoes 
 
You will need: 
• Small black plastic trash bag from cleaning closet (west side of hallway in animal facility) 
• Mice in the animal facility under your IACUC protocol number 
• Any supplies necessary for further dissection/collection at necropsy prepared and ready  
 
1. Mice are held in a clean room (passcode is 1-2-3-4-5 or hold card on reader until turns 
until it turns green) 
o Put on a lab coat (on hook of door, or if none available on cart in hall) and gloves 
(on cart), step soles of both shoes into sanitizing bucket before entering. 
o If using all mice in a cage, proceed to dirty room (dish room, passcode 1-2-3-4-5, 
step 2) for sacrifice.  If using less than the number of mice in a cage (5): 
? Prepare a new cage (from components on the side of the laminar flow 
hood) 
? Place cage of mice (labeled with your IACUC protocol number) in laminar 
flow hood, and transfer required number of mice to new cage.   
? Replace labeled cage to racks. 
? Exit the room with your mice and put the lab coat back on its hook. 
2. Enter the Dirty Room (Third room down from the entrance, passcode is 1-2-3-4-5) 
o Place the container with the mice near the sink and prep the CO2 chamber 
o The CO2 chamber is located against the wall next to the sink 
o The star-shaped valve should already be turned on. Turn the smallest valve 
located nearest to the hose until you can barely hear air flowing.   
o Allow the CO2 to run for 5 minutes and then turn the gas off.  
o Allow the CO2 to settle for 5 minutes. This creates a 1-2 inch layer of 95% CO2, 
and will allow for faster, more humane killing of the mice. 
o Gently transfer mice one at a time into the CO2 chamber ( try not to disrupt the 
CO2 layer) 
o Allow the mice to remain in contact with the CO2 for at least 2-3 minutes (Mice 
should become unconscious within the first 20 seconds, but will show signs of 
gasping). 
o One minute after mice stop gasping, pinch their tail to ensure they are dead. 
Once mice are dead, place them in the black garbage bag and bring to lab where 































































































































The Yan Lab by Mei Zhang   
7/17/2012 
Obtained from Dorthyann Isackson 
 
Oil Red O Staining for Cultured Cells 
 
1. Culture and treat cultured cells in tissue culture plate as needed (see other protocols). 
2. Take the plate (35-mm) out of incubator and remove the medium.  
3. Add ~2 ml of PBS to wash the cells and remove PBS completely. 
4. Add 2 ml of 10% formalin (RT) and incubate for 10 min at RT. 
5. Discard formalin and add 2 ml fresh formalin. Incubate for at least 1 hour, or longer (Cells 
can be kept in formalin for a couple of days before staining. Wrap with parafilm and cover 
with aluminum foil to prevent cells from drying). 
6. Remove formalin with a pipette. 
7. Wash cells with 2 ml of ddH2O twice. 
8. Wash cells with 2 ml of 60% isopropanol for 5 min at RT. 
9. Let the cells dry completely at RT. If possible, use a hairdryer to dry. 
10. Add 1 ml of Oil Red O working solution and incubate at RT for 10-20 min. 
11. Remove Oil Red O solution and immediately add ddH2O. Wash the cells 4 times with 
ddH2O. 
12. Acquire images under the microscope for analysis. 
13. Remove all the water and let dry. 
14. Elute Oil Red O dye by adding 1 ml of 100% isopropanol and incubate for 10 min with 
gently shaking. 
15. Pipet the isopropanol with Oil Red O up and down several times to ensure that all Oil Red 
O is in the solution. 
16. Transfer the solution to a 1.5-ml eppendorf tube. 
17. Measure OD at 500 nm using100% isopropanol as blank. 
 
Reagents 
1. Oil Red O Stock: Sigma (Cat# O-0625), FW 408.5. Weigh 0.35 g Oil Red O and put in 
100 ml of isopropanol. Stir O/N, filter (0.2 µ) and store at RT. 
2. Oil Red O Working Solution: Mix 6 ml of Oil Red O stock solution with 4 ml of ddH2O. Let 
sit at room temp for 20 min followed by filtering (0.2 µ). 
3. 10% Formalin in PBS: Dilute 27 ml of formalin stock solution (37%, Merck, Cat# 
K36658003) in 63 ml of ddH2O and 10 ml of 10X PBS.  
4. 100% Isopropanol (Merck, Cat# K36543834 ) 
5. 60% Isopropanol: Mix 6 ml of 100% Isopropanol with 4 ml of ddH2O.  
 
Summary 
Sudan III, Oil red O and Sudan black are lysochromes (fat soluble dye) predominantly used for 
demonstrating triglycerides in frozen sections. Oil Red O has largely replaced sudan III and sudan 
IV as it is much deeper red in color, and consequently more clearly visible. 
 
Originally written by Lenka Janderova          
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Protocol:  Primary Fibroblast Harvest   
Dolly Holt 
Date Entered:  03-7-2012   
Reference(s):  Diaz M, Watson NB, Turkington G, Verkoczy LK, Klinman NR, McGregor WG. 
Decreased frequency and highly aberrant spectrum of ultraviolet-induced mutations in the hprt 
gene of mouse fibroblasts expressing antisense RNA to DNA polymerase zeta.  Mol Cancer Res. 
2003 Sep;1(11):836-47 
 
Primary fibroblast media 
• 10% FBS 
• 1% antibiotic/antimycotic 
• 1% HEPES 
• 1% Sodium Pyruvate 
• 1% MEMs nonessential amino acids 
 
Primary fibroblast isolation 
• Prepare two 30 mm Petri dishes: 1 with 70% ethanol and 1 with sterile PBS 
o Remove mouse ears  
o Snip mouse ears before long-hair begins 
o Dip in 70% ethanol for 1-5 min 
o Wash in sterile PBS 
• Use the lid or the base of a 30 mm Petri dish for each set of mouse ears (2 ears per 
mouse) 
• Sterilize a razor blade by soaking in 70% ethanol and rinsing with PBS. To be extra 
cautions, spray with ethanol and UV in hood for 20 minutes on each side (though with just 
soaking in ethanol and rinsing with PBS, I never had contamination issues). 
• Take autoclaved forceps and sterilized razor blade and mince ears into as small of pieces 
possible.  Note: the number of fibroblasts obtained will be directly proportional to how 
small of pieces you mince at this stage. 
o Incubate minced tissue in 4 mg/ml collagenase Type I (though probably, most 
collagenases will work, eg Type IV works) in incomplete DMEM for 2 hours in 
37°C shaking water bath. 
o Use 2-3 ml of collagenase solution per set of ears 
• After the incubation period disperse cells with sterile pipette, or vortex briefly  
• Filter cells with 70 µm filter to remove debris.  Add 3 ml complete media to wash filter to 
ensure all cells are obtained. 
• Collect filtrate and spin at 500X g (rcf) for 5 min 
• Aspirate media 
• Resuspend pellet in pre-warmed DMEM with 10% FBS and 1% Penn/strep and fugazone 
(antibiotic/antimycotic). 
• Plate cells in DMEM with 10% FBS and 1% Penn/strep and fugazone, 1% HEPES, 1% 
Non essential MEMs, and 1% NaPyruvate 
o Can plate cells in a T75 flask to be confluent in 6-7 days or in a T25 flask or 6-
well plate to be confluent in 3 days. 
• Next day, change media to remove non-adherent debris 
• For co-culture with BMMOs, 1X10^7 BMMOs to 100 mm Petri dish to ensure 80% 
confluency by day 7, so that both cell types can be placed into an experiment by day 7. 
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Protocol:  3T3 cell culture   
Date Entered:  03-7-2012 
Name:  Dolly Holt   
 
• Complete Media 
o DMEM high glucose + L glutamine 
o + 10% FBS 
o + 1% antibiotic/antimycotic 
• Place 10 ml of complete media  in a T75 flask and place in incubator to prewarm for 10 
min 
o Spray with 70% ethanol and place in sterile hood 
• Thaw a cryovial of RAW 264.7 cells in a 37 °C water bath (this will only take a couple of 
minutes) 
• When the vial is nearly thawed, remove from water bath, dry off, spray with 70% ethanol 
and place in hood. 
• Using a 5 ml pipette, transfer contents of vial into T75 
• Remove some of the media in the T75 and add it to the cryovial to remove any residual 
cells 
o Repeate this a couple of times until you feel you have removed all of the cells 
• Place T75 in incubator and allow cells to adhere (~2 hours or less) 
• After cells have adhered, prewarm complete media and replace media above cells (add 
15-20 mls) 
o The purpose of this is to remove residual DMSO that was in the frozen cells 
• Replace T75 in incubator 
• Cells will take 3-4 days to reach confluency 
• These cells are highly metabolically active and their media will turn acidic very quickly.  
Keep a close eye on them to either passage or replace their media every few days. 
Passaging 
• When cells are 80% confluent they need to be passaged 
o This occurs when what appears to only be 20% of the area of the T75 is still 
available for cell growth 
• RAws are not contact inhibited, so they will begin to grow over the top of one another if 
they become more than 100% confluent. 
o Once they begin to grow on top of one another, they may change their 
phenotype, so it is important to keep a close watch on these cultures 
• These cells only need to be scraped to be passaged 
• Spray T75 flask and rubber scraper and place in hood 
• Scrape of the bottom of the flask, much like you would with a squeegee on a car window.  
Hold the flask at an angle and you should be able to see where the flask turns clear after 
the cells have been removed.  This way you can ensure you’ve gotten them all.  Keep the 
bottom of the scraper flat and move gently to avoid creating bubbles. 
• Use a 5-10 ml pipette to gently mix the cells, and transfer 10% into a new flask.  You can 
use the remaining cells for experimentation. 
• Place T 75 in 37 °C incubator with 5% supplemental carbon dioxide 




   
 
 
Protocol:  Senescence and BCA Assays   
Name:  Dolly Holt   












  Ph 7.4 
 Plate shaker 
 70% glycerol in DI water  
 Respective assay components 
 
Senescence and BCA Assays for macrophages:  Qualitative and quantitative SA beta-gal assays 
 
Colorimetric Senescence Assay 
 A colorimetric assay for senescence-associated beta-galactosidase (SA beta-gal) used 
as a labeling kit (Cell Signaling Technology, Danvers, USA) was used according to 
manufacturer’s instructions [1].  
 This commonly employed assay [2] labels fixed cells positive for SA beta-gal with a blue 
precipitate and allows for subsequent visualization of percent positive cells (imaging 
described below). 
 Add just enough senescence stain to cover the well (eg 50 µl per well of a 96 well plate) 
 Fresh senescence stain should be made prior to each experiment 
 Incubate samples at 37°C for 24 hours and stain was removed 
 Store samples in 70% glycerol in DI water at  4°C  
 
Quantitative fluorescence-based SA beta-gal assay 
 A second quantitative fluorescence-based SA beta-gal assay, was employed according to 
a previously established protocol [2] and requires cell lysis and subsequently measures 
the relative fluorescence of total SA beta-gal in the culture well, rather than distinct of SA-
positive cells. 
 Samples were obtained and stored at at 4°C until all samples were collected 
 Samples were thawed and vortexed vigorously for 30 sec 
 Samples were centrifuged for 5 min at 20,000 rcf at 4°C 
 50 µl of supernatant was added to 50 µl of reaction buffer (according to the protocol 
referenced above). 
 Samples were then incubated for 3 hours at 37°C 
 Plates were read on the Biotech plate reader 
o Excitation 360 nm, emission 465 µs, integration, gain 46 
o Protocol is listed under Dolly’s protocols and is entitled “Senescence” 
 Normalized fluorescence divided by total protein in µg of cells in each well 
 Control used was the lysis buffer (from protocol referenced above) + reaction buffer 
 Important: stop solution for senescence assay is not required, you actually get more 
accurate readings, but you must read it on the plate reader shortly after completing the 




 Cell density was approximated using cell-derived protein content from each culture well 
detected by the microBCA assay (Pierce Thermo Scientific, USA) used according to 
manufacturer’s instructions. 
 Samples were thawed, vortexed, and centrifuged along with those samples used in the 
quantitative senescence assay described above. 




  = 150 µl of diluted lysate 
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 150 µl of diluted lysate was added to 150 µl of working reagent (described in 
manufacturer’s instructions for BCA assay) 
 Plate was added to shaker plate for 30 seconds 
 Plate was covered and incubated at 37°C for 2 hours 
 Plate was allowed to cool to room temperature 





1. Severino J, Allen RG, Balin S, Balin A, Cristofalo VJ. Is beta-galactosidase staining a 
marker of senescence in vitro and in vivo? Exp Cell Res 2000 May 25;257(1):162-171. 
2. Gary RK, Kindell SM. Quantitative assay of senescence-associated beta-galactosidase 






Modified: Dolly Holt 
SOP:  WEASEL 
 
Analyses of the CBA-data measured with a flow cytometer (FacScan, Becton Dickinson) 
• Open WEASEL (unlicensed) (just click okay when it asks you to register) 
• Drag first file into open space 
• Move file over to the right using arrows 
• Minimize that window 
• Display->dot plot 
• Select FL 4 –X-axis vs. FL 5 –Y-axis->enter or okay or whatever 
• Enlarge chart/graphic. You should see dot clusters on the right upper side of the graphic 
that represent the beads of different cytokines. The position of the different cytokine 
clusters is noted on the bead vials. 
• ex. Cytokine X: B7 
• A9 is located in the upper right-hand corner, the numbers go from right to left in 
descending order and the letters go from top to bottom in ascending order 
• Ex. A5 A6 A7 A8 A9 
     B5  B6 B7 B8 B9 
     C5  C6 C7 C8 C9 







• Right click on dot plot->create region->draw region, name region, say okay 
• Draw a polygon around the clusters with the mouse by clicking to start and finish 
a line creating a circle 
• If there is an error, just start again by clicking on the “start again” 
• Determine region for every cytokine 
• Right click on dot plot->gates->create a gate->select the region you just created->say 
okay 
• Display->Histogram->select first file in sequence 
• Deselect all parameters expect FL 2 – X-axis versus count y-axis 
• Ok 
• Right click on histogram->select gates->select gate you made for the region you created 
• Look to make sure the histogram changes to be smaller when you gate it 
• Right click on histogram->set stats list-> check 1) cells, 2) mean, and 3) Read all files in 
sequence->okay 
• The statistics should appear underneath the histogram and should list all of the 
files for the CBA in a column 
• The cell # represents how many beads were counted for each sample 
• You can now copy the statistics into excell 
• Repeat for all cytokine bead clusters. 
• Hint: It is better to do one cytokine at the time if you have a large amount of data. 




Lisa Chamberlain 05/08/2007 (reference ATCC website 2007) modified by Dolly Holt 03-31-2011  
 
Thawing/Bringing Up Cells 
Components: 
• Complete media for cell line being thawed 
• New flask  
• Centrifuge Tubes  
• Centrifuge 
• Hood and Incubator 
All cell culture reagents and tools should be sterilized before placing them into the hood or 
incubator!!!!  All steps should be performed using sterile technique!!!!  If you don’t know sterile 
technique, find someone who does to show you before attempting!!!! 
1. Warm media to 37° C by placing in the water bath.  This should take approximately 10-20 
minutes.   
2. Dry media bottle, spray with 70% ethanol and place in the hood. 
3. Place approximately 5 mL of media into a 15mL centrifuge tube. 
4. Remove stock of cell line from liquid nitrogen and place in 37° C water bath, watch 
carefully and do not allow water to touch cap/threads of tube.   
5. Once thawed, remove from water bath, and dry.  Spray liberally with 70% ethanol before 
bringing into hood. 
6. Open cell stock and transfer content into tube of media. 
7. Centrifuge cells at 500 rcf (g) for 5 minutes to pellet, aspirate supernatant.   
8. Re-suspend pellet in complete media and transfer to flask. 
9. For sensitive cells, change media once cells are adherent (overnight) to remove any 
residual DMSO. 
10. You will mark the passage number on the flask as the same number as is on the tube. 
11. Don’t forget to mark the removal of your stocks from the liquid nitrogen inventory! 
 
*RAW 264.7 cells and NIH 3T3 cells are not very sensitive to DMSO.  In the case of these cells, 
place warmed media into the T75 flask and as soon as the cells are thawed you can place them 
into the flask.  You can change the media once they are adherent, but this isn’t necessary, they 
usually do just fine. 
Freezing Cells for New Stocks 
Components: 
• Flask of cells at about 80% confluence 
• Freezing solution:  90% FBS, 10% DMSO (should be in freezer) 
• Freezing tubes (screw-on 2mL tubes, in drawers opposite hood) 
All cell culture reagents and tools should be sterilized before placing them into the hood or 
incubator!!!!  All steps should be performed using sterile technique!!!!  If you don’t know sterile 
technique, find someone who does to show you before attempting!!!! 
1. Place FBS/DMSO solution in water bath to thaw.  Vortex before use. 
2. Remove cells from flask, count and spin down (500g for 5 minutes). 
3. Decant supernatant and re-suspend cells in freezing solution, and aliquot into freezing 
tubes 
4. Add at least 20% of your T75 flask to each freezer stock, as about half of them may die 
and 10% will be needed to repopulate the flask once thawed.  You can make 3-5 vials 
from a single T75 flask depending how confluent your flask is and if they are primary 
cells, you will want to make only 3 vials, as more cells will likely die in the freezing 
process. 
5. Label the cells with the passage number they will be once thawed and plated.  For 
example if you just removed cells from the surface of a passage 3, and once replated will 
be a passage 4, you will label the freezer tube “passage 4”.   
6. Place freezing tubes in nunc rate freezer container, secure lid and leave overnight in -80° 
C freezer 
7. Remove stocks from freezer, place in liquid nitrogen. 
8. Add your new stocks to the liquid nitrogen inventory. 
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